Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.8098077381655818,-2.0344850579042224,0.0,0.04629676340653085,0.038,6/11,13.20%,ITPR1;TRPC3;ITPR3;TRPC6;ITPR2;TRPC4
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7917605128470101,-1.9974393993273172,0.0,0.04682286299069597,0.078,5/11,9.89%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1
prerank,calcium-release channel activity (GO:0015278),-0.6645101279821701,-1.986831849691378,0.004081632653061225,0.038229903115998956,0.096,6/17,10.39%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1;ITPR2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7266100878307953,-1.93883707229955,0.0,0.057081804881915874,0.181,6/14,9.01%,SLC7A11;SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,solute:sodium symporter activity (GO:0015370),0.8019290871300695,1.9059224848667673,0.0,0.01776391914428974,0.014,5/27,3.52%,SLC4A10;SLC4A4;SLC5A6;SLC5A2;SLC4A8
prerank,metalloendopeptidase activity (GO:0004222),0.6543520909678329,1.832510440179675,0.0,0.07154911877561146,0.117,13/76,6.79%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;ADAM9;ADAMTSL1;ECE1;ADAMTS10;MMP28;ADAM10;SPG7;MMP14
prerank,chloride transmembrane transporter activity (GO:0015108),0.8236043215037331,1.8307345910761887,0.0,0.04901525837961429,0.12,4/16,3.52%,SLC26A7;SLC26A2;SLC26A6;SLC4A8
prerank,retinoid binding (GO:0005501),-0.6012022539182109,-1.8124022042683448,0.0,0.15467327774454623,0.475,5/22,2.50%,ALDH1A2;NR2F2;PTGDS;RBP4;CYP26B1
prerank,platelet-derived growth factor binding (GO:0048407),0.8818747734094794,1.778026845919424,0.0,0.11571219553710956,0.324,4/11,1.32%,COL6A1;COL3A1;COL1A2;COL1A1
prerank,cAMP binding (GO:0030552),-0.7053639914896844,-1.7740390021092467,0.013745704467353952,0.1857131532102885,0.612,5/11,10.27%,RAPGEF4;PDE4D;RAPGEF2;PDE2A;PDE4B
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7250936347205859,-1.7701011317572575,0.012461059190031152,0.16474432692713573,0.623,3/10,2.06%,SLC6A13;SLC6A1;SLC6A12
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5901322912568235,-1.750711284679249,0.023809523809523808,0.17308676319032557,0.69,7/19,10.00%,ITPR1;RYR2;ITPR3;GRIN2B;RASA3;MCOLN1;GRIN2A
prerank,metallopeptidase activity (GO:0008237),0.6040179022932906,1.7464420087860626,0.0,0.1648096942831326,0.499,17/113,6.79%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;BMP1;ADAM9;ADAMTSL1;ECE1;ADAM30;PAPPA;PSMD7;ADAMTS10;MMP28;ADAM10;SPG7;MMP14
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7888003967874752,1.7369457128027006,0.003952569169960474,0.1643162520846801,0.562,5/15,5.65%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;SLC4A11
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6214142229025184,-1.7317247975361882,0.007905138339920948,0.17571726111115116,0.733,6/15,11.01%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.6606067125164521,-1.7263775242864046,0.01098901098901099,0.16582658892884686,0.75,4/12,11.79%,DUSP16;DUSP10;DUSP3;DUSP6
prerank,sulfate transmembrane transporter activity (GO:0015116),0.7962907878164767,1.7259913869865704,0.005277044854881266,0.17016706672347395,0.635,3/14,2.98%,SLC26A7;SLC26A2;SLC26A6
prerank,intracellular chloride channel activity (GO:0061778),-0.6262397352854718,-1.7185171336126712,0.008438818565400843,0.1467817839820694,0.775,8/16,16.27%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6262397352854718,-1.7185171336126712,0.008438818565400843,0.1467817839820694,0.775,8/16,16.27%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6797756329311418,1.7153820305068055,0.004842615012106538,0.17899615748864176,0.699,9/32,9.01%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SFXN3;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,anion:anion antiporter activity (GO:0015301),0.759930735403196,1.695205982095162,0.005188067444876783,0.21810145171600182,0.812,7/17,15.62%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7987581094528983,1.6636932585127637,0.005681818181818182,0.30701973587714104,0.926,3/11,2.03%,SLC23A1;SLC23A2;SLC5A2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5589356621785094,-1.662167540908851,0.024793388429752067,0.20736417455862244,0.893,7/18,11.01%,ALDH1A2;ALDH1A1;FAR2;ALDH6A1;HSD17B12;ALDH2;ALDH9A1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.62524897158466,-1.6434424885010765,0.03018867924528302,0.22005994034792584,0.922,6/13,11.01%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6303692001412157,-1.636141347052575,0.03508771929824561,0.21626200239747664,0.931,8/12,14.78%,PDE8B;PDE7B;PDE4D;PDE2A;PDE4B;PDE8A;PDE1B;PDE4C
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6031942797285087,1.6255378328323515,0.0011325028312570782,0.45647889195023333,0.988,10/55,7.05%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;ABCC1;SLC25A32;SLC38A3
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5985158244230812,1.5964414392096415,0.01048951048951049,0.5890055042194589,0.998,8/47,7.48%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7358941500858898,1.5918048207898283,0.015068493150684932,0.5721652076517597,0.999,4/15,14.43%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,gated channel activity (GO:0022836),0.721911827651711,1.5912244705759442,0.03125,0.5346093761519579,0.999,3/14,7.38%,PIEZO2;TMEM266;TMC8
prerank,chemorepellent activity (GO:0045499),-0.5075930511186564,-1.5892152289581558,0.019230769230769232,0.27692566861491674,0.972,7/25,3.43%,SEMA6A;DPP4;EPHA7;SEMA3D;SEMA7A;NRG3;SEMA5A
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5431432434485817,1.571704049524545,0.0020512820512820513,0.6164079943068541,1.0,18/134,5.92%,SLC38A2;SLC38A1;SLC26A7;SLC26A2;SLC23A1;SLC23A2;SLC5A6;SLCO3A1;SLCO2A1;SLC16A1;SLC26A6;SLC38A6;SLC4A8;SLC1A5;ABCC1;SFXN3;SLC4A11;SLC25A32
prerank,symporter activity (GO:0015293),0.7979540408503617,1.5701186584267013,0.013177159590043924,0.5871345358836599,1.0,3/10,7.53%,SLC4A4;SLC5A6;SLC28A2
prerank,diacylglycerol kinase activity (GO:0004143),-0.6147922774873417,-1.568203732563625,0.04472843450479233,0.2956679663007992,0.983,7/11,14.57%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,R-SMAD binding (GO:0070412),0.6974418308778022,1.5641475353372356,0.040207522697795074,0.5864415398549508,1.0,5/18,6.33%,PMEPA1;DDX5;SMAD6;LDLRAD4;SMAD4
prerank,mechanosensitive ion channel activity (GO:0008381),0.7280487723941576,1.5542759127062038,0.03591160220994475,0.6128552104779961,1.0,2/12,7.38%,PIEZO2;TMC8
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.67386074365145,1.5477078246003662,0.0258732212160414,0.6197634012563309,1.0,9/20,18.25%,DLG2;MAGI3;AK3;AK6;DLG1;DTYMK;AK1;LRGUK;MPP1
prerank,ankyrin binding (GO:0030506),-0.5199095615976734,-1.5454536025261492,0.04128440366972477,0.31793951536378945,0.994,5/19,9.29%,SLC8A1;CACNA1D;CDH1;KCNQ2;FLNC
prerank,chemoattractant activity (GO:0042056),0.6517009285824944,1.5424119853376173,0.017632241813602016,0.6199114339158667,1.0,6/26,9.70%,PGF;VEGFA;FGF2;CCL15;HMGB1;BMP4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.6366580583369426,1.540439357515307,0.017964071856287425,0.6016235261513155,1.0,4/29,3.80%,SLC26A7;SLC26A2;SLC26A6;SLC1A5
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.6182948548218556,1.5325910519894939,0.027710843373493974,0.6179242076075535,1.0,3/31,1.20%,KCNK5;SLC12A7;SLC12A2
prerank,aspartic-type peptidase activity (GO:0070001),0.7510708692493171,1.5305672302104332,0.028409090909090908,0.6016991259912441,1.0,4/10,17.80%,BACE2;DDI2;BACE1;NAPSA
prerank,BMP binding (GO:0036122),-0.6024735885500825,-1.5252564189521722,0.05387205387205387,0.3416324562857521,0.996,3/11,9.14%,ENG;GREM2;BMPR2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5692962443415379,1.5174942187585652,0.018411967779056387,0.6514259423236992,1.0,9/53,9.01%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6271314007416008,1.513115859895077,0.0364963503649635,0.6511858004537857,1.0,5/27,5.65%,SLC26A7;SLC26A2;SLC39A14;SLC26A6;SLC4A11
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.6116490104042231,-1.494631627228219,0.05985915492957746,0.3688208608609021,0.999,3/10,11.79%,DUSP16;DUSP10;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.6116490104042231,-1.494631627228219,0.05985915492957746,0.3688208608609021,0.999,3/10,11.79%,DUSP16;DUSP10;DUSP6
prerank,endopeptidase activity (GO:0004175),0.5031068748859463,1.4912932742032772,0.0,0.7595214146949524,1.0,76/257,24.22%,ADAMTSL3;ADAMTS3;ADAMTS17;HTRA3;ADAMTS2;TRABD2B;PCSK5;F3;HTRA4;ADAM9;ADAMTSL1;ECE1;PRSS38;PRSS12;FAP;USP24;ADAMTS10;USP2;PSMA8;PRSS53;MMP28;ADAM10;SPG7;MMP14;BACE2;TASP1;CLPP;MBTPS1;DDI2;BACE1;PSMA4;USP40;PDIA3;RHBDL3;ADAMTS6;USP48;ADAMTS20;USP34;USP11;PSMA6;MMP16;USP7;CASP1;USP33;USP36;NLN;USP13;PSEN2;HGF;USP35;IDE;PRSS36;PCSK7;NAPSA;TPP2;USP10;USP46;USP1;RHBDD3;CTSZ;PSMA3;UCHL1;USP5;CTSB;PSMB1;SENP1;USP47;CTSK;CTSO;MMP2;PSMA5;AFG3L2;PSMA7;USP49;PHEX;USP14
prerank,O-acyltransferase activity (GO:0008374),0.5978648461117596,1.4901969234482935,0.05055487053020962,0.7383722852547264,1.0,8/30,10.45%,PLA2G4A;SOAT1;PIGW;LPCAT1;MBOAT2;LPCAT4;GPAT4;LPCAT3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.7084596170163411,1.486619702653967,0.047683923705722074,0.7351231380802601,1.0,5/12,12.68%,CRYZ;AKR1C1;CBR4;DHRS4;NDUFS7
prerank,hyaluronic acid binding (GO:0005540),-0.58314207682657,-1.4774380033615548,0.0782312925170068,0.3877353935296958,0.999,4/10,16.29%,CEMIP;LAYN;HYAL2;CD44
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.5768281430018245,1.4737134664499025,0.030915576694411414,0.7899499139777736,1.0,19/40,24.80%,PRMT8;PEMT;TPMT;LRTOMT;TARBP1;NNMT;LCMT1;HNMT;CARNMT1;THUMPD3;GNMT;PCMT1;ARMT1;SUV39H1;FBL;ASMT;METTL8;METTL9;DNMT1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5541933358343417,1.472804546756437,0.025433526011560695,0.7691448028011822,1.0,12/48,13.39%,PIEZO2;SLC12A7;SLC12A2;SLC4A11;CALHM6;CALHM5;SLC12A4;TRPM7;TRPM4;TMEM165;TRPM6;ATP6V1B2
prerank,glutamate receptor activity (GO:0008066),-0.5063660702866323,-1.4688092187050699,0.05019305019305019,0.3893136922821912,0.999,9/19,7.74%,GRM7;GRM5;GRM3;GRIA1;GRM8;GRID2;GRM1;GRIK2;GRIA4
prerank,solute:anion antiporter activity (GO:0140323),0.6856681757356311,1.4668012695026964,0.06557377049180328,0.7823764818818363,1.0,7/14,15.62%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,SUMO transferase activity (GO:0019789),0.6522962618408175,1.4637672225824696,0.07552447552447553,0.7761537380283678,1.0,5/16,14.16%,HDAC4;TOPORS;TRIM28;RANBP2;PIAS4
prerank,cation transmembrane transporter activity (GO:0008324),0.5487904308299759,1.4528825434233326,0.04503464203233257,0.821685929980648,1.0,7/48,9.01%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SFXN3;SLC38A3;SLC6A7
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.712074570468953,1.451890855381586,0.07503607503607504,0.8028885089055532,1.0,4/10,7.57%,DSE;GALE;FUOM;GFUS
prerank,histone methyltransferase activity (GO:0042054),0.5823275594579574,1.4449736952931664,0.05118601747815231,0.8241330615068263,1.0,19/32,30.73%,PRMT8;KMT5A;KMT2C;EHMT1;CARM1;SETDB1;MEN1;NTMT1;SUV39H1;FBL;SETD2;PRMT1;SMYD2;EHMT2;SETD7;PRMT5;NSD3;TTLL12;SUZ12
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5898762257879896,-1.433360865660727,0.12121212121212122,0.44415957393140526,1.0,4/11,5.34%,KCNK2;KCND3;KCND2;KCNT1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6628131020802199,1.4321304284693548,0.07702702702702703,0.8806298435048822,1.0,6/14,22.75%,CAPN5;CAPN10;CAPN2;CAPN15;CAPNS1;CAPN6
prerank,acetylation-dependent protein binding (GO:0140033),0.6239115755919682,1.4314059132728634,0.07682291666666667,0.8389815905793568,1.0,15/20,25.54%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;TAF1;SMARCA4;ZMYND8
prerank,lysine-acetylated histone binding (GO:0070577),0.6239115755919682,1.4314059132728634,0.07682291666666667,0.8389815905793568,1.0,15/20,25.54%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;TAF1;SMARCA4;ZMYND8
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6909550720575839,1.4302425505056962,0.0776978417266187,0.8252124889094483,1.0,2/12,0.78%,PGF;VEGFA
prerank,RNA polymerase II complex binding (GO:0000993),0.5765014508729345,1.4291805415110992,0.056303549571603426,0.8102814340788385,1.0,18/32,25.45%,ELOF1;BRD4;CCAR2;ERCC5;SCAF1;ESRRB;URI1;AGO1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,tropomyosin binding (GO:0005523),-0.5027251591032788,-1.4271081179789245,0.06666666666666667,0.4416290349315711,1.0,5/16,10.01%,NEBL;TMOD3;TMOD1;LMOD1;S100A6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6673196181664376,1.4211669802258076,0.07340720221606649,0.8377445012166127,1.0,3/14,6.99%,KCNJ2;KCNE5;KCNIP2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6787747530364683,1.419148476710569,0.08831908831908832,0.8295468273412765,1.0,9/12,27.09%,ARSJ;ARSB;SULF1;ARSA;ARSI;SULF2;GNS;ARSG;SGSH
prerank,RNA cap binding (GO:0000339),0.6371897474369266,1.4155778723501846,0.08957219251336898,0.831140268593422,1.0,12/16,28.61%,CYFIP1;EIF4E3;EIF4A1;SNUPN;AGO2;NCBP3;EIF3D;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1
prerank,semaphorin receptor binding (GO:0030215),-0.45776742812126775,-1.4147494446461257,0.0821256038647343,0.45268845757469756,1.0,13/23,21.23%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;RIT2;SEMA4A;PLXNB1;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,manganese ion binding (GO:0030145),0.5266506073542245,1.4133041519259333,0.05017103762827822,0.8260895277819893,1.0,17/48,23.64%,ME1;ADCY2;B4GALT1;XPNPEP1;PPM1M;WRN;HMGCL;ABL1;GALNT1;GALNT3;MPPED2;XYLT2;NEK4;GALNT2;B4GALT7;PRIMPOL;ARG2
prerank,cation:chloride symporter activity (GO:0015377),0.6939207268967857,1.408762112444306,0.09329446064139942,0.8325137464646702,1.0,3/10,7.65%,SLC12A7;SLC12A2;SLC12A4
prerank,ATPase binding (GO:0051117),0.5125082660748684,1.4084454215463904,0.032362459546925564,0.8161748502490515,1.0,17/71,14.53%,ESR1;EGFR;ATP1B1;SLC2A13;PTPN3;RDX;TCIRG1;ATP6V0A1;ANK2;CLPP;SNTA1;SYVN1;TMEM106B;EZR;S100A1;ABCA1;ATP6V1E1
prerank,ion gated channel activity (GO:0022839),-0.45404787820065945,-1.4076821921798393,0.0975609756097561,0.4508478584597267,1.0,7/24,8.49%,ANO4;ANO1;KCNT1;ANO3;TTYH2;ANO10;ANO6
prerank,pre-mRNA binding (GO:0036002),0.5678930317279686,1.4064028725985944,0.07904191616766468,0.8104210677222302,1.0,15/28,24.32%,SRSF6;DDX5;CELF4;CELF3;HNRNPL;U2AF1;ZRSR2;PTBP1;RBM4;U2AF2;RBM22;TRA2B;HNRNPA1;HNRNPU;RBM24
prerank,inward rectifier potassium channel activity (GO:0005242),0.5860663113269021,1.4047987242782618,0.08155583437892096,0.803179978439443,1.0,3/24,4.12%,KCNJ2;KCNJ15;KCNN1
prerank,insulin-like growth factor I binding (GO:0031994),-0.5307801466033021,-1.402918881130876,0.10469314079422383,0.445418455079229,1.0,6/13,4.96%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5815572078436133,1.4003163442487565,0.09517923362175525,0.8111988337580022,1.0,7/27,6.94%,SLC23A1;SLC9B2;SLC4A8;SLC9A8;SLC4A11;SLC9A4;SLC9A1
prerank,frizzled binding (GO:0005109),0.5554724041067973,1.3993413321441328,0.06318347509113001,0.8005803604572624,1.0,5/34,6.70%,MYOC;LRP6;WNT9A;DVL1;FZD7
prerank,store-operated calcium channel activity (GO:0015279),-0.5645830748342693,-1.3992983220860937,0.12797619047619047,0.4376422885654977,1.0,5/10,13.20%,TRPC3;TRPC6;ORAI1;ORAI2;TRPC4
prerank,Wnt-activated receptor activity (GO:0042813),0.6422800651620233,1.3934846752252672,0.11288180610889774,0.8190753480822398,1.0,5/15,9.47%,PKD1;LRP5;FZD7;FZD5;ROR1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6078041103538866,1.3921515862075324,0.088348271446863,0.8106306393269741,1.0,6/19,9.53%,EFNA5;GAS6;ABI1;DGKQ;ANGPT4;PAK2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5521529051140639,1.391790936072052,0.0993939393939394,0.7974398336198664,1.0,14/30,25.13%,GAS6;NOL3;CARD16;CST3;CD27;SERPINB9;PRDX3;BIRC6;BIRC5;CAST;BIRC3;DPEP1;UBE2Z;XIAP
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6760736780148358,1.387740669778333,0.10150891632373114,0.8041463027447459,1.0,2/11,3.77%,EGFR;MAP3K5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5401000728433785,1.3870122157341918,0.07354685646500593,0.7934550551116084,1.0,5/42,3.29%,IRS1;NEDD4;PTPN3;VAV2;SHC1
prerank,ubiquitin-specific protease binding (GO:1990381),0.6103169185447598,1.3828917908889042,0.1011826544021025,0.8014382449651434,1.0,12/19,32.06%,VCP;SYVN1;CHMP3;CLTC;SUMO1;LCOR;DERL1;AMFR;SELENOS;PRKN;SPATA2;SART3
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.488341701276598,-1.3793270834873155,0.1198501872659176,0.4525474681079734,1.0,5/16,6.89%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.488341701276598,-1.3793270834873155,0.1198501872659176,0.4525474681079734,1.0,5/16,6.89%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.542039970244171,-1.3777783001727197,0.11363636363636363,0.4418907694746932,1.0,3/11,6.84%,LEF1;MBD2;GATA2
prerank,serine-type peptidase activity (GO:0008236),0.4890915892106719,1.3750038866976868,0.038865546218487396,0.8284807943210609,1.0,10/96,7.85%,HTRA3;PCSK5;F3;HTRA1;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6491238750736814,1.3746973907834323,0.10404624277456648,0.8155238320561906,1.0,6/12,23.62%,HM13;BACE2;DDI2;BACE1;NAPSA;SPPL2A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.536983005379002,1.3745142057920472,0.08468677494199536,0.8026380980590803,1.0,16/37,25.81%,VARS1;VARS2;WARS2;HARS2;YARS1;DARS2;YARS2;NARS2;EPRS1;SARS2;SARS1;DARS1;CARS2;TARS2;QARS1;CARS1
prerank,I-SMAD binding (GO:0070411),0.6513599868657437,1.3741398336171808,0.11650485436893204,0.7911029806323182,1.0,7/13,12.61%,SMAD9;SMAD6;SMAD4;AXIN1;SMAD7;TGFB1I1;TGFBR1
prerank,gap junction channel activity (GO:0005243),-0.44014339105055733,-1.3684355332643219,0.0990990990990991,0.4477266885361612,1.0,4/22,4.91%,GJB6;GJB2;GJC1;GJD3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5641083742305364,-1.3618605855010741,0.1461794019933555,0.4486391571553995,1.0,4/10,7.49%,PRKAG2;PRKAR2B;PRKAR1B;PKIG
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6506730524125252,1.360565153185206,0.1103448275862069,0.8496103951387758,1.0,4/12,8.51%,GNAS;IRS1;SHC1;SOCS2
prerank,poly(A) binding (GO:0008143),-0.42888009464673627,-1.3587697461983579,0.09900990099009901,0.4417132108650375,1.0,5/21,5.11%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X
prerank,sodium:proton antiporter activity (GO:0015385),0.6558442829686792,1.3585437516729084,0.130374479889043,0.8466990600736597,1.0,4/11,6.94%,SLC9B2;SLC9A8;SLC9A4;SLC9A1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4953313754468294,1.358405527296782,0.04477611940298507,0.8339329802164097,1.0,32/78,24.22%,CAPN5;USP24;USP2;GPAA1;CAPN10;CAPN2;USP40;PDIA3;USP48;USP34;USP11;USP7;CASP1;USP33;USP36;USP13;USP35;CAPN15;USP10;USP46;USP1;CTSZ;UCHL1;USP5;CTSB;CAPNS1;USP47;CTSK;CTSO;CAPN6;USP49;USP14
prerank,myosin binding (GO:0017022),0.5040908087150808,1.3560533655465985,0.0764904386951631,0.8327453901633882,1.0,13/55,15.84%,MYOC;GSN;DMD;RAB8A;LLGL1;GIPC1;RHOA;RAB3D;STXBP5;KIRREL1;RAB11B;RAB3B;CXCR4
prerank,LRR domain binding (GO:0030275),-0.5002525449568346,-1.3556886615528072,0.08571428571428572,0.43593196099015624,1.0,3/14,2.99%,ROBO1;PAWR;LRRFIP2
prerank,histone demethylase activity (GO:0032452),0.5534372353600419,1.3537967950785417,0.10955414012738854,0.8319131809171519,1.0,10/27,16.74%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;FBXL19;HR;KDM5C;KDM6B
prerank,nuclear import signal receptor activity (GO:0061608),0.6151385810587896,1.3522140763189028,0.12771739130434784,0.827906292239928,1.0,9/15,19.36%,IPO5;IPO4;HIKESHI;KPNA2;TNPO2;KPNA3;IPO9;TNPO1;KPNA4
prerank,metal ion:proton antiporter activity (GO:0051139),0.6352222484719817,1.3520003013656334,0.1346938775510204,0.8165952847763507,1.0,10/13,29.53%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC11A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5435660369865032,1.3512390675487285,0.11463414634146342,0.8085630941877568,1.0,18/33,25.45%,ELOF1;CCAR2;ERCC5;ESRRB;URI1;AGO1;SPTY2D1;AGO2;PCF11;ERBB2;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5415983570739407,1.3510919455383368,0.10827250608272507,0.7975170140785797,1.0,24/33,35.35%,ELOF1;CCAR2;ERCC5;ESRRB;URI1;AGO1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;TBP;HNRNPU;SMYD2;RECQL5;UVSSA;ZNF326;ELP2;RPRD2;WAC;LLPH;DHX9;SUPT4H1
prerank,transcription coactivator binding (GO:0001223),0.5837763041145884,1.3506864111665347,0.11573472041612484,0.788097682671267,1.0,7/20,11.85%,ESR1;CIT;SMAD4;RORA;CCNT2;TERT;MED25
prerank,protease binding (GO:0002020),0.47800723273949525,1.3496205910032404,0.04250797024442083,0.7816402419092248,1.0,22/99,14.08%,F3;COL3A1;SLC2A13;COL1A2;COL1A1;TIMP2;TIMP3;COMP;NOL3;FAP;ANXA2;CRADD;CARD16;VCP;SYVN1;CST3;STIM1;ITGAV;ATP9A;SERPINB9;CHMP3;CLTC
prerank,wide pore channel activity (GO:0022829),-0.43522211625813245,-1.3482354433363908,0.0970873786407767,0.4384257994093894,1.0,4/23,4.91%,GJB6;GJB2;GJC1;GJD3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.44176331537414437,-1.3469838456652121,0.08762886597938144,0.4292972606787405,1.0,7/22,12.04%,CPEB2;RBMS3;ELAVL4;ELAVL1;EXOSC8;ZC3H12A;ZFP36
prerank,histone acetyltransferase activity (GO:0004402),0.5436023622609915,1.3414745487050665,0.1079136690647482,0.8103691571363412,1.0,17/30,29.39%,NAA60;NAA40;TADA2A;KAT14;KAT6B;KAT2A;ARRB1;CREBBP;ATF2;KAT7;KAT8;KAT2B;TAF1;SRCAP;TAF10;USP22;TADA3
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6713927823465373,1.3376535490372494,0.1473533619456366,0.8179378995334569,1.0,5/10,14.33%,GNAS;DLG4;NSF;SHANK1;SQSTM1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5108551266865966,-1.3364867595588128,0.13898305084745763,0.43911778624982284,1.0,3/12,1.02%,TGFBR3;ENG;LTBP1
prerank,transferrin receptor binding (GO:1990459),0.6553732868616678,1.3363464946830632,0.14782608695652175,0.8129926989152003,1.0,4/10,12.49%,SNX2;SNX1;CHUK;RGMA
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.6312675585600669,1.3341700013107385,0.14617486338797814,0.8126532462460667,1.0,9/12,29.53%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5052572027322504,-1.3331852208918653,0.16783216783216784,0.43468978141643305,1.0,3/13,2.28%,CDH5;BMP6;BMP7
prerank,amino acid:sodium symporter activity (GO:0005283),0.6419598608553232,1.3303589844374772,0.1318051575931232,0.8195165943825072,1.0,2/11,0.11%,SLC38A2;SLC38A1
prerank,transcription corepressor binding (GO:0001222),0.5582715452385897,1.3293953111259078,0.12285012285012285,0.8135516101031282,1.0,10/27,17.71%,ESR1;PHF1;PER3;EHMT1;RORA;USP11;PER1;HDAC6;LCOR;THAP7
prerank,ligand-gated cation channel activity (GO:0099094),0.4781906200187207,1.3258969117230661,0.08061002178649238,0.8197213629061565,1.0,9/75,9.14%,KCNJ2;KCNJ15;GRIK4;GRIN3A;KCNN1;CHRNB2;CHRNA5;TRPM4;KCNK6
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6086017326620857,1.3235566699425372,0.15612382234185734,0.8208504662813886,1.0,8/15,22.61%,KMT2C;WDR5;KMT2D;SETD4;KMT2B;WDR82;SETD1A;KMT2A
prerank,NAD binding (GO:0051287),0.5461158178281333,1.3232404863553895,0.1223203026481715,0.8119961457184608,1.0,9/26,17.47%,ME1;SORD;SIRT5;CRYZ;NNT;BDH2;SIRT2;CRYL1;HSD17B8
prerank,endonuclease activity (GO:0004519),0.50184184324289,1.3170727496732157,0.097926267281106,0.831821709011038,1.0,16/49,19.54%,N4BP2;ERN2;SMG6;ERCC5;ZC3H12D;ERCC4;OGG1;AGO1;ZC3H12C;AGO2;YBEY;LACTB2;SND1;DIS3;KHNYN;NOB1
prerank,protein kinase inhibitor activity (GO:0004860),0.5042400960030708,1.3160651735342275,0.10392609699769054,0.8269369135529459,1.0,19/42,27.06%,CIT;SPRED2;GMFB;PARVA;HEXIM1;CAMK2N1;GSKIP;CDKN1C;DUSP19;RPTOR;TAOK3;SMCR8;YWHAB;IBTK;MAPK8IP1;QARS1;SOCS1;NCK1;SH3BP5
prerank,sodium channel activity (GO:0005272),0.510028929658495,1.3160545865408713,0.13615023474178403,0.8170332690762179,1.0,5/37,6.62%,CACNA1G;GRIK4;HCN4;SLC4A11;SCN11A
prerank,methyltransferase activity (GO:0008168),0.5014042600683402,1.3152157011566916,0.11010215664018161,0.8111367338894895,1.0,21/46,29.58%,PRMT8;LRTOMT;EEF1AKMT3;EHMT1;NNMT;LCMT1;EEF1AKMT2;CARNMT1;GCSH;ARMT1;NTMT1;SUV39H1;ASMT;PRMT1;BUD23;DNMT1;NSUN3;METTL27;MEPCE;PRMT5;PRMT3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5453390274761554,1.3148463077618953,0.15024630541871922,0.803219405438633,1.0,4/25,8.81%,FMO1;MICAL2;MTRR;AKR1C1
prerank,phosphotyrosine residue binding (GO:0001784),0.5223111152666505,1.3144546239149741,0.12742718446601942,0.7957042335045547,1.0,4/37,3.29%,IRS1;PTPN3;VAV2;SHC1
prerank,3'-5' DNA helicase activity (GO:0043138),0.5916542209953884,1.3131811096142714,0.15803452855245684,0.7920484612585483,1.0,4/16,12.11%,NAV2;MCM2;WRN;ERCC3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6324706730416603,1.3121508182705275,0.14738292011019283,0.7878589719973403,1.0,7/11,29.58%,PRMT8;CARM1;PRMT1;FBXO11;PRMT9;PRMT5;PRMT3
prerank,alkali metal ion binding (GO:0031420),-0.49226658228360354,-1.3071516608102935,0.14338235294117646,0.47644091609880546,1.0,1/13,0.01%,ATP1A2
prerank,ferrous iron binding (GO:0008198),0.553203391786314,1.3070213490933067,0.1583011583011583,0.8018934711345824,1.0,9/21,23.69%,FTO;FXN;ALKBH1;FECH;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,fibroblast growth factor binding (GO:0017134),0.5620411291866145,1.3060667643381145,0.1625806451612903,0.7971174927623448,1.0,5/21,13.27%,THBS1;FGFR1;FGFR2;ITGAV;GLG1
prerank,small GTPase binding (GO:0031267),0.44880848614004387,1.3052004117886755,0.04339051463168517,0.7924898604816684,1.0,82/170,28.56%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;GOLGA4;NDRG1;PDE6D;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;SOD1;RCC2;EVI5L;TRIP11;CDC42EP5;OCRL;LSM2;STK19;ABCA1;USP33;RANBP2;CCDC186;HPS4;TMEM127;AKAP13;IQGAP1;GGA1;DAPK3;BIRC5;MYCBP2;RAB3GAP2;EVI5;MAPKAP1;RTKN;OPTN;ABI2;LRRK2;KCTD13;MLPH;TSC2;RAPGEF6;RABGAP1;RAB11FIP4;AFDN;NUTF2;TBC1D20;ARHGDIB;CYRIB;RABGGTB;WAS;GCC2;XPO5;MYO5A;GGA3;NOX1;SPHK2;ULK1;MTSS2
prerank,ribonuclease activity (GO:0004540),0.48849282996713134,1.3033216034100703,0.11049107142857142,0.791974728516251,1.0,20/56,19.54%,RNASE7;ERN2;PPP1R8;RNASE3;SMG6;ZC3H12D;RNASE6;AGO1;DIS3L2;ZC3H12C;AGO2;YBEY;LACTB2;SND1;EXOSC4;RPP40;N4BP1;ELAC2;KHNYN;NOB1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6248632158685277,1.3015872755453446,0.1490857946554149,0.7908870333476191,1.0,10/12,31.78%,CYFIP1;EIF4E3;AGO2;NCBP3;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1;DCPS
prerank,mannose binding (GO:0005537),0.6202598773206669,1.3014507504084902,0.17059639389736478,0.7831977566459044,1.0,4/12,21.83%,COLEC11;LMAN2L;LMAN2;LMAN1
prerank,calcium channel regulator activity (GO:0005246),-0.3722683638186772,-1.3003457747160299,0.09032258064516129,0.48027881562045605,1.0,11/37,15.11%,ITPR1;PRKG1;NRXN1;CACNG7;CACNG8;REM1;PACSIN3;CACNG4;SLC30A1;MCUB;INAFM1
prerank,methylation-dependent protein binding (GO:0140034),0.47507248659411033,1.2984630959379084,0.12316384180790961,0.7879908320297977,1.0,24/57,25.68%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;L3MBTL2;ING4;CBX5;THAP7;ZMYND11;CHD8;CDYL;BPTF;MPHOSPH8;KAT8;ZCWPW2;ZMYND8;CHD1
prerank,GTPase inhibitor activity (GO:0005095),0.612946113621117,1.2968315246600008,0.16363636363636364,0.7869786262569195,1.0,8/13,20.89%,SLIT2;IPO5;GPS1;PDE6D;ARL2;IQGAP1;RTKN;GPS2
prerank,acylglycerol lipase activity (GO:0047372),0.6253896884556281,1.2944047614570227,0.16666666666666666,0.789283688073144,1.0,1/11,0.40%,MGLL
prerank,cation channel activity (GO:0005261),0.45795586431637864,1.2942240088257337,0.09062170706006323,0.7820756738003571,1.0,13/94,8.87%,PIEZO2;KCNK5;PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;SLC4A11;MCU;CALHM6;CALHM5;TRPM7;TRPM4
prerank,BMP receptor binding (GO:0070700),-0.5052586176939659,-1.2916576402009754,0.18243243243243243,0.4879512468761266,1.0,3/12,2.28%,CDH5;BMP6;BMP7
prerank,kinase inhibitor activity (GO:0019210),0.5068494921100164,1.2888667410548649,0.14420803782505912,0.7973926241699668,1.0,16/33,28.77%,LRP6;GMFB;PARVA;HEXIM1;GSKIP;CDKN1C;DUSP19;TAOK3;SMCR8;YWHAB;MAPK8IP1;QARS1;SOCS1;NCK1;SH3BP5;WARS1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5995152795976256,1.286641986418197,0.19917582417582416,0.7994257057128836,1.0,1/13,1.04%,EHHADH
prerank,nuclear export signal receptor activity (GO:0005049),0.6393160230930162,1.2863331287205348,0.1927007299270073,0.7926831356328411,1.0,3/11,11.20%,XPO1;XPO6;XPO4
prerank,signal sequence binding (GO:0005048),0.5097696940913562,1.2851005645334503,0.1686602870813397,0.7903782978741988,1.0,17/35,19.73%,KDELR3;SEC61A1;IPO5;IPO4;KCNIP2;PEX5;KDELR1;KDELR2;KPNA2;TNPO2;CAT;TOMM70;KPNA3;POM121;TNPO1;KPNA4;NFKBIA
prerank,E-box binding (GO:0070888),-0.363756438094788,-1.2841935896707943,0.13736263736263737,0.49340966909449946,1.0,4/34,4.51%,TCF4;ZEB1;AHR;MITF
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49242275549368025,1.2836953559356559,0.148664343786295,0.7888943078016397,1.0,23/44,26.51%,KMT5A;KMT2C;KMT5C;EHMT1;NSD1;ASH1L;SETD5;WDR5;KMT2D;SETDB1;SETD4;KMT2B;MEN1;WDR82;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SETDB2;SMYD2;EHMT2;SETD7
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4711209076569544,1.2833702487804037,0.10807860262008734,0.7827796229335497,1.0,17/70,19.99%,EXT1;GXYLT2;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;OGT;MGAT4B;HEXA;B3GNT9;B4GAT1;B3GNT6;GXYLT1;EXT2;GCNT7;B4GALNT3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.632365031332643,1.282617363465931,0.1806543385490754,0.7785484012688342,1.0,5/10,22.46%,EHHADH;ECHDC2;AUH;ECHDC1;HADHA
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.34120067228395934,-1.2818973275334606,0.10077519379844961,0.4873552725668294,1.0,10/49,7.56%,ATP1A2;PPP1CB;DUSP16;PTPRO;DUSP10;PXYLP1;SAMHD1;PLCXD3;DUSP3;ACP2
prerank,histone deacetylase binding (GO:0042826),0.4541477256534652,1.2812433057256085,0.10515247108307045,0.7765011259911935,1.0,36/88,25.76%,NCOR2;HDAC9;HDAC4;DACT1;ANKRA2;MEF2B;IKZF3;BEX4;PKN2;MAPK8;MIER2;KPNA2;SFPQ;KAT2A;HDAC1;MEF2D;MEF2A;YWHAE;NACC1;SIRT2;HDAC6;NIPBL;MTA3;LCOR;THAP7;AKAP8;MIER1;KAT2B;GLI3;TP53;CHD4;PHF6;YWHAB;NCOR1;HDAC2;SUDS3
prerank,miRNA binding (GO:0035198),0.5245714521372199,1.2806738943791853,0.1652593486127865,0.7716329197557468,1.0,13/30,23.78%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;ZC3H10;TUT7;ZNF346;HNRNPA1;YBX1
prerank,transforming growth factor beta binding (GO:0050431),0.5330768487702856,1.2748258552689276,0.1694915254237288,0.7882921876648369,1.0,7/23,9.72%,THBS1;LTBP3;TGFB3;ACVR1;TGFBR2;TSKU;ITGAV
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.597122730367723,1.2736025014442311,0.18565400843881857,0.7860126792010038,1.0,4/12,13.30%,AOX1;XDH;FXN;ISCA2
prerank,GTPase binding (GO:0051020),0.4353502586293378,1.2734461963365773,0.050200803212851405,0.7795848434969257,1.0,90/195,28.56%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;LAMTOR1;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;GOLGA4;NDRG1;PDE6D;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;SOD1;RCC2;EVI5L;TRIP11;CDC42EP5;OCRL;LSM2;STK19;ABCA1;USP33;RANBP2;CCDC186;HPS4;TMEM127;AKAP13;IQGAP1;GGA1;SPTBN1;EPRS1;DAPK3;BIRC5;MYCBP2;RAB3GAP2;EVI5;MAPKAP1;RTKN;GNB1;OPTN;ATG16L1;ABI2;LRRK2;KCTD13;MLPH;TSC2;RAPGEF6;STOML2;RABGAP1;YBX1;RAB11FIP4;AFDN;NUTF2;TBC1D20;ARHGDIB;CYRIB;RABGGTB;WAS;GCC2;AMBRA1;XPO5;MYO5A;GGA3;NOX1;SPHK2;ULK1;MTSS2
prerank,damaged DNA binding (GO:0003684),0.48509756151539485,1.2722997517330887,0.14678899082568808,0.7770958903340843,1.0,25/44,33.39%,MPG;HMGB1;ERCC5;RBBP8;RAD1;ERCC4;OGG1;TDG;SDE2;ERCC3;ERCC2;DCLRE1B;CREBBP;FANCG;CRY2;POLD1;SMC6;XPA;PNKP;DDB1;XRCC1;ERCC1;POLQ;RPA3;CUL4B
prerank,receptor antagonist activity (GO:0048019),0.5647488737846759,1.2700439092002436,0.1928020565552699,0.7793126492452468,1.0,2/17,3.94%,DKK3;LRPAP1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6066254335101458,1.2691235415636004,0.1888412017167382,0.7761452774596999,1.0,3/12,3.29%,IRS1;GAB2;SHC1
prerank,clathrin adaptor activity (GO:0035615),0.5893140904262203,1.2681130410640822,0.2073170731707317,0.7733970625885483,1.0,6/15,16.45%,STON2;AP2A1;STON1;AP2A2;DAB2;HIP1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.45778801303728944,1.26625205451409,0.12392241379310345,0.7746956699669623,1.0,19/75,18.76%,ME1;EHHADH;LDHC;SORD;KDSR;GFUS;AKR1C1;NSDHL;CBR4;DHRS4;DHRS9;BDH2;MDH1B;CRYL1;PHGDH;PGD;AKR1A1;HSD17B8;DHRS3
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5757783205047987,1.2623280853636418,0.19815059445178335,0.7832033680575524,1.0,5/17,14.34%,AK5;AK3;DTYMK;CLP1;AK1
prerank,methylated histone binding (GO:0035064),0.45715703957579923,1.262153067409437,0.14748603351955308,0.7772515942017411,1.0,25/62,25.68%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;L3MBTL2;ING4;CBX5;THAP7;ZMYND11;CHD8;CDYL;BPTF;MPHOSPH8;KAT8;TAF1;ZCWPW2;ZMYND8;CHD1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.4029523617242581,-1.2602051670143404,0.15121951219512195,0.5224168870759673,1.0,13/24,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5729579624556934,1.2586870657679343,0.19209809264305178,0.784681820091665,1.0,2/15,8.47%,CMKLR1;ACKR4
prerank,ubiquitin binding (GO:0043130),0.45303423090516076,1.2580751077214356,0.12473347547974413,0.7806338510980362,1.0,28/73,21.03%,NEDD4;MVB12B;RAE1;TOM1L1;OTUB1;NBR1;FAF2;DDI2;SHARPIN;UCHL3;WDR48;OTUB2;USP33;MARK4;SQSTM1;UBAP1;USP13;UBE2L6;SIRT2;CXCR4;N4BP1;USPL1;NPLOC4;CKS1B;UCHL1;UBAP1L;NUP62;USP5
prerank,thiol-dependent deubiquitinase (GO:0004843),0.45249601647233095,1.2570591406192662,0.11927582534611289,0.7782488113626307,1.0,48/83,30.65%,USP24;USP2;OTUB1;USP50;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;USP26;COPS5
prerank,calcium channel inhibitor activity (GO:0019855),-0.5031881885385852,-1.2565016286793584,0.19155844155844157,0.5199430996695739,1.0,4/11,14.45%,ITPR1;PACSIN3;SLC30A1;MCUB
prerank,lysophospholipase activity (GO:0004622),0.5463854175422709,1.2552721354774772,0.2196078431372549,0.7790188122808496,1.0,2/20,1.79%,MGLL;PLA2G4A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6078411584020289,1.2535143058043328,0.21145374449339208,0.7795092460930494,1.0,8/11,30.05%,UBR5;STUB1;UBE4A;UBOX5;AMFR;UBE4B;RBX1;ANAPC11
prerank,cyclic nucleotide binding (GO:0030551),-0.4216682694442215,-1.2520154363201077,0.16753926701570682,0.5191068438589285,1.0,6/21,10.27%,RAPGEF4;PDE4D;RAPGEF2;KCNH1;PDE2A;PDE4B
prerank,androgen receptor binding (GO:0050681),0.5237944852444596,1.2480477550156381,0.2099236641221374,0.7950356748367327,1.0,5/25,12.50%,FOXP1;DDX5;NSD1;RNF14;TGFB1I1
prerank,glucuronosyltransferase activity (GO:0015020),0.5453671554118319,1.2475715966632557,0.18229166666666666,0.7904705256854845,1.0,4/19,18.86%,EXT1;B4GAT1;B3GAT2;EXT2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5100139579405708,1.2474911225038394,0.2042875157629256,0.7844309841863092,1.0,4/28,8.43%,GRIK4;GABRA3;CHRNB2;CHRNA5
prerank,protein kinase C binding (GO:0005080),0.4865110960804027,1.2458268366177767,0.18872266973532797,0.7846749169454934,1.0,11/43,14.33%,IRS1;ADAM9;HDAC9;DACT1;PRKCSH;DACT3;ITGAV;ABL1;NELL1;PICK1;SQSTM1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5482597881522667,1.2444282592086813,0.21866666666666668,0.7835395866828623,1.0,9/18,25.13%,GAS6;NOL3;CD27;SERPINB9;PRDX3;BIRC5;BIRC3;DPEP1;XIAP
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3373734242936645,-1.2439229423644964,0.13286713286713286,0.5265505266658361,1.0,14/42,10.11%,STXBP6;BSG;ESAM;LRRC4C;NTNG1;TMOD3;CNTN6;DSCAML1;CNTN4;BAIAP2;ROBO4;CD200;PDLIM5;NEXN
prerank,CARD domain binding (GO:0050700),0.5798950589996617,1.243239407637897,0.19973190348525469,0.781897713619729,1.0,4/14,13.71%,CARD14;CARD16;MAVS;CASP1
prerank,cell adhesion mediator activity (GO:0098631),-0.39790538005620635,-1.2420810947487153,0.1796116504854369,0.520038916955541,1.0,10/24,10.11%,BSG;ESAM;LRRC4C;BCAM;NTNG1;CNTN6;DSCAML1;CNTN4;ROBO4;NEXN
prerank,deubiquitinase activity (GO:0101005),0.4454765904483809,1.2417416887803143,0.13997879109225875,0.7816430434153193,1.0,49/88,30.65%,USP24;USP2;OTUB1;USP50;MINDY4;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;USP26;COPS5
prerank,potassium ion antiporter activity (GO:0022821),0.5677946306640858,1.241265844417375,0.24661246612466126,0.7775130763923741,1.0,4/15,6.94%,SLC24A3;SLC9A8;SLC9A4;SLC9A1
prerank,phospholipid transfer activity (GO:0120014),0.5301939685997894,1.2399856942590215,0.21139240506329113,0.7764218824291491,1.0,5/21,4.74%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,MHC class II protein complex binding (GO:0023026),0.5942622680775889,1.237529440538351,0.22349570200573066,0.7797283903182936,1.0,2/11,13.56%,ATP1B1;YWHAE
prerank,histone methyltransferase binding (GO:1990226),0.5898622310692159,1.236092357322568,0.23163841807909605,0.7791266808978977,1.0,5/11,20.94%,CBX1;PHF1;PRDM4;LCOR;NOP56
prerank,insulin-like growth factor binding (GO:0005520),-0.4537027473839662,-1.2350078993524252,0.19157088122605365,0.5256044316153208,1.0,6/15,4.96%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,poly-pyrimidine tract binding (GO:0008187),0.522332727765784,1.232549411918217,0.20854271356783918,0.7862522719759885,1.0,10/23,14.12%,HNRNPH1;PABPC1;SSB;DAZAP1;DIS3L2;PATL1;KHDRBS1;PTBP1;HNRNPC;U2AF2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5137544269714134,1.2321203305581183,0.23673997412677877,0.7819340935595916,1.0,3/22,6.62%,CACNA1G;HCN4;SCN11A
prerank,sequence-specific DNA binding (GO:0043565),0.41179546674149164,1.2310517844153788,0.011,0.7800450377183701,1.0,114/590,15.99%,TBX15;FOXP2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;ZNF423;FOXD1;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;PRRX2;JDP2;GLI2;PRDM5;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;TCF7L1;ZNF250;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;LBX2;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;HOXA9;HOXA6;SMG6;MAEL;IKZF3;RARA;FOXJ3;SOX9;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;SLTM;ZIC1;MBNL2;RORA;FOXA1;SMG1;ZBTB2;UBP1;CSRNP1;PRDM4;SREBF1;RUNX2;KDM2A;ABL1;ZIC4;RFX5;POU6F1;CHTOP;TERT;HSF4;TELO2;NEUROD2;KDM5B;SRF;NR1D2;HEY1;GLIS1;TEN1;LONP1;FBXL19;MEF2D;HOXB4;ZNF740;MEF2A;NFATC3;HOXA4;ERF;ZNF148;CPSF4;EN2;MAFG;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;CREB1
prerank,double-stranded DNA binding (GO:0003690),0.4109439110758935,1.2266917951291967,0.014,0.790861782243829,1.0,119/531,20.21%,TBX15;ESR1;EGFR;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;RARB;ELF4;VSX1;HOXB6;PRRX2;JDP2;GLI2;GLIS2;LHX9;CUX1;NFAT5;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;TCF7L1;ZNF250;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;PRKDC;LBX2;SAFB;BHLHE40;HMGB1;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;HOXA9;HOXA6;RARA;FOXJ3;ERCC5;SOX9;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;RFX2;PSIP1;RBBP8;ZIC1;MBNL2;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;RUNX2;ABL1;ZIC4;RFX5;POU6F1;WDR48;TDG;HSF4;NEUROD2;KDM5B;SRF;TDP1;NR1D2;HEY1;GLIS1;RAD50;MEF2D;HOXB4;ZNF740;NFATC3;HOXA4;CPSF4;EN2;MAFG;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;CREB1;HOXA2;POLG2;NFKB2;KLF3;NR3C1;MEN1;HDGFL2;E2F1;ZMYND11;ZBTB32;ATF2;RAD51;KLF10;HOXB2;TEAD2;XRCC6;IRF3;NR3C2;NFATC4;ATF6;MAX
prerank,RNA polymerase binding (GO:0070063),0.5380036244816586,1.224878766277955,0.2388663967611336,0.792053393214555,1.0,7/18,20.52%,NEDD4;PKN2;ANP32B;CCNT2;PABPN1;STOM;PHRF1
prerank,mRNA methyltransferase activity (GO:0008174),0.5871221131454831,1.2245582947936944,0.24705882352941178,0.7874769496281984,1.0,6/12,25.90%,TRMT61B;METTL16;TRMT61A;METTL8;METTL14;RNMT
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5041523624620063,1.222877213889047,0.23751522533495736,0.7885206331270834,1.0,5/27,4.08%,SLC23A1;SLC12A2;SLC9B2;SLC4A8;CNNM2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4608334038933178,1.2224515112009713,0.19444444444444445,0.7844611086575453,1.0,11/53,11.54%,MICAL2;ACOXL;AOX1;XDH;ACOX3;NOX4;QSOX1;MTRR;ETFDH;ETFA;AIFM1
prerank,serine-type endopeptidase activity (GO:0004252),0.438127728198266,1.2185905342699161,0.18076109936575052,0.7936913513756562,1.0,8/80,7.85%,PCSK5;F3;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,phospholipase A2 activity (GO:0004623),0.5038287018599676,1.2184145528093089,0.2193627450980392,0.788858796312037,1.0,6/26,16.49%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A;PNPLA3;PLA2G15
prerank,tRNA binding (GO:0000049),0.47119905263810313,1.2161225077360098,0.22598870056497175,0.7922831298902838,1.0,17/43,22.94%,SSB;ELP5;TRNAU1AP;TERT;DALRD3;DARS2;ALKBH1;ELP1;YARS2;XPOT;ALKBH8;SARS2;SARS1;EIF2AK4;EIF2A;NSUN6;PUS1
prerank,tRNA methyltransferase activity (GO:0008175),0.5375253374442963,1.2146148000192152,0.2563758389261745,0.7925430378068824,1.0,5/16,17.88%,TARBP1;TYW3;THUMPD3;TRMT44;ALKBH8
prerank,adrenergic receptor binding (GO:0031690),0.5504449499072732,1.214550657033647,0.23731138545953362,0.7873174453007199,1.0,3/16,7.83%,GNAS;NEDD4;DLG4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.40506414324627543,1.2126333023933453,0.013,0.7892121235548469,1.0,126/730,13.92%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;HOXA9;HOXA6;IKZF3;NRIP1;RARA;NSD1;FOXJ3;SOX9;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;EHF;RUNX2;ZNF260;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;MEF2A;NACC1;RUNX1;NFATC3;HOXA4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4048577969945424,1.2125725114681096,0.014,0.7841129940300957,1.0,138/731,15.99%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;HOXC6;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;HOXA9;HOXA6;IKZF3;NRIP1;RARA;NSD1;FOXJ3;SOX9;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;EHF;RUNX2;ZNF260;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;MEF2A;NACC1;RUNX1;NFATC3;HOXA4;ZNF148;EN2;VDR;ZKSCAN1;MAFG;PER1;GRHL1;FOXO3;HDAC6;FOXN3;NKX6-2;NFE2;CREB1
prerank,cytokine activity (GO:0005125),0.4212976100508146,1.2125009840945218,0.13402061855670103,0.7790425688856673,1.0,21/131,15.26%,GDF10;WNT9A;VEGFA;FGF2;IL33;INHBC;TGFB3;CCL13;SLURP1;CCL15;TGFB2;HMGB1;CXCL16;FAM3C;BMP4;CTF1;INHBA;NDP;BMP5;CLCF1;IL6
prerank,vitamin D receptor binding (GO:0042809),0.5511149553481934,1.211111363059549,0.25277777777777777,0.7790070675409194,1.0,5/14,17.99%,RXRA;THRAP3;MED13;MED14;MED12
prerank,nuclear localization sequence binding (GO:0008139),0.531323416284304,1.2110530362920793,0.23159303882195448,0.7740376144281336,1.0,9/18,19.73%,IPO5;IPO4;KPNA2;TNPO2;KPNA3;POM121;TNPO1;KPNA4;NFKBIA
prerank,ion channel activity (GO:0005216),0.43045427542310744,1.2103919788923834,0.1843817787418655,0.7715877745275559,1.0,11/80,8.87%,PIEZO2;GRIK4;GRIN3A;TRPV3;CHRNB2;CALHM6;TMC8;CALHM5;TRPM7;CHRNA5;TRPM4
prerank,translation initiation factor activity (GO:0003743),0.4802060937140443,1.2091624436837771,0.203125,0.7710147229754487,1.0,22/36,36.53%,EIF4A2;EIF4G2;EIF4G3;EIF4E3;EIF4A1;AGO2;EIF4G1;EIF2S2;EIF3D;EIF3A;EIF2A;EIF2S1;EIF4E;EIF3M;EIF3I;EIF3K;COPS5;EIF2D;EIF5B;EIF2B5;EIF1B;EIF3E
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5459302099361205,1.20887073513472,0.2527322404371585,0.7621294342550115,1.0,8/16,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5459302099361205,1.20887073513472,0.2527322404371585,0.7621294342550115,1.0,8/16,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,myosin II binding (GO:0045159),0.5915546942851272,1.207279732418205,0.26843657817109146,0.7631716217270945,1.0,3/10,12.59%,GSN;LLGL1;STXBP5
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.43533200995344146,-1.2051612496624493,0.22393822393822393,0.583282562043994,1.0,5/15,9.01%,SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,potassium:proton antiporter activity (GO:0015386),0.5992499120175856,1.205138265793117,0.24964131994261118,0.7654325669498095,1.0,7/10,29.53%,SLC9A8;SLC9A4;SLC9A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,N-acyltransferase activity (GO:0016410),-0.3602972524340523,-1.2048031207434136,0.20606060606060606,0.5731110488935388,1.0,4/32,3.31%,CERS4;NMT2;TGM2;PLAAT3
prerank,iron ion binding (GO:0005506),0.4576725854699142,1.2043905230265575,0.2122260668973472,0.7632051745153372,1.0,16/48,23.69%,AOX1;FTO;FXN;SCD5;PHF8;ABCE1;AGMO;ISCA2;ALKBH1;FECH;ALKBH8;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,endoribonuclease activity (GO:0004521),0.479848800315774,1.2031874409362502,0.23030303030303031,0.7625823319027695,1.0,12/32,21.20%,ERN2;SMG6;ZC3H12D;AGO1;ZC3H12C;AGO2;YBEY;LACTB2;SND1;KHNYN;NOB1;ENDOV
prerank,SH3 domain binding (GO:0017124),0.44371250187621036,1.2011043358090348,0.197136563876652,0.7656557552562911,1.0,16/62,12.57%,ADAM9;DPYSL3;MAPK15;AFAP1L1;CD3E;SOCS7;DNM2;ABI1;CBL;ZNF106;SYNJ1;WIPF1;ABL1;SHANK1;REPS1;KHDRBS1
prerank,histone deacetylase activity (GO:0004407),0.5231052783243337,1.200827637862426,0.26007802340702213,0.7618747544106489,1.0,9/19,25.76%,HDAC9;HDAC4;MIER2;HDAC1;SIRT2;HDAC6;MIER1;HDAC2;SUDS3
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5890482963449885,1.198501788557666,0.27095808383233533,0.7655908005965257,1.0,4/10,12.08%,RIOX2;KDM2A;PHF8;KDM4A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4013511165275814,1.1975973092924042,0.018,0.7643086656226478,1.0,103/597,13.92%,TBX15;BNC2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;SMAD6;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;TCF7L1;ZNF250;ATF4;MCMDC2;NR2F1;CHD3;TCFL5;GMEB1;FOXC2;RXRB;LBX2;PER3;SMAD4;NFE2L2;BHLHE40;HMGB1;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;HOXA9;HOXA6;MCM2;CENPC;RARA;FOXJ3;SOX9;ESRRB;TFE3;FOXK1;ZNF76;CDC6;CARM1;NFATC1;RFX2;HNRNPL;ZIC1;MBNL2;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;RUNX2;ABL1;ZIC4;RFX5;POU6F1;HSF4;NEUROD2;KDM5B;SFPQ;SRF;NR1D2;HEY1;GLIS1;ZW10;MEF2D;CDC45;HSPD1;HOXB4;ZNF740;ARID4B;KMT2D;RUNX1;NFATC3;HOXA4
prerank,voltage-gated potassium channel activity (GO:0005249),0.42809280756288554,1.1974382828060233,0.19230769230769232,0.7603041639985013,1.0,9/80,9.14%,KCNJ2;KCNJ15;KCNB1;HCN4;KCNN1;KCNE5;KCNIP2;KCND1;KCNK6
prerank,RNA binding (GO:0003723),0.39510020333648876,1.1967940678762987,0.001,0.7580827258795109,1.0,492/1321,27.93%,SRSF6;STRBP;C1D;LRP1;RRBP1;RPSA;COL14A1;DDX5;P4HB;HOXB6;HELB;SERPINH1;FNDC3B;YBX3;DDX17;HNRNPH1;RCC1L;PPP1CC;ERI3;TCF20;RDX;GNL3;AHNAK;PNISR;KHDC4;LUC7L2;ANXA7;SRSF1;PABPC1;NOL3;ARC;SAMD4A;SRSF5;SIDT2;CLK3;ARCN1;TSR1;HDLBP;RBFOX2;MBNL1;EIF4A2;IPO5;GCN1;RBM39;ZRANB2;BAZ2A;ANXA2;DUSP11;STAT3;KCTD12;ZC3H7A;ZCCHC24;TRIM28;RAE1;CELF4;RBM42;SPATS2L;RRS1;DYNC1H1;VCP;CHD3;SRSF2;CASC3;EIF4G2;SREK1;ATXN2L;TENT4B;KMT2C;GOLGB1;SNRNP70;RTCA;CCAR2;NFX1;PRKDC;RRP7A;SAFB;SSB;FAM98A;PUM1;MRPS35;MRPS28;HMGB1;DAP3;GNL2;PRKRA;TENT5A;MTHFSD;MATR3;PRPF40B;ABCF1;FUS;PPP1R8;CKAP4;HNRNPA2B1;CS;HNRNPDL;LAS1L;EIF4G3;ELP5;THRAP3;FBRSL1;TES;EWSR1;RBM47;HUWE1;SMG6;PURG;SRSF11;GDI2;PA2G4;ACO1;CHERP;RBBP6;TRNAU1AP;HARS2;CELF3;LUC7L;GSPT1;EMG1;RBM45;NOA1;LUC7L3;ZC3H12D;SLTM;UBAP2L;HNRNPL;RAVER2;HNRNPH2;PSIP1;SRFBP1;MBNL2;RBM28;ALG13;R3HDM2;SF3B2;SF3B1;PRRC2C;RBM25;PKN2;ZNF106;ILF3;ZCCHC9;PCBP4;MYEF2;SF3A1;PNN;TBRG4;NXF1;PDIA3;ZC3H11A;SMG1;RBM10;LARP1B;WDR3;BZW1;FAM98B;DAZAP1;RBM26;GTF2F1;SRRM1;U2AF1;AGO1;RBM6;NVL;ZC3H15;MRPL39;KPNA2;YARS1;CHTOP;RBM5;TERT;TRMT1;NUFIP2;ARF1;MAZ;PABPN1;TAF15;MSI2;FAM120A;SFPQ;ZC3H12C;DGCR8;FUBP1;METTL16;DALRD3;PRRC2A;USO1;DARS2;SRF;RCC2;ESF1;DDX50;CRNKL1;PATL1;EIF4A1;NOSIP;EZR;LONP1;MRPS14;RRP12;SNUPN;KHDRBS1;CSNK1E;AGO2;PSMA6;EIF4G1;CCDC59;HSPD1;DHX29;HNRNPM;ADD1;PCBP2;DIDO1;LSM2;ALKBH1;PTBP1;YWHAE;RALY;HMGN2;MANF;RBM4;NOLC1;SUGP2;HNRNPC;SUPV3L1;ETF1;TIAL1;UTP14A;CLTC;FAM133B;USP36;U2AF2;DCAF13;SRPK1;ZCCHC7;HEXIM1;ARHGEF1;G3BP2;ELP1;FNDC3A;PRR3;LACTB2;SND1;EIF2S2;CPSF4;HNRNPK;HEATR6;FLNB;YTHDC1;RTCB;XRN1;CMSS1;NCBP3;SARNP;DDX19A;LRRC59;NOC4L;IREB2;MRTO4;THOC2;DDX56;SRSF3;RPP40;FYTTD1;ISY1;UBAP2;PPAN;N4BP1;PCF11;BYSL;ZC3H10;PARP1;EIF3D;AATF;RPS27A;UBC;TUT7;ELAC2;TSN;YARS2;EIF3A;SUMO1;RC3H2;NCBP1;MRPL45;SSRP1;ADAT1;XPOT;SLC4A1AP;SPTBN1;RPP14;SNRPA;BOP1;TUFM;SECISBP2;ACIN1;EPRS1;SRSF7;SRSF10;KHNYN;TRMT6;ALKBH8;COA6;CPSF7;TFB2M;AQR;CPSF6;U2SURP;RBM22;TOP3B;NCBP2;USP10;SPATS2;TNPO1;SARS2;SARS1;FASTKD3;ZCCHC17;POLR1G;CAST;SEC23IP;PEBP1;DRG2;SAFB2;SYNCRIP;PTCD3;UCHL5;CAVIN1;CLUH;CCT4;XRCC6;LARP7;GANAB;ZNF346;CSTF2;AKAP8;TRA2B;CCT6A;RPL7A;RAMAC;TRIP6;EIF2AK4;NOC2L;MTREX;HNRNPH3;DNAJC21;UNK;DARS1;PARP12;RTRAF;CALR;MRPL12;PYM1;CIRBP;EIF2A;EIF2S1;TRA2A;RCAN3;AFF2;ZCCHC8;NOP56;ABT1;CSTF2T;DHX8;PPP1R10;ENDOV;DDX49;FBL;SBDS;CHD2;SAP18;WDR36;PSMD4;ATXN2;SCAF4;HNRNPA3;SNRPB;MRPS24;HNRNPA1;FXR2;UPF1;SRSF4;POLR2B;SHFL;DNAJC2;MRPS21;TASOR;DHX16;NGDN;MCAT;MRPS26;FAM50A;SUMO2;NSUN6;UNC50;TOP1;SLC3A2;RSRC2;PRDX1;DHX32;EIF4B;SRP72;PUS1;DCP1A;TCP1;NIFK;PRMT1;RBM19;FKBP4;BCLAF1;PPIG;WDR46;SF3B6;R3HDM1;WDR75;ZC3H14;HNRNPU;YBX1;RPP21;DUS3L;SMC1A;RPS9;SF1;TBL3;BUD23;MRPL37;KRI1;STAU1;METAP2;ZFR;GTPBP4;PABPC4;PHF6;RPS27L;CDK13;SUGP1;UPF3B;MTO1;RBM3;HDAC2;C1QBP;SNRNP35;DDX39B;UTP11;SLC25A11;TUBB4B;RTF1;FAM120C;NOP58;METTL14;PUS10;PSMC1;CARS1;DDX20;RNMT;MRPL13;TOE1;ANKHD1;NAA15;TPR;YY1;EIF1AX;SEC61B;DDX41;DKC1;SRBD1;RIDA;MAK16;EIF4E;POP5;UBTF;FCF1;SLC25A5;PSMA1;XPO5;NOP53;MEX3B;SRRT;TNRC6A;TRMT1L;RPL41;MRPL4;GPATCH1;SON;FXR1;CCDC47;GPATCH8;LSM5;YTHDF1;RBM27;ZC3H18;RPL30
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41010908116016237,1.1946776554151977,0.13488843813387424,0.7607451879322636,1.0,30/173,14.56%,FOXP2;PLAGL1;FOXP1;KLF12;ZFHX3;SKIL;JDP2;PRDM5;DEAF1;HES5;ZBTB25;NR2F1;TCFL5;ZNF25;NFX1;BHLHE40;SKI;HEYL;TBX21;FOXK1;ZBTB2;ZFP90;POU6F1;FOXP4;HEY1;MYPOP;NACC1;NFATC3;ERF;ZNF148
prerank,regulatory RNA binding (GO:0061980),0.47468595890998655,1.1908609645557942,0.24734982332155478,0.7695157216274042,1.0,13/38,23.78%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;ZC3H10;TUT7;ZNF346;HNRNPA1;YBX1
prerank,glutamate receptor binding (GO:0035254),0.5368691029230077,1.1905540030731279,0.27058823529411763,0.7659045323646776,1.0,7/17,19.84%,GNAS;DLG4;NSF;SHANK1;SQSTM1;HIP1;HOMER2
prerank,lipoprotein particle receptor binding (GO:0070325),0.49454428111497667,1.19041994914808,0.24685138539042822,0.761775482015694,1.0,9/27,20.48%,LRP1;APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.40020181149766115,1.186073926470932,0.119358074222668,0.771958390866084,1.0,58/254,20.04%,PLAGL1;ESR1;SIX1;PRRX1;HOXA5;NFIB;ELF4;NFIA;GLIS2;NFAT5;ELF1;HOXB3;ONECUT2;MEOX2;KLF5;STAT3;ATF4;GMEB1;FOXC2;RXRB;SMAD4;MEF2B;E2F3;MEIS3;MDM4;FOXJ3;SOX9;ESRRB;ZNF76;NFATC1;FOXA1;UBP1;PRDM4;EHF;RFX5;NRF1;SRF;ZNF112;MEF2A;RUNX1;NFATC3;TFDP1;GRHL1;FOXO3;CREB1;PRDM2;NFKB2;NR3C1;RFXANK;E4F1;ATF2;KLF10;HOXB2;FOSL2;IRF3;VEZF1;TCF3;ATF6
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4282451345337338,-1.1854250402208961,0.2600732600732601,0.6086777337092637,1.0,5/15,9.30%,HS3ST3A1;NDST3;NDST4;NDST1;HS6ST3
prerank,GTP binding (GO:0005525),0.40732172525301247,1.1838896513403216,0.14140386571719227,0.7753621745016838,1.0,28/172,11.34%,RHOJ;RHOBTB1;RHOQ;MRAS;TUBG2;RND3;GNL3;ATL2;TSR1;RAB2A;DNM2;GNL1;RAB21;ATL3;GNL2;RABL6;RAB8A;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5950513094384233,1.1838522946464747,0.25920471281296026,0.77097474658211,1.0,2/10,1.18%,SLCO3A1;SLCO2A1
prerank,retinoic acid binding (GO:0001972),-0.4623696427210253,-1.1833776778006095,0.23344947735191637,0.6027379454075045,1.0,2/12,2.50%,NR2F2;CYP26B1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5413094138020216,1.1831826765063602,0.2799442896935933,0.7685433547573652,1.0,1/16,0.08%,THBS1
prerank,transcription coregulator binding (GO:0001221),0.4497061566869777,1.1780865067330524,0.23536036036036037,0.781663488093416,1.0,17/50,20.18%,ESR1;CIT;PHF1;PER3;SMAD4;EHMT1;RORA;CCNT2;TERT;MED25;USP11;PER1;HDAC6;LCOR;THAP7;TEAD2;CHD6
prerank,protein serine/threonine kinase activity (GO:0004674),0.395914766092303,1.177373598147116,0.09009009009009009,0.7796161161972951,1.0,125/335,24.83%,EGFR;PRKCD;CIT;ULK2;CLK1;MARK1;PRKCE;ACVR1B;MAPK15;CAMKK1;CLK3;CSNK1D;CAMK2D;MAP3K5;CSNK2A2;CSNK2A1;LIMK2;FASTK;PRKCA;DYRK4;NRBP2;ACVR1;BRD4;ILK;NEK7;PRKDC;ERN2;TGFBR2;TLK1;STK39;BCR;IRAK3;CDK10;RAF1;RPS6KA4;PAK4;AKT2;KALRN;CDK12;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;RIOK1;RIPK3;ALPK1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;MAPK12;PDPK1;GRK6;NRBP1;UHMK1;CSNK1E;TGFBR1;CLK4;STK19;MAP3K10;DMPK;MARK4;WNK1;SRPK1;SQSTM1;BRD2;LATS2;CAMK4;CDC42BPB;TLK2;TRIO;TP53RK;STK16;MKNK2;SIK2;DAPK3;ARAF;BCKDK;VRK2;CLK2;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;STK35;CDK5;EIF2AK4;SGK3;MAPK9;PRKACA;VRK3;MOK;NEK4;LRRK2;CSNK1G3;MAST4;CAMK1;CDKL3;STK38;EIF2AK3;MAP3K14;PRKCI;TOP1;FAM20A;PDIK1L;NEK8;HIPK4;PLK4;TAOK3;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2;CDK13;TAOK2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3921735781008038,1.1764357878655074,0.018,0.7783265658908717,1.0,138/830,13.92%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;TWIST2;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;DEAF1;LHX9;CUX1;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;ZNF25;RXRB;NFX1;NFXL1;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;HOXA9;HOXA6;PURG;IKZF3;NRIP1;RARA;NSD1;FOXJ3;SOX9;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;ZFP90;PRDM4;SREBF1;EHF;RUNX2;ZNF260;FOXM1;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;NPAS1;MEF2A;NACC1;RUNX1;NFATC3;ZBTB9;HOXA4
prerank,nuclease activity (GO:0004518),0.4479164325178694,1.17630226598431,0.24327354260089687,0.7743697144867171,1.0,15/52,18.12%,N4BP2;RNASE7;ERN2;RNASE3;ERCC5;RNASE6;OGG1;WRN;DIS3L2;REXO1;SND1;N4BP1;AEN;DIS3;DFFB
prerank,poly(U) RNA binding (GO:0008266),0.5106190436303878,1.1754165512116672,0.2772151898734177,0.7730964062046697,1.0,8/20,13.80%,HNRNPH1;PABPC1;SSB;DAZAP1;DIS3L2;PATL1;KHDRBS1;HNRNPC
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.510743119375457,1.1751214323157597,0.2661498708010336,0.7698470160750321,1.0,15/20,34.80%,OTUB1;USP50;SENP5;USP7;OTUD5;YOD1;SENP1;USP47;DESI2;SENP3;USP21;COPS5;USP9X;COPS2;USP25
prerank,GTPase activity (GO:0003924),0.4020985094402548,1.1739338060925195,0.15532994923857868,0.7696217969263529,1.0,47/192,21.88%,GNAS;RHOJ;RHOBTB1;RHOQ;MRAS;RND3;ATL2;GNG8;TSR1;RAB2A;RAB43;RAB24;DNM2;GNL1;RAB21;ATL3;GNL2;RAB8A;RHOT2;TBC1D24;GBP6;GSPT1;RHOA;RHOT1;RAB38;RAB11B;ARL2;GNAO1;RAB23;RHOB;GNA11;RAB3B;RASL12;GPN3;NKIRAS1;EFL1;RAB5B;DRG2;RHEB;ENTPD7;GNB1;RAB4A;ATL1;LRRK2;RAB1A;RAB18;MFN1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.39939439334537974,-1.1723659452568937,0.2073170731707317,0.6190125285828566,1.0,3/18,1.02%,TGFBR3;ENG;LTBP1
prerank,phospholipase activity (GO:0004620),0.42506343960775905,1.1721145370920556,0.2261904761904762,0.7718035747795107,1.0,15/67,20.26%,MGLL;PLCE1;PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;PDIA3;ABHD6;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;SEC23IP;PLCB2
prerank,kinase binding (GO:0019900),0.3933944126760119,1.1712287957666347,0.066,0.7706157304975216,1.0,110/435,20.24%,ESR1;EGFR;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;TCF7L2;TTC28;GSN;SRCIN1;CNTLN;TIAM1;DLG2;GHR;RND3;PPP1CC;SHC1;SPRED2;STRADA;CARD16;STAT3;CD3E;CSPG4;NISCH;ATF4;TAX1BP1;NBEA;AP2A1;CALM2;MAVS;DVL1;TOM1L1;ILK;PRAM1;ADAM10;ANKRA2;ANK2;IRAK3;SKI;LLGL1;SLC12A4;DLG4;TRIM27;FZD5;LAPTM4B;RBBP6;CDC6;CDK5RAP3;DGKQ;DLG1;TSKS;RHOA;DCTN2;NSF;PAK2;CDC25B;FOXM1;IRAK1;MAP3K12;TELO2;AXIN1;CHEK2;RCC2;CHP1;PTPN2;AP2A2;MAPRE3;SNAP91;CASP1;WNK1;UBQLN1;CLTC;SQSTM1;ACSL3;PRDX3;RHOB;CAMK2N1;PER1;STX1A;STUB1;IQGAP1;FOXO3;GSKIP;PIP5K1A;PARP1;TPRKB;CDC25A;CALM3;UFL1;NR3C1;PRKAG1;TRIM6;VRK2;CNOT9;SUFU;RB1CC1;LRRC14;ATF2;CRK;CKS1B;PEBP1;PTPN23;WWC2;PRKAB1;TRIP6;MAP2K3;MAPKAP1;DCTN1
prerank,NADP binding (GO:0050661),0.47185078289538923,1.170895880424379,0.26181818181818184,0.7677043830065741,1.0,8/32,16.24%,ME1;GMDS;CRYZ;MTRR;CBR4;NNT;CAT;PGD
prerank,calcium ion binding (GO:0005509),0.39412881035327507,1.1700686614605218,0.0990990990990991,0.766353278711821,1.0,58/323,16.03%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;GSN;PLA2G4F;ACER3;PLA2G4A;COLEC11;SYT8;DMP1;COMP;CALML4;CRACR2A;ANXA7;NOL3;SPARC;ANXA2;ANXA4;C2CD5;PITPNM1;DSG3;CALM2;THBS3;S100A10;TKT;ARSA;KCNIP2;S100B;TRPM4;STIM1;PGS1;CALU;ANXA1;PLA2G5;RCN1;HSPA5;AOC3;CHP1;MICU2;LETM1;LRP2;S100A1;DCHS1;NUCB1;SRR;MICU1;SCIN;CALB2;NCS1;PKD2L1;IQGAP1;TCHH;PLSCR3;GALNT3
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5178580493638569,1.1685090137166618,0.27807486631016043,0.7671772576026681,1.0,2/17,2.49%,GRIK4;GRIN3A
prerank,cGMP binding (GO:0030553),0.5728983190668128,1.1675621666194949,0.2863013698630137,0.7664749090994479,1.0,1/11,0.87%,PDE11A
prerank,omega peptidase activity (GO:0008242),0.4183064293153098,1.1665795959140528,0.22375397667020147,0.765806459628265,1.0,49/89,30.65%,USP24;USP2;OTUB1;USP50;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;ASRGL1;USP26;COPS5
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.4778575463549182,1.1654620390423718,0.2968944099378882,0.7653603461103559,1.0,4/26,2.98%,SLC5A6;SLC16A9;SLC16A1;SLC26A6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3998860818885903,1.1645950657961508,0.1743119266055046,0.7641096037327406,1.0,35/181,14.16%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;MDFIC;NCOR2;HDAC4;RXRA;BAZ2A;STAT3;ANXA4;ATF4;BCAS3;TACC2;DACT1;NFE2L2;BHLHE40;JUP;NRIP1;CDK5RAP3;NFATC1;WWP2;RBBP8;MIER2;ATN1;RNF25;COMMD7;TAF6;HDAC1;PSMA6;BBS5;MEF2A;PIAS4
prerank,secondary active transmembrane transporter activity (GO:0015291),0.44442699796916246,1.1641227114065391,0.26996625421822273,0.7617189305585059,1.0,9/51,12.46%,SLC4A4;SLC5A6;SLCO3A1;SLCO2A1;MCU;SLC28A2;CLCN4;SLC25A3;SLC35E1
prerank,mRNA binding (GO:0003729),0.39091539720175583,1.1595774407786392,0.13869346733668342,0.7728389883909231,1.0,94/249,25.09%,SRSF6;DDX5;YBX3;GNL3;LUC7L2;SRSF1;PABPC1;ARC;SAMD4A;SRSF5;HDLBP;RBFOX2;CELF4;EIF4G2;SNRNP70;SSB;PUM1;CRYZ;PPP1R8;HNRNPA2B1;EIF4G3;RBM47;ACO1;CELF3;LUC7L;LUC7L3;ZC3H12D;HNRNPL;SF3B1;RBM25;PCBP4;MYEF2;ZC3H11A;DAZAP1;AUH;RBM5;ZC3H12C;FUBP1;EIF4A1;MARF1;KHDRBS1;AGO2;EIF4G1;HNRNPM;PCBP2;PTBP1;RBM4;HNRNPC;ETF1;G3BP2;EIF2S2;HNRNPK;YTHDC1;NCBP3;IREB2;THOC2;FYTTD1;N4BP1;PCF11;EIF3D;EIF3A;RC3H2;NCBP1;SLC4A1AP;SHMT2;SECISBP2;KHNYN;AQR;CPSF6;NCBP2;SHMT1;SYNCRIP;CLUH;CSTF2;TRA2B;UNK;CALR;CIRBP;EIF2A;CSTF2T;FXR2;SRSF4;SHFL;RNF20;DCP1A;SF3B6;HNRNPU;SF1;TP53;RBM24;PABPC4;UPF3B;C1QBP;SNRNP35
prerank,sodium channel regulator activity (GO:0017080),0.45654371264637367,1.1594748781513955,0.2925089179548157,0.7691478868149226,1.0,6/37,7.38%,FGF13;FXYD5;NEDD4;PTPN3;CAMK2D;SNTA1
prerank,phospholipase inhibitor activity (GO:0004859),0.5726559044681727,1.1583245468944063,0.3124108416547789,0.7690744084564636,1.0,3/10,9.70%,ANXA2;ANXA4;ANXA1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.385182225499236,-1.1578597936798243,0.23557692307692307,0.6209758481569352,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.385182225499236,-1.1578597936798243,0.23557692307692307,0.6209758481569352,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.385182225499236,-1.1578597936798243,0.23557692307692307,0.6209758481569352,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4907213800397373,1.1569787873708963,0.3098958333333333,0.7700445293664706,1.0,9/22,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5044234994644148,1.1563661748546006,0.2917771883289125,0.7680136814539604,1.0,2/19,5.17%,GRIK4;GABRA3
prerank,poly-purine tract binding (GO:0070717),-0.3488723185602177,-1.1563284096800825,0.22077922077922077,0.6138705314566713,1.0,9/27,14.42%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X;ATXN1;MCRS1;PABPC4L;KHDRBS2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4574046463889695,1.1543474368906514,0.29376498800959233,0.7704042552696133,1.0,15/35,27.07%,FOXP1;BAZ2A;AGO1;HDAC1;AGO2;NR3C1;KLF10;TAF1C;TBP;FOS;TAF1;TP53;SMARCA4;H3-3A;UBTF
prerank,nuclear receptor binding (GO:0016922),0.402316316416343,1.1528025963286703,0.23180873180873182,0.7715281870646382,1.0,29/111,20.37%,ESR1;FOXP1;TCF7L2;DDX5;NCOR2;JMJD1C;RXRA;BAZ2A;BCAS3;TACC2;THRAP3;JUP;NRIP1;NSD1;MED13;RNF14;MED25;TGFB1I1;DCAF13;MMS19;DNAAF4;MED14;LCOR;HMGA1;MED12;CCDC62;BRD8;TRIP6;CALR
prerank,copper ion binding (GO:0005507),-0.31709569764781376,-1.1502383923305155,0.2348993288590604,0.6182273834774485,1.0,11/42,18.02%,PAM;MOXD1;SOD3;LACC1;LOXL3;SUMF1;CUTA;SNCA;S100A13;ATP13A2;MT3
prerank,carboxylic acid binding (GO:0031406),0.44643579088040053,1.1501164376861612,0.2888631090487239,0.7764736655143596,1.0,15/38,20.41%,GCLC;GRIN3A;SESN3;EPDR1;CASTOR2;AKR1C1;SESN2;SRR;SHMT2;GNMT;CAD;SHMT1;UBR2;PHYH;GLRB
prerank,N-methyltransferase activity (GO:0008170),0.5029176851424727,1.1496459042150904,0.3011734028683181,0.7741438599279501,1.0,10/20,29.92%,PEMT;NNMT;TRMT1;HNMT;GNMT;TFB2M;PRMT1;RNMT;TRMT1L;METTL15
prerank,phosphatidate phosphatase activity (GO:0008195),0.5346889957089848,1.1491045656523247,0.31911966987620355,0.7719212375711416,1.0,3/13,6.19%,PLPP3;PLPP5;PLPP1
prerank,cysteine-type peptidase activity (GO:0008234),0.4207214206891162,1.1469688435717733,0.26282051282051283,0.7749693846919702,1.0,37/73,30.41%,USP24;USP2;USP50;CAPN2;USP40;PDIA3;USP48;USP34;USP11;USP7;CASP1;USP33;USP36;USP13;USP35;OTULIN;USP10;USP46;USP1;CTSZ;UCHL1;USP5;CTSB;USP47;CTSK;CTSO;USP49;USP14;USP21;USP16;USP37;USP30;ATG4A;CASP2;BLMH;CASP6;USP26
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.40208246637399725,-1.1465347968183675,0.26953125,0.6168093350477872,1.0,7/16,16.40%,SLC13A3;SLC25A13;SLC1A1;SLC38A7;SLC25A14;SLC13A5;SLC25A30
prerank,growth factor activity (GO:0008083),0.417329462207361,1.145437009116127,0.27116827438370844,0.7758719019212071,1.0,5/74,2.08%,PGF;VEGFA;FGF2;OSGIN2;FGF17
prerank,filamin binding (GO:0031005),-0.44450296992712524,-1.1453180481489122,0.2876712328767123,0.6100750987423371,1.0,6/11,13.26%,NEBL;SYNPO2;RFLNA;CEACAM1;FBLIM1;RFLNB
prerank,carbohydrate kinase activity (GO:0019200),-0.4471959013364233,-1.1436634677460824,0.2971246006389776,0.6045541846537472,1.0,5/11,21.65%,HK2;GALK2;FGGY;XYLB;KHK
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4996385440680275,1.1435814792269627,0.3201024327784891,0.7779663177296416,1.0,5/20,9.86%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5302826797954359,1.141997451654608,0.32865168539325845,0.7789759129550563,1.0,6/14,21.74%,RSAD1;ACO1;ETFDH;ISCA2;IREB2;ISCU
prerank,lipoprotein particle binding (GO:0071813),0.5000550819206608,1.1368818300514465,0.3189771197846568,0.7913994471239089,1.0,1/20,0.08%,THBS1
prerank,protein kinase C activity (GO:0004697),0.529710960172761,1.1355622657633977,0.32602739726027397,0.7919076587028692,1.0,4/14,9.99%,PRKCD;PRKCE;PRKCA;SMG1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.37468645338795914,-1.1334756698277182,0.25471698113207547,0.6198586239031045,1.0,8/22,21.99%,DUSP16;DUSP10;DUSP3;MTMR3;DUSP6;DUSP15;DUSP4;CDKN3
prerank,DNA-binding transcription factor binding (GO:0140297),0.3895231323581776,1.1325140209706663,0.21169354838709678,0.7979985373833497,1.0,58/189,25.09%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;PRDM5;TWIST1;TLE2;HDAC9;HDAC4;STAT3;ATF4;TLE6;DACT1;NFE2L2;BHLHE40;HMGB1;SKI;DGKQ;NFATC1;WWP2;TLE3;RBBP8;MIER2;ATN1;SRF;HDAC1;MEF2D;BBS5;MEF2A;MAP3K10;PIAS4;PSMC5;CRTC2;CREB1;CREBBP;RBL2;MTA3;CBX5;DAPK3;HCFC1;ATF2;HIPK2;TCF3;NOC2L;MAD2L2;MIER1;TBP;TXLNG;FOS;TAF1;TP53;CHD4;CRTC1;NCOR1;HDAC2;BBS7
prerank,calcium-dependent phospholipid binding (GO:0005544),0.42343839464658883,1.13033694342163,0.30419977298524403,0.8010417289128154,1.0,6/49,4.37%,PLA2G4F;PLA2G4A;SYT8;ANXA2;ANXA4;C2CD5
prerank,alpha-actinin binding (GO:0051393),0.4751453511458209,1.1295006396469482,0.32614213197969544,0.8001035394697051,1.0,4/24,8.22%,CACNA1C;PDLIM7;RARA;PALLD
prerank,Toll-like receptor binding (GO:0035325),-0.46188316694596343,-1.1292712168154988,0.31715210355987056,0.6207496820799213,1.0,6/11,29.65%,TOLLIP;UNC93B1;MYD88;CD36;TLR6;TLR2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.532887892438768,1.1283566945816195,0.3342503438789546,0.7999402954341268,1.0,4/14,21.79%,AK5;DTYMK;AK1;NME3
prerank,solute:proton symporter activity (GO:0015295),0.5126122654760941,1.1279259824560393,0.3478854024556617,0.7975148449529047,1.0,5/16,17.11%,SLC2A13;SLC2A9;SLC25A3;SLC17A5;SLC2A10
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5289659086654069,1.12677133715705,0.34535367545076284,0.7975981075325775,1.0,6/14,22.24%,MINDY4;USP7;USP13;OTUD5;YOD1;DESI2
prerank,acid-thiol ligase activity (GO:0016878),-0.42651852840572685,-1.1210890522575758,0.29454545454545455,0.6310996384853624,1.0,3/13,5.77%,ACSS3;ACSL1;ACSS2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4048874158077486,1.1200149284585947,0.2849344978165939,0.8153842750672483,1.0,11/72,7.66%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;FZD7;SLC9A1;FCHO2
prerank,DNA replication origin binding (GO:0003688),0.4771508233693166,1.1193897296614352,0.32595325953259535,0.813801475481444,1.0,8/23,20.43%,MCMDC2;MCM2;CDC6;CDC45;HSPD1;MCM4;ORC2;KAT7
prerank,guanyl ribonucleotide binding (GO:0032561),0.3840248783393948,1.119226925737502,0.22672064777327935,0.8105534010579856,1.0,29/196,11.34%,RHOJ;RHOBTB1;PDE11A;RHOQ;MRAS;TUBG2;RND3;GNL3;ATL2;TSR1;RAB2A;DNM2;GNL1;RAB21;ATL3;GNL2;RABL6;RAB8A;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5212464341220296,1.1183499985156984,0.3537803138373752,0.8095878736554579,1.0,4/12,13.22%,JMJD1C;PHF8;KDM4A;HR
prerank,neurexin family protein binding (GO:0042043),0.5584746140080109,1.1158187571466616,0.3472622478386167,0.8136520763404335,1.0,4/10,17.30%,CEL;SYTL5;NLGN1;SYTL4
prerank,lipase activator activity (GO:0060229),-0.4584105410715835,-1.1133009855594485,0.33774834437086093,0.640123932274323,1.0,1/10,0.73%,ARHGAP6
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4357616960480902,-1.1132633955279465,0.3191489361702128,0.630999266468656,1.0,5/12,25.54%,SLC2A1;SLC5A3;SLC2A4;SLC2A3;MFSD4A
prerank,FAD binding (GO:0071949),0.4721298535345147,1.1097080881457788,0.3379396984924623,0.8294672816133477,1.0,8/24,21.86%,MICAL2;QSOX1;MTRR;AIFM1;AGPS;DAO;MTHFR;CRY2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5090338485261888,1.1088480349668657,0.36129905277401897,0.8285142359696942,1.0,3/14,2.67%,TIMP2;TIMP3;RARRES1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4861941775983521,1.1078307127431501,0.35149863760217986,0.828067782413967,1.0,7/18,12.61%,INHBC;SMAD6;TGFB3;TGFB2;TGFBR2;SMAD7;TGFBR1
prerank,disordered domain specific binding (GO:0097718),0.4593886264116455,1.105681242905946,0.3363754889178618,0.8314835959443815,1.0,7/23,19.35%,HSPA2;CALM2;BCL2L2;CLTC;CALM3;DFFB;TEAD2
prerank,hydro-lyase activity (GO:0016836),0.4299406794930812,1.1051236751626956,0.3341121495327103,0.8295118990003307,1.0,14/41,24.87%,EHHADH;ECHDC2;GMDS;ACO1;AUH;IREB2;ENO2;L3HYPDH;CDYL;UROS;ECHDC1;HADHA;PCBD2;ENO4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5370283385807012,1.1041710417691017,0.37333333333333335,0.828766044362303,1.0,2/11,8.43%,CHRNB2;CHRNA5
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3897517871946491,1.1039218823763275,0.30965005302226933,0.8258195764493942,1.0,15/91,9.26%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;FZD7;SLC9A1;GBF1;WIPI2;FCHO2;LAPTM4B;SH3PXD2B
prerank,protein phosphatase binding (GO:0019903),0.3819628706298809,1.102623492332771,0.3062692702980473,0.8262459340061048,1.0,41/117,24.98%,EGFR;GRIN3A;PPP1R3C;ANAPC5;PPP1R9B;MAP3K5;STAT3;VCP;ADCY8;SLC9A1;STRN4;JUP;DLG4;PPP6R1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;SOD1;ANAPC4;TRAF3;ARPP19;IQGAP1;ERBB2;KCNN4;CDC27;IKBKE;ATP2B4;AKAP11;VRK3;MAP2K7;JAK1;EIF2AK3;PPP1R3B;BOD1L1;PXN;TP53;SNX3;BAD;TBK1;AP3B1
prerank,cholesterol transfer activity (GO:0120020),-0.384209243456586,-1.1022941515575049,0.3244274809160305,0.6473730540235294,1.0,4/16,6.96%,PLTP;ABCG1;GRAMD1B;STARD4
prerank,lysine N-methyltransferase activity (GO:0016278),0.48203862656919444,1.0974738533841242,0.3641025641025641,0.8388561041143568,1.0,9/20,26.51%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;EHMT2;SETD7
prerank,NF-kappaB binding (GO:0051059),0.46361033617210945,1.0972162444617695,0.3552123552123552,0.8360475944793536,1.0,6/24,12.75%,ANXA4;CDK5RAP3;RNF25;COMMD7;HDAC1;PSMA6
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3953203118747095,-1.0969942430915944,0.30714285714285716,0.6519781719932515,1.0,6/15,24.19%,COX8A;COX4I1;COX10;COX5B;NDUFA4L2;NDUFA4
prerank,"DNA binding, bending (GO:0008301)",0.49919400428783656,1.092393991997471,0.36644295302013424,0.848023702443982,1.0,3/14,8.86%,FOXD1;HMGB1;FOXL1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4195849680474529,1.0905309428943273,0.34762456546929316,0.850099633770644,1.0,14/46,26.08%,EXT1;B3GNT7;OGT;MGAT4B;HEXA;B3GNT9;B4GAT1;B3GNT6;EXT2;GCNT7;B3GNT2;PIGQ;MGAT5;RFNG
prerank,NADPH binding (GO:0070402),0.5076109368131152,1.089698721460542,0.3774373259052925,0.8490852994849699,1.0,3/13,10.36%,CRYZ;MTRR;CBR4
prerank,Hsp70 protein binding (GO:0030544),0.4411439365885188,1.0886865101559096,0.36609336609336607,0.8486564979358912,1.0,15/31,30.99%,SPN;DNAJB14;HIKESHI;PPEF2;STUB1;DNAJC18;DNAJA1;DNAJC2;RNF207;DNAJB12;PPID;ERN1;DNAJB1;PRKN;GPR37
prerank,metal ion binding (GO:0046872),0.3632110763508331,1.0870916273587339,0.213,0.850111577880477,1.0,82/477,16.03%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;EYA2;GSN;PLA2G4F;GCLC;ACER3;PLA2G4A;COLEC11;SYT8;MARK1;DMP1;COMP;CALML4;CRACR2A;ANXA7;NOL3;SPARC;MAP3K5;ANXA2;ANXA4;C2CD5;PITPNM1;DSG3;ADCY2;CALM2;THBS3;S100A10;ERN2;TKT;ARSA;KCNIP2;IRAK3;TRIM27;S100B;DCTPP1;TRPM4;STIM1;PGS1;CALU;ANXA1;WRN;HMGCL;PLA2G5;PPA2;SNN;RCN1;ABL1;DIS3L2;TDG;MAPK12;HSPA5;CLYBL;AOC3;MTHFD2;CHP1;MICU2;LETM1;LRP2;S100A1;DCHS1;PI4K2A;NUCB1;TRIM26;SRR;SRPK1;MICU1;SCIN;CALB2;NCS1;PKD2L1;IQGAP1;TCHH;HACL1;CDC42BPB;PLSCR3;GALNT3
prerank,protein homodimerization activity (GO:0042803),0.3608712253826553,1.0833343562647348,0.194,0.8583141142094884,1.0,158/590,22.80%,PRPS2;SLIT2;FOXP2;LRP6;EXT1;MGLL;PRMT8;VEGFA;ABCD3;SRGAP2;NPR3;ECE1;NTRK1;GHR;LDB1;PEX7;AOX1;PSMD7;GALE;CAMK2D;GOLGA5;FAP;MAP3K5;SNX2;TGFB2;STAT3;XDH;MID1;NECTIN3;PEX11A;HM13;TMEM266;STARD3NL;ADCY8;ACVR1;CPQ;S100A10;SMAD4;NAA60;ADAM10;KLHL7;BHLHE40;TKT;PRKRA;FGFR1;IRAK3;JUP;MUC13;TRIM27;XPNPEP1;IKZF3;S100B;NFS1;ERCC5;NOG;TIMM9;EEA1;ST3GAL2;SNX1;FGFR2;WRN;SLC39A13;PIP4K2B;MYOM3;ATIC;CHUK;CCDC66;IRAK1;MAP3K12;TDG;TERT;BCL2L2;NRF1;BMPR1A;AXIN1;CHEK2;SNX9;SFPQ;DGCR8;DARS2;SRF;MID2;NRBP1;TENM1;CIDEA;STK25;S100A1;ADD1;PAFAH1B2;ERP29;ALDH3A2;SRM;MAP3K10;UBA5;NDP;SUPV3L1;GUCY2D;SRR;CARNMT1;DCLRE1B;HPS4;CAT;GRHL1;STUB1;CRYL1;WDR54;GSTZ1;NECTIN1;IDE;FECH;HIP1;YARS2;ACP3;SHMT2;DNTTIP1;HMOX1;EPRS1;DAPK3;COQ9;GLB1;TRIM6;KIF20B;CNOT9;SHMT1;AOC1;AKT1;GDNF;ACSL6;EXT2;PAFAH1B3;PHETA2;SARS1;MLXIPL;IRF3;TCF3;DPY30;APPL2;APPL1;MTMR1;CHMP4A;CHMP4B;KYAT1;TPD52;PDCD6IP;FBLN5;LRRK2;PANK3;FXR2;SMIM1;STARD3;ABCD1;TRIM8;ASMT;ABCG2;KMT2A;SLC11A1;TSC2;TMEM192
prerank,telomeric DNA binding (GO:0042162),0.43285361385385046,1.078831852630351,0.4081145584725537,0.8690993223889067,1.0,11/32,22.91%,HNRNPA2B1;SMG6;WRN;SMG1;TERT;TELO2;TEN1;RAD50;XRCC6;UPF1;UPF3A
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.43165093223150297,1.0774435031745215,0.37484433374844334,0.8697853138271192,1.0,10/32,23.69%,FTO;RIOX2;KDM2A;PHF8;KDM4A;ALKBH1;HSPBAP1;TET2;PHYH;ALKBH3
prerank,voltage-gated calcium channel activity (GO:0005245),0.42127875633079054,1.075017148999827,0.37822014051522246,0.8740408568605745,1.0,6/37,11.24%,CACNA1G;CACNA1C;CACHD1;CATSPER3;ITGAV;CACNA2D2
prerank,acetyltransferase activity (GO:0016407),0.43920994390286083,1.071417626117353,0.391304347826087,0.8814543292035623,1.0,12/31,26.60%,SAT2;KAT6B;NAA16;ACAT1;PAFAH1B2;CREBBP;PAFAH1B3;ELP3;KAT8;KAT2B;NAA15;ESCO1
prerank,phosphatase binding (GO:0019902),0.37630836492178943,1.0709929641317875,0.36468129571577845,0.879085936122049,1.0,39/105,24.98%,EGFR;PPP1R3C;ANAPC5;MAP3K5;STAT3;SFI1;VCP;JUP;DLG4;TRPC4AP;PPP6R1;DLG1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;ANAPC4;TRAF3;WNK1;IQGAP1;ERBB2;KCNN4;CNST;MAST2;CDC27;IKBKE;RCAN3;VRK3;MAP2K7;CRY2;JAK1;EIF2AK3;TSC2;PXN;TP53;SNX3;BAD;TBK1;AP3B1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5051870560278869,1.0694558429698882,0.3994413407821229,0.8801481007727807,1.0,5/12,27.18%,OPN1MW;OPN1MW3;OPN3;RRH;GPR52
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.532140699113605,1.0690838943172187,0.41228070175438597,0.8775458297645541,1.0,3/10,12.37%,PIK3C2B;ATM;PIK3CB
prerank,3'-5' exonuclease activity (GO:0008408),0.4113590748466086,1.0684064935141784,0.37093023255813956,0.8760134631033155,1.0,10/45,17.07%,REV3L;ERI3;REXO2;RAD1;WRN;DIS3L2;RAD50;EXOSC4;CNOT8;DIS3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.40371164354831485,1.0674953309273854,0.377212389380531,0.8754194745057956,1.0,21/54,26.35%,ACER3;HDAC9;HDAC4;SIRT5;PM20D2;NTAN1;MIER2;HDAC1;PIGL;NGLY1;SIRT2;HDAC6;NTAQ1;ASAH1;DARS1;HINT3;MIER1;VNN1;HDAC2;SUDS3;FAAH
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4122631783487366,1.0655270562515673,0.37894736842105264,0.8777829053887076,1.0,18/38,26.23%,IRS1;GAB2;SHC1;CD3E;SH2B1;AXIN1;SHANK1;G3BP2;MMS19;SPAG9;TRAT1;NUP62;MAPK8IP3;LRRK2;DLG5;TRADD;PTPN11;NCK1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4267458921391454,1.0651470975453134,0.39927623642943305,0.8754635306511391,1.0,15/34,31.19%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETDB1;SETD4;MEN1;SUV39H1;SETD2;SMYD2;EHMT2;SETD7;NSD3;TTLL12;EEF2KMT
prerank,magnesium ion binding (GO:0000287),0.368972164737828,1.0633749294247217,0.3532440782698249,0.8773120321514777,1.0,41/135,27.62%,EYA2;GCLC;MARK1;MAP3K5;ADCY2;ERN2;TKT;IRAK3;DCTPP1;WRN;HMGCL;PPA2;ABL1;DIS3L2;TDG;MAPK12;CLYBL;MTHFD2;PI4K2A;SRR;SRPK1;HACL1;CDC42BPB;PLSCR3;XYLT2;SIK2;PPA1;MAST2;RHEB;ENDOV;MAP2K7;LRRK2;STK38;PINK1;NUDT18;STK3;NIM1K;ERN1;NEK6;ADPRS;ABL2
prerank,CCR chemokine receptor binding (GO:0048020),0.43593552449568845,1.062103940502024,0.4028605482717521,0.8775688971844005,1.0,4/28,12.09%,CCL13;CCL15;CNIH4;DEFB1
prerank,myosin V binding (GO:0031489),0.4885485439939901,1.061572791001199,0.40198863636363635,0.8756501393752901,1.0,4/15,15.41%,RAB8A;RAB3D;RAB11B;RAB3B
prerank,potassium channel regulator activity (GO:0015459),-0.29186742410841016,-1.0577684856470793,0.328,0.7421511467289339,1.0,9/49,8.91%,NEDD4L;DPP10;KCNIP3;KCNIP4;KCNIP1;ABCC9;WNK2;SLC5A3;DPP6
prerank,syntaxin binding (GO:0019905),0.39141461004431183,1.057260534766076,0.39499455930359084,0.8855536538292252,1.0,16/61,17.80%,SYT8;UNC13B;PRRT2;VPS52;NSF;SCFD1;ABL1;TMED9;STXBP5;PTPN2;ABCA1;SNAP23;SCFD2;STX16;VPS11;NAPA
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.49779561922567295,1.056766706645915,0.42097902097902096,0.8835667163486838,1.0,5/13,27.51%,TARBP1;TRMT1;THUMPD3;METTL1;TRMT1L
prerank,nucleotidase activity (GO:0008252),0.4807590662805119,1.056679061617198,0.4122448979591837,0.8803008820392472,1.0,6/15,22.70%,NT5DC3;NT5C3B;BPNT1;ACP3;NT5C;NT5DC1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4178645042910172,-1.056449920296004,0.38380281690140844,0.7353863228521804,1.0,6/11,24.15%,PPP1R1A;PPP1R2;PPP1R14C;PPP1R11;PPP1R14A;PPP1R14B
prerank,transition metal ion binding (GO:0046914),0.3529721410677902,1.0562858398689192,0.3123123123123123,0.8781030000557017,1.0,113/397,24.40%,ADAMTS3;ME1;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;AOX1;SEC23A;HDAC4;RXRA;SORD;TRIM28;ADCY2;CHD3;ADA;GLO1;SIRT5;SCD5;SKI;MDM4;B4GALT1;TES;XPNPEP1;NSD1;S100B;TIMM9;EEA1;PPM1M;SMPDL3A;SLC30A5;WRN;HMGCL;KDM2A;ABL1;PHF8;TAB2;ABCE1;KDM5B;AGMO;RNF2;SOD1;AOC3;KDM4A;CHORDC1;FBXL19;SEC24C;SEC24B;QPCTL;ISCA2;MMP16;USP33;UBA5;PIAS4;RNF11;LACTB2;LNPEP;MBD1;SIRT2;GALNT1;PLSCR3;IDE;GALNT3;ZFPL1;MPPED2;KDM5C;PLA2G15;KMT2B;XYLT2;DPF3;PRDM2;SHMT2;SEC24A;EPRS1;ALKBH8;COA6;SUV39H2;CAD;SHMT1;ZMYND11;RNF7;AOC1;ZBTB32;NPEPPS;MYCBP2;TK1;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20;ZKSCAN5;NEK4;ISCU;TRIM8;LOXL2;KMT2A;GPC1;GALNT2;CYLD;B4GALT7;DPEP1;CZIB;PRIMPOL;ARG2;PHEX;TP53;RASSF1;CHD4
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4132161417248787,-1.054779820759874,0.4175084175084175,0.729728561052386,1.0,5/12,22.57%,STAT1;BABAM2;TRAP1;TRAF2;TRAF1
prerank,ADP binding (GO:0043531),0.4408633151122081,1.0537895898425806,0.42039800995024873,0.8825918636749195,1.0,2/25,1.56%,ME1;GCLC
prerank,chemokine receptor activity (GO:0004950),0.4436493216012386,1.0536819973383187,0.3992146596858639,0.8793998136768556,1.0,2/24,8.47%,CMKLR1;ACKR4
prerank,sialyltransferase activity (GO:0008373),0.45704937188980804,1.0533177991274167,0.4183937823834197,0.8769555770560378,1.0,4/20,8.59%,ST3GAL4;ST8SIA2;ST6GALNAC5;ST3GAL2
prerank,lipid phosphatase activity (GO:0042577),0.484207501424872,1.0525059007675113,0.41517241379310343,0.876008902446433,1.0,2/14,6.19%,PLPP3;PLPP1
prerank,CoA-ligase activity (GO:0016405),-0.3920152378917652,-1.0523127704435224,0.3663003663003663,0.7265505403931573,1.0,3/14,5.77%,ACSS3;ACSL1;ACSS2
prerank,calcium channel activity (GO:0005262),0.37409738734158865,1.0515193558450706,0.4021164021164021,0.8755399358276157,1.0,13/84,11.24%,PKD1;CACNA1C;SLC24A3;SEC61A1;TRPV3;ANXA2;CACHD1;MCU;TRPM7;TRPM4;CATSPER3;ITGAV;CACNA2D2
prerank,heme binding (GO:0020037),0.3871085918933006,1.0513901854619576,0.40331491712707185,0.8725939677023278,1.0,14/65,14.94%,PTGIS;CYP19A1;CYP1B1;FLVCR1;HMOX2;NOX4;HEBP1;PTGES2;RSAD1;DGCR8;SUOX;CYP2U1;ABCB6;CAT
prerank,gamma-tubulin binding (GO:0043015),0.44570411374528274,1.0510289423708834,0.41229193341869397,0.8703058086705932,1.0,6/22,13.88%,TUBGCP3;BLOC1S2;NDRG1;GIT1;RAB11FIP5;MARK4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.361211653602289,1.0496881345383757,0.3961499493414387,0.8709311958153501,1.0,25/188,9.84%,BNC2;SIX1;TCF7L2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;PER3;SMAD4;NFE2L2;HMGB1;PBX1;TBX21;TFE3;FOXK1;CARM1;HNRNPL;FOXA1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5155081311390376,1.0495347743970413,0.4229137199434229,0.8680331498438745,1.0,5/10,24.16%,NSD1;ASH1L;SETD5;SETD2;SMYD2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4489126696285656,1.049189419220801,0.4165588615782665,0.8657774223897757,1.0,8/22,20.48%,APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU
prerank,single-stranded RNA binding (GO:0003727),0.4024653038391953,1.048420252296974,0.41446613088404133,0.8646388006563047,1.0,19/43,29.21%,STRBP;SRA1;ILF3;AGO1;LONP1;AGO2;PTBP1;U2AF2;LACTB2;AQR;ENDOV;HNRNPA1;EIF4B;PUS1;HNRNPU;ZFR;FXR1;EIF4H;DDX11
prerank,actin monomer binding (GO:0003785),0.4430931310079108,1.0459412284350105,0.42987012987012985,0.8688897966742736,1.0,6/22,13.38%,PRKCE;LIMA1;COBL;PFN2;ABL1;PFN4
prerank,ribosome binding (GO:0043022),0.40050832667368713,1.045895326186768,0.40711009174311924,0.8657443371848986,1.0,20/46,29.73%,RPSA;SEC61A1;NAA16;NCLN;ETF1;EIF6;EFL1;PYM1;EIF2A;EIF2S1;SBDS;SHFL;SRP72;C1QBP;NAA15;SEC61B;CCDC47;YTHDF1;IGHMBP2;ERI1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35522191906645423,1.0455288809296814,0.36958710976837866,0.8635163991077348,1.0,95/269,27.28%,EGFR;SMAD6;PRR7;ACVR1B;FHIT;GLMN;UBE2B;SNCAIP;TRIM28;MID1;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;FAF2;SLF2;FZD5;PA2G4;LAPTM4B;CDK5RAP3;ITCH;CUL4A;LTBR;UBE2C;AXIN1;CHEK2;SNX9;SMAD7;HSPA5;KDM4A;TRAF3;CUL1;HSPD1;TANK;MC4R;PCBP2;YWHAE;USP7;SLC22A18;PIAS4;SQSTM1;PSMD1;USP13;UBE2L6;PER1;ARRB1;STUB1;CKB;HDAC6;CXCR4;RPS27A;UBC;APBB1;SUMO1;YOD1;NPLOC4;BLZF1;DNAJA1;IKBKE;NFKBIA;SCAMP3;PSMA3;UCHL1;CALR;CLU;PRKACA;PRKAR2A;UBOX5;MUL1;SLF1;SMAD5;ABI2;JAK1;SUMO2;DERL1;RNF20;TCP1;DET1;CAMLG;TP53;PINK1;UBE2W;DAXX;SMC6;SHPRH;JKAMP;RIPK1;AMBRA1;SLC25A5;RALA;NEK6
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5193924657186915,1.043596585784132,0.427536231884058,0.8659465371835126,1.0,5/10,27.85%,NAA60;NAA40;ATF2;KAT8;USP22
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4076585518458106,1.041406609210035,0.4334916864608076,0.8691014074226849,1.0,15/38,29.19%,PLEKHA4;PLA2G4A;WIPI2;SH3PXD2B;ZFYVE19;BBS5;HIP1;SNX13;RUFY4;DENND1A;SNX3;PARD3;ATG2B;PLEKHF1;ZFYVE1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3546520290495403,1.041195255599033,0.39213709677419356,0.8664697708647131,1.0,91/254,27.28%,EGFR;SMAD6;ACVR1B;FHIT;GLMN;UBE2B;SNCAIP;TRIM28;MID1;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;FAF2;SLF2;FZD5;PA2G4;LAPTM4B;CUL4A;LTBR;AXIN1;CHEK2;SNX9;SMAD7;HSPA5;KDM4A;TRAF3;CUL1;HSPD1;TANK;MC4R;PCBP2;YWHAE;USP7;SLC22A18;PIAS4;SQSTM1;PSMD1;USP13;UBE2L6;PER1;ARRB1;STUB1;CKB;HDAC6;CXCR4;RPS27A;UBC;APBB1;SUMO1;YOD1;NPLOC4;BLZF1;DNAJA1;IKBKE;NFKBIA;SCAMP3;PSMA3;UCHL1;CALR;CLU;PRKACA;PRKAR2A;UBOX5;MUL1;SLF1;SMAD5;ABI2;JAK1;SUMO2;DERL1;RNF20;TCP1;DET1;CAMLG;TP53;PINK1;UBE2W;DAXX;SMC6;SHPRH;JKAMP;RIPK1;AMBRA1;SLC25A5;RALA;NEK6
prerank,cholesterol binding (GO:0015485),-0.2897277792680593,-1.0405344840480317,0.35537190082644626,0.7471444778698695,1.0,10/47,6.96%,OSBPL8;APOD;SIDT1;PTCH1;PROM1;ABCG1;GRAMD1B;NR1H3;OSBPL10;STARD4
prerank,nuclear receptor coactivator activity (GO:0030374),0.3911867965461468,1.0399188539375583,0.4371523915461624,0.8671118507869295,1.0,18/52,19.18%,FGF2;ZMIZ1;DCAF6;CCAR2;THRAP3;MED13;SRA1;ENY2;CARM1;SFR1;ZMIZ2;SLC30A9;MED14;HMGA1;MED12;CNOT9;CCDC62;BRD8
prerank,receptor tyrosine kinase binding (GO:0030971),0.38843420386626043,1.0395298604235534,0.44,0.8651138277090983,1.0,11/56,14.33%,IRS1;GAS6;DOCK4;GAB2;SHC1;PITPNM1;CBL;ANGPT4;SH2B1;PTPN2;SQSTM1
prerank,pyrophosphatase activity (GO:0016462),0.3959325478882458,1.0386101770779712,0.44154370034052215,0.8646491140027245,1.0,8/50,10.11%,ALPL;ENTPD2;PLPP5;ENTPD6;PLPP1;DCTPP1;DOLPP1;PPA2
prerank,zinc ion binding (GO:0008270),0.34885319515802166,1.0385580247125952,0.3807615230460922,0.8615972457670221,1.0,74/293,20.51%,ADAMTS3;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;SEC23A;HDAC4;RXRA;SORD;TRIM28;CHD3;ADA;GLO1;SIRT5;SKI;MDM4;TES;NSD1;S100B;TIMM9;EEA1;SMPDL3A;SLC30A5;KDM2A;PHF8;TAB2;KDM5B;RNF2;SOD1;KDM4A;CHORDC1;FBXL19;SEC24C;SEC24B;QPCTL;MMP16;USP33;UBA5;PIAS4;RNF11;LACTB2;LNPEP;MBD1;SIRT2;IDE;ZFPL1;KDM5C;PLA2G15;KMT2B;DPF3;PRDM2;SHMT2;SEC24A;EPRS1;ALKBH8;SUV39H2;CAD;SHMT1;ZMYND11;AOC1;ZBTB32;NPEPPS;MYCBP2;TK1;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.385034644827691,1.0371730127540941,0.42046718576195774,0.8624321290212936,1.0,15/60,11.74%,EGFR;DDR2;NTRK3;NTRK1;ACVR1B;EPHB2;ACVR1;EPHB3;EPHB6;TGFBR2;FGFR1;ROR1;FGFR2;MUSK;DDR1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.425232103332463,1.0368445758819014,0.43636363636363634,0.8602138226175715,1.0,6/30,11.18%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;TMEM165
prerank,nucleoside-triphosphatase activity (GO:0017111),0.35148987942748566,1.03667624986422,0.4159113796576032,0.8575343561702827,1.0,58/248,22.00%,GNAS;RHOJ;RHOBTB1;RHOQ;MRAS;RND3;ATL2;GNG8;TSR1;RAB2A;RAB43;CHD1L;RAB24;VCP;CHD3;MYO1E;DNM2;GNL1;RAB21;ATL3;GNL2;RAB8A;RHOT2;TBC1D24;GBP6;GSPT1;RHOA;RHOT1;RAB38;DHX29;RAB11B;ARL2;ABCB6;VWA8;GNAO1;RAB23;RHOB;GNA11;RAB3B;RASL12;GPN3;KLC1;NKIRAS1;EFL1;RAB5B;KIF20B;DRG2;RHEB;ENTPD7;CLU;GNB1;RAB4A;ATL1;LRRK2;RAB1A;RAB18;MFN1;ABCD1
prerank,Hsp90 protein binding (GO:0051879),0.41502481322089835,1.0363241829922418,0.4430992736077482,0.855371324013082,1.0,15/33,27.84%,SLC12A2;CSNK2A1;TELO2;CHORDC1;PPEF2;PTGES3L;STUB1;USP19;HDAC6;NR3C1;TSC2;UNC45A;PPID;ERN1;HSF1
prerank,chloride channel activity (GO:0005254),0.3874310729717375,1.033358910747532,0.4311111111111111,0.8605916961775925,1.0,4/59,5.17%,SLC26A7;CLIC3;CLIC4;GABRA3
prerank,chemokine activity (GO:0008009),0.41891754102940737,1.0330896400371752,0.41947115384615385,0.8583693287871644,1.0,3/31,7.22%,CCL13;CCL15;CXCL16
prerank,DNA secondary structure binding (GO:0000217),0.4131115918505762,1.030698191934538,0.42719614921780985,0.8619993054457477,1.0,9/31,22.61%,HMGB1;ERCC5;RBBP8;WRN;ABL1;MEN1;HMGA1;XRCC3;KMT2A
prerank,ligand-gated channel activity (GO:0022834),0.41665988029569995,1.030090138231551,0.44114002478314746,0.8606689317151016,1.0,4/29,8.43%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,DNA polymerase binding (GO:0070182),0.457895152220507,1.0298522938130166,0.4453125,0.8582698292926816,1.0,9/18,30.44%,HMGB1;SMG6;LONP1;POLG2;CDT1;RAD51;SMARCA4;RTEL1;HSP90AA1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.38928044982711824,-1.0297789873660126,0.4228187919463087,0.765809685604723,1.0,5/13,8.04%,IL1R1;PDGFD;PDGFRB;PDGFRA;PDGFC
prerank,ligand-gated ion channel activity (GO:0015276),0.4147238410916194,1.0290627551374587,0.437192118226601,0.8575115515688739,1.0,4/30,8.43%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.47190934587366323,1.028312835172272,0.4697802197802198,0.8566575032017355,1.0,4/15,8.51%,SOCS7;SOCS4;SOCS6;SOCS2
prerank,G protein-coupled receptor binding (GO:0001664),0.3542178604189195,1.0276100805695438,0.43465045592705165,0.8557260705782892,1.0,5/132,1.91%,MYOC;GNAS;LRP6;WNT9A;PROK2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.507983348133948,1.0273034272912245,0.44624447717231225,0.853537269745638,1.0,1/10,0.48%,CACNA1C
prerank,metalloaminopeptidase activity (GO:0070006),0.4640489806934913,1.0267279112311805,0.45152722443559096,0.8521574235037329,1.0,7/16,21.27%,MMP14;XPNPEP1;MMP16;LNPEP;NPEPPS;LVRN;RNPEPL1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4017677114082735,1.0266843515462403,0.43530834340991537,0.8492948311441524,1.0,11/35,27.91%,FTO;MTFMT;PTRH2;ALKBH1;TYW3;ELAC2;DUS1L;DUS3L;TARS2;PUS10;DTWD1
prerank,potassium channel activity (GO:0005267),0.36423999670297147,1.0259506579260356,0.44195953141640043,0.8483950465545863,1.0,8/89,9.14%,KCNK5;GRIK4;KCNB1;HCN4;KCNN1;KCNE5;KCND1;KCNK6
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.37678814758397705,-1.025673326109844,0.452,0.7668373579859126,1.0,5/16,26.49%,SLC44A1;SLC22A2;SLC22A4;SLC44A2;SLC29A4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5080507776208781,1.0242555884846019,0.46769662921348315,0.8501343188480409,1.0,1/11,2.89%,HCN4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.38036887656219875,1.0241327826360176,0.45200892857142855,0.8475941719059581,1.0,15/60,12.40%,EGFR;DDR2;CRIM1;NTRK3;NTRK1;IGF2R;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;DDR1;NRP1
prerank,receptor ligand activity (GO:0048018),0.34581600531496676,1.0234674304233338,0.4678714859437751,0.8464687214085801,1.0,21/245,7.26%,PGF;GDF10;WNT9A;VEGFA;GAS6;FGF2;OSGIN2;IL33;FGF17;INHBC;INSL6;TGFB3;SLURP1;LRPAP1;CCL15;TGFB2;SEMA3E;HMGB1;JAG1;SEMA4B;FAM3C
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.342877072582581,1.0227430261144443,0.429,0.8455571436824552,1.0,119/431,23.82%,PRPS2;RHOJ;RHOBTB1;ABCD3;N4BP2;RHOQ;MARK1;MRAS;TUBG2;RND3;GNL3;ACVR1B;ATL2;HSPA2;TSR1;SMC4;RAB2A;MAP3K5;TNK1;DNM2;ACVR1;GNL1;RAB21;ATL3;ERN2;GNL2;TLK1;RABL6;RAB8A;ABCF1;IRAK3;RHOT2;ARF4;RPS6KA4;AK6;GBP6;AKT2;NOA1;RHOA;RHOT1;RRAD;HSPA14;PIP4K2B;PEX1;ARFIP2;RAB38;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;ARF1;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;PSMA6;EIF4G1;LIG4;RAB11B;ARL2;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;RHOB;RASL12;LATS2;HACL1;CDC42BPB;TLK2;IDE;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2;DRG2;ABCF3;RHEB;MTREX;RAB4A;ATL1;LRRK2;PANK3;ANXA6;ABCD1;STK38;TUBB6;PRKCI;TOP1;PPIP5K1;CARS2;RAB1B;PYGL;ARF5;HNRNPU;SYN3;NRAS;KRAS
prerank,protein kinase binding (GO:0019901),0.34405076301746973,1.0226284415810636,0.416,0.8429710534696297,1.0,116/480,21.32%,ESR1;IRS1;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;ADAM9;TCF7L2;SRCIN1;CNTLN;GHR;PRR7;RND3;PPP1CC;SHC1;HDAC9;SPRED2;STAT3;CD3E;CSPG4;NISCH;ATF4;NBEA;AP2A1;CALM2;MAVS;DACT1;ACVR1;DVL1;PRKCSH;TOM1L1;ILK;NOX4;PRAM1;ADAM10;ANKRA2;ANK2;NBR1;IRAK3;SKI;LLGL1;SLC12A4;TRIM27;RARA;FZD5;SOX9;DACT3;RBBP6;CDK5RAP3;DLG1;TSKS;RHOA;DCTN2;NSF;PAK2;ITGAV;CDC25B;FOXM1;ABL1;IRAK1;MAP3K12;TELO2;AXIN1;CHEK2;RCC2;EZR;NELL1;KHDRBS1;PPEF2;PTPN2;AP2A2;MAPRE3;SNAP91;PICK1;WNK1;CLTC;SQSTM1;ACSL3;PRDX3;RHOB;CAMK2N1;IQGAP1;FOXO3;GSKIP;SPAG9;PARP1;TPRKB;CDC25A;CALM3;UFL1;NR3C1;PRKAG1;TRIM6;VRK2;SUFU;RB1CC1;ATF2;CRK;CKS1B;PEBP1;PTPN23;DUSP19;TCF3;PRKAB1;MAP2K3;APPL1;MAPKAP1;DCTN1;MAD2L2;PRKACA;PRKAR2A;BANK1;MAP2K7;MAPK8IP3
prerank,TBP-class protein binding (GO:0017025),0.4401572792025105,1.0217361447756304,0.4619289340101523,0.8426045834771962,1.0,1/21,0.26%,ESR1
prerank,ligand-gated anion channel activity (GO:0099095),-0.3628914247023388,-1.0210524063902804,0.38016528925619836,0.7693840146552533,1.0,7/17,14.72%,GLRA2;GABRB1;GABRB3;GABRB2;GABRA5;GLRA1;CFTR
prerank,phosphatidylinositol kinase activity (GO:0052742),0.47435088401223535,1.0201488631690887,0.4513888888888889,0.8440939334707637,1.0,5/15,16.07%,PIK3C2B;ATM;PIK3CB;PI4K2A;PI4KB
prerank,DNA binding (GO:0003677),0.338849299853604,1.0188064986998295,0.42,0.8448063844397523,1.0,154/694,20.49%,FOXP2;PLAGL1;EGFR;SIX1;KLF12;HOXA5;C1D;ZNF423;FOXD1;NFIB;TCF7L2;RARB;COLEC11;GLI2;PRDM5;CUX1;HDAC4;TOPORS;RXRA;MEOX2;STAT3;TCF7L1;ATF4;TRIM28;MCMDC2;MPG;NR2F1;CHD3;TCFL5;PHF1;FOXC2;PRKDC;SAFB;SMAD4;NFE2L2;HMGB1;EZH1;E2F3;PBX1;TSHZ2;MEIS3;TBX21;THRAP3;HUWE1;MAEL;MCM2;CENPC;IKZF3;MBD6;FOXJ3;ERCC5;SOX9;ESRRB;ZNF76;HMGN1;FOXL1;RFX2;SLTM;PSIP1;RBBP8;RAD1;ERCC4;RORA;OGG1;ILF3;WRN;FOXA1;CSRNP1;SREBF1;EHF;ABL1;ZIC4;RBM6;SPTY2D1;RFX5;POU6F1;WDR48;TDG;RBM5;TERT;KDM5B;AIFM1;SFPQ;SDE2;FUBP1;TAF6;PMS2;CCDC25;TDP1;ERCC3;RAD50;LONP1;KHDRBS1;CDC45;HSPD1;LIG4;PCBP2;KMT2D;MEF2A;ERCC2;SUPV3L1;TRIM26;ERF;DEDD;MSH4;DCLRE1B;RNF11;ZNF148;VDR;SNAPC4;XRN1;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;ZFPL1;CREBBP;MCM4;TSN;RC3H2;POLG2;PRDM2;NFYA;SMARCAD1;DNTTIP1;MEN1;HDGFL2;HMGA1;CDT1;E2F1;RYBP;ZMYND11;ZBTB32;ZMYM3;CHD8;RAD51;HOXB2;MLXIPL;SAFB2;QRICH1;GTF3C1;XRCC6;IRF3;GTF3C4;CBFB;TCF3;APLP2;ATF6;TWNK;MAX;BPTF;CALR;FANCG
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5035615275340659,1.0184922007375647,0.46657381615598886,0.8428092434861195,1.0,3/11,11.62%,NAA60;NAA40;NAA16
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4244135198801098,1.0175216663890436,0.4542079207920792,0.8424879758517938,1.0,8/24,24.13%,CAMKK1;CAMK2D;PHKA1;EEF2K;CAMK4;MKNK2;CAMK1;PHKA2
prerank,DNA polymerase activity (GO:0034061),0.4275603733616804,1.0160042668968048,0.43896103896103894,0.8436640365354167,1.0,8/22,26.27%,REV3L;POLE2;TERT;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,anion channel activity (GO:0005253),0.37737740524830793,1.0128388524143352,0.4666666666666667,0.8491844170048329,1.0,5/61,5.40%,SLC26A7;CLIC3;CLIC4;GABRA3;LRRC8D
prerank,sterol transfer activity (GO:0120015),-0.347071975138862,-1.0109952360161112,0.43253968253968256,0.7853483067520918,1.0,4/17,6.96%,PLTP;ABCG1;GRAMD1B;STARD4
prerank,growth factor receptor binding (GO:0070851),0.35661280632351183,1.0106512470897868,0.4921135646687697,0.8523795945839554,1.0,10/95,8.79%,PGF;VEGFA;FGF2;FGF17;SHC1;GLMN;SNX2;AGR2;ARF4;SNX1
prerank,transcription cis-regulatory region binding (GO:0000976),0.3382250474533712,1.0075540940867262,0.48096192384769537,0.8578247532911926,1.0,82/406,20.21%,PLAGL1;BNC2;SIX1;FOXP1;TCF7L2;TWIST2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;TWIST1;DEAF1;LHX9;CUX1;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;ZNF25;RXRB;NFX1;NFXL1;PER3;SMAD4;NFE2L2;HMGB1;E2F3;PBX1;TBX21;PURG;RARA;SOX9;ESRRB;TFE3;FOXK1;CARM1;HNRNPL;RORA;FOXA1;ZFP90;SREBF1;FOXM1;AGO1;RFX5;SFPQ;LONP1;HDAC1;AGO2;MEF2D;ARID4B;KMT2D;NPAS1;MEF2A;RUNX1;ZBTB9;TFDP1;PER1;GRHL1;FOXO3;FOXN3;NFE2;RBL2;PRDM2;NFYA;NR3C1;RFXANK;E4F1;MEN1;HMGA1;E2F1;SUV39H2;ATF2;KLF10;FOSL2;XRCC6;VEZF1;TCF3;ATF6;MAX
prerank,pseudouridine synthase activity (GO:0009982),0.46955786830356316,1.0074696144823565,0.4607977991746905,0.855195585236133,1.0,8/13,34.70%,RPUSD1;PUS3;TRUB1;PUS1;PUS10;DKC1;PUS7;PUS7L
prerank,chemokine receptor binding (GO:0042379),0.3981744521043181,1.00649778681022,0.4764705882352941,0.8549535354240033,1.0,4/35,9.83%,CCL13;CCL15;CXCL16;ITCH
prerank,dynactin binding (GO:0034452),-0.40319984076988136,-1.005512338994209,0.44673539518900346,0.7904613776798003,1.0,2/12,10.14%,BICDL1;SNX6
prerank,anion transmembrane transporter activity (GO:0008509),-0.3841653081849389,-1.0034244517837632,0.4389312977099237,0.7863905613551117,1.0,3/12,4.15%,SLCO2B1;SLC22A6;SLC39A8
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4360195941988654,1.0024886528999524,0.4829842931937173,0.8628572958631332,1.0,2/21,2.08%,FGF2;FGF17
prerank,chemokine binding (GO:0019956),0.40007124461498017,1.000962457978444,0.4743276283618582,0.8640398652771722,1.0,7/30,21.41%,FGF2;HMGB1;ACKR4;ITGAV;CXCR4;PLP2;ACKR3
prerank,hormone receptor binding (GO:0051427),0.4632301930051508,0.9998175119396314,0.4811188811188811,0.8641153350085742,1.0,4/14,25.22%,SOCS2;VIP;JAK1;TYK2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3332863839907202,0.9982150828537791,0.523,0.8654783910649535,1.0,106/346,26.18%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXW8;TOPORS;COP1;UBE2B;TRIM28;UBR4;RNF182;DTX3;LRSAM1;UBE2R2;ERCC8;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;SHARPIN;ITCH;CUL4A;FBXO25;RNF114;UBR5;RNF25;UBE2C;FBXO22;RNF14;FBXO3;RNF2;ANAPC4;MYLIP;TRAF3;CUL1;RNF38;DTX2;LTN1;RNF103-CHMP3;TRIM26;FBXL14;RNF11;RING1;UBE2L6;FBXO17;STUB1;RNF214;TRAF3IP2;RNF121;RC3H2;BIRC6;TRIM13;VPS11;GID4;TRIM6;HECTD1;UHRF2;RNF7;FBXW2;UBR2;RNF141;MYCBP2;NEURL1B;NEURL3;UBE2G2;RMND5B;TRAIP;TRIM47;SMURF2;TRIM43;MUL1;SH3RF1;RNF4;KCTD13;BIRC3;AREL1;TTC3;RNF20;RNF216;ZFP91;RNF146;FBXO11;UBE2Z;TAF1;FBXO9;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBE2W;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,nucleosomal DNA binding (GO:0031492),0.4249074092593496,0.9973782167103697,0.4904214559386973,0.8648396931544026,1.0,12/21,32.03%,SMARCC2;RCC1;HDAC1;HNRNPC;CHD4;SMARCA4;HDAC2;H3-3A;SMARCD2;SMARCC1;MBD3;GATAD2B
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.43952885376077344,0.9958616824984435,0.4754316069057105,0.8660228932646702,1.0,4/18,21.84%,AKR1C1;DHRS9;HSD17B8;HSD3B7
prerank,Notch binding (GO:0005112),0.4180693206502483,0.9930803625098107,0.504424778761062,0.870387612406028,1.0,3/22,6.53%,CCN3;NCOR2;JAG1
prerank,ubiquitin protein ligase activity (GO:0061630),0.3338039334405581,0.9890356312508766,0.5305305305305306,0.8780297826899595,1.0,70/228,26.18%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;ITCH;RNF114;UBR5;RNF25;RNF14;RNF2;MYLIP;RNF38;DTX2;LTN1;TRIM26;RNF11;RING1;FBXO17;STUB1;TRAF3IP2;RNF121;RC3H2;TRIM13;VPS11;UBE4A;GID4;TRIM6;HECTD1;UHRF2;RNF7;UBR2;MYCBP2;NEURL1B;NEURL3;UBOX5;SMURF2;TRIM43;MUL1;SH3RF1;BIRC3;AREL1;RNF216;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,5'-nucleotidase activity (GO:0008253),0.4648602124487289,0.9887224171670167,0.49232914923291493,0.8760065160693283,1.0,5/13,22.70%,NT5DC3;NT5C3B;ACP3;NT5C;NT5DC1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3683782925237131,-0.9867428337959614,0.47,0.8221351863199173,1.0,6/13,21.74%,SLC38A5;SLC7A1;SLC38A7;SLC25A29;SLC3A1;SLC7A3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3716347025691223,0.9855259874705078,0.5081206496519721,0.8813443394270576,1.0,15/49,21.59%,VCP;FAAP20;SHARPIN;TAB2;UBQLN1;SQSTM1;HDAC6;ATRIP;UBL7;ZFAND2B;IKBKE;ZRANB1;BRCC3;OPTN;PSMD4
prerank,phosphatidylcholine transporter activity (GO:0008525),0.44121116837225643,0.984858489243588,0.5111989459815547,0.8803980039957681,1.0,6/17,13.71%,PITPNC1;PITPNA;PITPNM1;ATP8B2;PCTP;ABCA1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.33172312378235347,0.9842849305127496,0.5466399197592778,0.8790985070620053,1.0,70/232,26.18%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;ITCH;RNF114;UBR5;RNF25;RNF14;RNF2;MYLIP;RNF38;DTX2;LTN1;TRIM26;PIAS4;RNF11;RING1;FBXO17;STUB1;TRAF3IP2;RNF121;RC3H2;UFL1;TRIM13;VPS11;GID4;TRIM6;HECTD1;UHRF2;RNF7;UBR2;MYCBP2;NEURL1B;NEURL3;SMURF2;TRIM43;MUL1;SH3RF1;BIRC3;AREL1;RNF216;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.39307345930324844,0.9837761958239231,0.5188335358444714,0.8776079640476926,1.0,14/31,31.49%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UBE2Q2;UBE2H;UBE2S;UBE2A;UBE2N
prerank,retinoid X receptor binding (GO:0046965),0.4807199637596579,0.9837748174267322,0.5209235209235209,0.8748481905758445,1.0,5/11,17.76%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,phosphatidylinositol binding (GO:0035091),0.3459285961902266,0.9817506674847782,0.5350052246603971,0.8771669826848122,1.0,31/91,23.51%,TNFAIP8L3;PITPNC1;SNX2;PITPNA;PITPNM1;BCAS3;MYO1E;GPAA1;GAP43;FCHO2;EEA1;SNX24;SNX1;SNX9;SNAP91;MITD1;SCIN;HIP1;SNX13;DENND1B;C2CD2L;ZFYVE16;AIDA;APPL2;APPL1;SNX11;RUBCN;DENND1A;MTM1;SNX4;DPEP1
prerank,semaphorin receptor activity (GO:0017154),0.4772865010428359,0.9808748701400067,0.5225618631732168,0.8764767050012403,1.0,1/11,0.51%,PLXNA4
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.46618629900289543,0.9802156519896196,0.5085714285714286,0.8752250373685615,1.0,5/12,22.07%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,potassium ion leak channel activity (GO:0022841),0.4467492088081085,0.9787466824648028,0.4993234100135318,0.8758568373947991,1.0,1/15,0.40%,KCNK5
prerank,protein phosphatase 1 binding (GO:0008157),0.4111666492783735,0.9770538841008055,0.5075757575757576,0.8773493949574819,1.0,4/21,11.40%,PPP1R3C;PPP1R9B;PPP1R3F;SHOC2
prerank,single-stranded DNA binding (GO:0003697),0.3500654390297926,0.9762786477777083,0.5233545647558386,0.8766213871273297,1.0,43/93,32.97%,MCMDC2;HMGB1;MCM2;ERCC5;RBBP8;ERCC4;WDR48;FUBP1;PMS2;TDP1;LONP1;CDC45;HSPD1;PCBP2;MCM4;RAD51;TWNK;CRY2;HNRNPA1;TOP1;NUP35;HNRNPU;TOP3A;RNF138;RTF1;SMC6;POLR2H;MCM7;FBH1;SWSAP1;IGHMBP2;HMCES;DDX11;RAD52;CTC1;SSBP1;TDP2;MSH2;BLM;ERCC1;RAD23B;RPA3;PURA
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.34284114183400144,0.974923411308169,0.5464994775339603,0.87726735123153,1.0,29/100,22.42%,CYTH3;ARAP1;PLEKHA4;PLA2G4A;GAB2;GAP43;GBF1;WIPI2;LAPTM4B;SNX24;OGT;DAPP1;SH3PXD2B;ARFIP2;ZFYVE19;OSBP;BBS5;IQGAP1;HIP1;SNX13;GOLPH3;DENND1B;AKT1;ZFYVE16;MAPKAP1;SNX11;RUFY4;RUBCN;DENND1A
prerank,exoribonuclease activity (GO:0004532),-0.3865451322645568,-0.9729095610432602,0.5056179775280899,0.8501268232885377,1.0,5/12,18.55%,EXOSC8;ZC3H12A;EXOSC1;EXOSC9;EXOSC10
prerank,general transcription initiation factor binding (GO:0140296),0.40865708670025785,0.9718384492898946,0.5319949811794228,0.8821898877560224,1.0,8/25,25.78%,ESR1;TAF13;PSMC5;THAP7;YEATS2;TBP;TAF1;PSMC1
prerank,sterol binding (GO:0032934),-0.26379875992681784,-0.9718024296744537,0.5102040816326531,0.8431952770586243,1.0,11/56,6.96%,OSBPL8;APOD;SIDT1;PTCH1;PROM1;ABCG1;GRAMD1B;NR1H3;OSBPL10;INSIG2;STARD4
prerank,four-way junction DNA binding (GO:0000400),0.42927773330699165,0.9699498265786045,0.5172872340425532,0.8842182396758915,1.0,8/17,31.69%,HMGB1;WRN;ABL1;MEN1;XRCC3;YY1;MSH2;BLM
prerank,N-acetyltransferase activity (GO:0008080),0.42118877776445285,0.9697963201523423,0.5191815856777494,0.8819075779781108,1.0,3/19,9.48%,NAT1;ATAT1;SAT2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.39902968047525655,0.9684203850639863,0.5118601747815231,0.8824156343183293,1.0,11/27,22.06%,POLR3H;TERT;CRCP;POLR2F;MED21;POLR3K;TENT2;MED20;POLR1D;POLR1C;POLR2B
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.39043392762720674,-0.9671318879067182,0.48534201954397393,0.8458702523451153,1.0,4/11,18.42%,KCND3;KCNJ3;KCNJ8;KCNQ1
prerank,O-methyltransferase activity (GO:0008171),0.47640614827376043,0.9651873683304716,0.521497919556172,0.8873944874618491,1.0,1/10,2.38%,LRTOMT
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3602599777240952,0.9649891008090009,0.5447338618346546,0.8852203964044835,1.0,7/55,8.21%,PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;MCU;TRPM7
prerank,endopeptidase regulator activity (GO:0061135),-0.27509062865591793,-0.9634285585902684,0.5066666666666667,0.8462825816636856,1.0,8/40,12.01%,ITIH2;TFPI;PROS1;SERPIND1;PSME3;PSME1;A2M;SPINT2
prerank,leucine zipper domain binding (GO:0043522),0.47405281175818015,0.9631591490332234,0.5446685878962536,0.8869831595219051,1.0,4/10,17.86%,ATF4;ERC1;AATF;DAPK3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.39448556719745403,-0.9613763196215714,0.4789156626506024,0.8420104276475487,1.0,3/10,10.17%,ADARB2;LACC1;GDA
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3294190660323147,0.957383767597015,0.5940390544707091,0.8978840205582782,1.0,36/147,17.20%,PLCE1;ARHGEF28;CYTH3;TIAM1;FARP1;DOCK4;RCC1L;ANKRD27;VAV2;FGD6;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;LAMTOR1;RASGEF1B;RIC1;BCR;DOCK5;MON1A;KALRN;RGP1;MADD;RCC1;IQSEC2;GAPVD1;WDR41;NUCB1;PREB;HPS4;FARP2;AKAP13;SOS1;EEF1B2;DIS3;NGEF
prerank,phospholipase activator activity (GO:0016004),-0.3992726835567305,-0.9571950921062413,0.51,0.8434263018859339,1.0,1/10,0.73%,ARHGAP6
prerank,Tat protein binding (GO:0030957),0.46999808362089135,0.9570299617173799,0.5089163237311386,0.8959994353349244,1.0,4/10,25.19%,MDFIC;DNAJA1;SMARCA4;CTDP1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3830550261536722,0.9568066323973515,0.5451306413301663,0.8938698060157976,1.0,9/35,16.32%,PLCE1;PDE11A;SMPD4;SMPDL3A;PDIA3;PLCXD2;ENPP6;MPPED2;GDPD3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4031277439519463,0.954836640715397,0.530209617755857,0.8958795571618188,1.0,7/24,22.66%,AK5;AK3;IP6K1;DTYMK;AK1;NME3;PPIP5K1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3763314874458018,0.9541146894324082,0.5536992840095465,0.8948933002878453,1.0,15/34,31.49%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UFC1;UBE2Q2;UBE2H;UBE2S;UBE2A;UBE2N
prerank,aminopeptidase activity (GO:0004177),0.3975010887914852,0.9531006818593313,0.547945205479452,0.8948034110316349,1.0,10/26,24.45%,MMP14;XPNPEP1;MMP16;LNPEP;LAP3;NPEPPS;LVRN;RNPEPL1;METAP1D;METAP2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4424497124998699,0.951311654463074,0.535230352303523,0.8963967045480604,1.0,7/14,30.84%,RPP40;ELAC2;RPP14;TSEN34;RPP21;POP5;PRORP
prerank,cadherin binding (GO:0045296),0.31667897808611295,0.9510592799636385,0.632,0.8943349586834696,1.0,64/315,15.80%,EGFR;CDH11;CTNND2;MPP7;FXYD5;FMNL2;CTTN;EHD1;RDX;AHNAK;PDXDC1;STX5;SCYL1;LIMA1;CSNK1D;HDLBP;GCN1;SNX2;ANXA2;ERC1;BAG3;ARGLU1;EIF4G2;ATXN2L;ACVR1;EPS8L1;ABI1;KLC2;GIPC1;JUP;TES;NDRG1;PAK4;CBL;DLG1;SNX1;PKN2;PAK2;ANXA1;ATIC;BZW1;ARFIP2;CKAP5;ZC3H15;SNX9;HSPA5;USO1;EZR;EEF1G;PARVA;DHX29;GAPVD1;ADD1;DCHS1;RAB11B;MPRIP;YWHAE;SND1;HNRNPK;FLNB;TBC1D10A;LRRC59;IQGAP1;UBAP2
prerank,transaminase activity (GO:0008483),0.4610155214732535,0.9470984156232258,0.5547550432276657,0.9012019938118214,1.0,3/11,21.05%,AGXT2;PSAT1;BCAT1
prerank,telomerase RNA binding (GO:0070034),0.4039132029665406,0.9468012421586096,0.5468549422336328,0.8992709932241986,1.0,8/22,26.91%,TENT4B;SMG6;TERT;HNRNPC;XRN1;SNRPB;HNRNPU;DKC1
prerank,glutathione transferase activity (GO:0004364),0.3959467436766887,0.9458616561962594,0.5400254129606099,0.8987582097539571,1.0,4/23,16.01%,GSTT1;GSTM5;GSTZ1;PTGES
prerank,sequence-specific mRNA binding (GO:1990825),0.47115418991808344,0.9453358150141787,0.5463623395149786,0.8971008675865599,1.0,6/10,34.60%,SSB;ETF1;SHFL;RBM24;DHFR;DHX9
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4513010969929434,0.9448396394915407,0.549929676511955,0.8957306050447703,1.0,6/11,31.14%,AKR1C1;AKR1A1;AKR1B10;RDH14;RDH13;ALDH3A1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.38816362644686486,-0.9428295018112007,0.5445544554455446,0.8712676757849253,1.0,6/10,17.63%,CXADR;CD200;PKP2;SIRPA;DSP;CD47
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4630922204619435,0.9415762789705325,0.5544267053701016,0.900666068726824,1.0,8/10,26.40%,EHMT1;ASH1L;SETD5;SETDB1;SUV39H2;SUV39H1;SETDB2;EHMT2
prerank,leak channel activity (GO:0022840),0.41546247369627815,0.9411847044000231,0.5548128342245989,0.8989322355958023,1.0,1/18,0.40%,KCNK5
prerank,mannosyltransferase activity (GO:0000030),-0.3194250832369041,-0.9404046775062079,0.509009009009009,0.8680990017571235,1.0,2/21,1.25%,TMTC2;TMTC4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4572264893939106,0.9402401520624656,0.5718518518518518,0.8987227241148068,1.0,4/10,27.45%,DPYSL3;CAD;DPEP1;OPLAH
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3987332836368967,0.9393347074776977,0.5616797900262467,0.8981948776369973,1.0,7/21,26.27%,REV3L;POLE2;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,vinculin binding (GO:0017166),-0.3611465405427555,-0.9338848682473169,0.5284810126582279,0.875120910468755,1.0,4/11,5.15%,UTRN;DAG1;CORO2B;SYNM
prerank,amino acid binding (GO:0016597),0.371510383702588,0.9336545471636547,0.5704057279236276,0.9083904316448684,1.0,10/31,20.41%,GCLC;GRIN3A;DDAH1;CASTOR2;SRR;SHMT2;GNMT;CAD;SHMT1;GLRB
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3981563170502574,0.9333786884334527,0.5762925598991173,0.9064687825577507,1.0,4/21,4.85%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4420608955640459,0.9327028717948258,0.5752461322081576,0.9053374663130015,1.0,3/12,12.37%,PIK3C2B;ATM;PIK3CB
prerank,thyroid hormone receptor binding (GO:0046966),0.3782122416426484,0.9325811419273231,0.56625,0.9030327716461436,1.0,9/28,25.93%,JMJD1C;THRAP3;NSD1;MED13;MED12;BRD8;TRIP6;NCOR1;MED24
prerank,ATP binding (GO:0005524),0.3139748107337243,0.9293350040677603,0.6906906906906907,0.9073509930651485,1.0,64/266,18.96%,PRPS2;ABCD3;N4BP2;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ACVR1;ERN2;TLK1;ABCF1;IRAK3;RPS6KA4;AK6;AKT2;HSPA14;PIP4K2B;PEX1;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;EIF4G1;LIG4;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;LATS2;HACL1;CDC42BPB;TLK2;IDE;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.39575587418844127,0.92930300665888,0.5644329896907216,0.904847893939729,1.0,7/22,20.95%,FAAP20;TAB2;SQSTM1;ATRIP;IKBKE;ZRANB1;OPTN
prerank,nucleotidyltransferase activity (GO:0016779),0.40500944831307145,0.9281444768173785,0.5751633986928104,0.9048205238668444,1.0,6/19,21.07%,PAPSS2;TENT4B;TERT;TUT7;REV1;TENT2
prerank,protein kinase regulator activity (GO:0019887),0.3258070587959326,0.9267695738347561,0.6096033402922756,0.9052660164606728,1.0,33/95,27.18%,FGF13;STRADA;CCNL2;KIDINS220;CCNL1;GMFB;MADD;CCNT2;PARVA;WNK1;CCNG2;CCNE2;HEXIM1;GSKIP;CDKN1C;PRKAG1;ELP4;DUSP19;PRKAR2A;ELP3;RPTOR;TAOK3;SMCR8;YWHAB;MAPK8IP1;QARS1;DAXX;CCNC;SOCS1;NCK1;WNT11;SH3BP5;CNPPD1
prerank,kinase activity (GO:0016301),0.3263102740351216,0.9258023057005134,0.6497933884297521,0.9047386758341149,1.0,31/109,20.14%,PAPSS2;MAPK15;PIK3C2B;NADK;SCYL3;CSNK2A1;SHPK;STK39;HYKK;TRRAP;FCSK;DGKQ;ETNK1;PKN2;PANK4;ABL1;IRAK1;DCAKD;IP6K1;PIK3CB;ADPGK;CKB;CHKB;COQ8B;PI4KB;PGK1;BCKDK;AKT1;RFK;CDK5;SEPHS2
prerank,antiporter activity (GO:0015297),0.40801607763751335,0.9228228318064965,0.5801526717557252,0.9086758701864708,1.0,7/20,25.25%,CLCN4;SLC35E1;TMEM241;SLC35C2;SLC35E2B;SLC35E2A;SLC25A11
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.38639404285785656,0.9209355841642504,0.5939849624060151,0.9101568763911699,1.0,4/23,4.85%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,adenylate cyclase binding (GO:0008179),-0.37788993179480457,-0.9192711991448816,0.5614617940199336,0.9031149915443577,1.0,3/10,5.05%,ADCY5;CAP2;AKAP6
prerank,hexosyltransferase activity (GO:0016758),0.3255924448894653,0.917782025729918,0.6529968454258676,0.9143278905940294,1.0,32/101,29.49%,EXT1;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;B4GALT5;OGT;MGAT4B;FUT4;HEXA;B3GNT9;B4GAT1;B3GNT6;ALG1;TMTC1;EXT2;GCNT7;B4GALNT3;B3GNT2;PIGV;DPY19L2;B4GALT7;POMT1;ALG12;RFNG;PIGB;B3GAT3;ALG9;DPY19L4;B3GALNT2;HAS3
prerank,phosphatase inhibitor activity (GO:0019212),0.3976518522725032,0.9153103034897547,0.59526938239159,0.9171754631236031,1.0,11/20,27.66%,PPP1R9B;URI1;CABIN1;ARPP19;STYX;SAG;BOD1L1;LMTK2;ANP32E;MGAT5;PPME1
prerank,peptide hormone receptor binding (GO:0051428),0.44837454297944246,0.9135009841916705,0.601418439716312,0.9183163214935789,1.0,2/11,15.57%,VIP;PSMC5
prerank,endopeptidase inhibitor activity (GO:0004866),0.32607518323369883,0.9132320574301677,0.6418703506907545,0.9164034991523977,1.0,16/82,19.33%,SERPINH1;TIMP2;TIMP3;RARRES1;ANXA2;CARD16;SERPINF1;CST3;SERPINB9;SERPINE2;CRB2;RENBP;BIRC6;SERPING1;CAST;UCHL5
prerank,galactosyltransferase activity (GO:0008378),0.43207996389720343,0.9131784977068094,0.5701754385964912,0.9140009563489013,1.0,4/11,23.30%,B4GALT1;B4GALT5;B3GNT6;B4GALT7
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.362318960372195,0.9088078723525612,0.6062052505966588,0.9205366442540455,1.0,6/35,14.24%,PKDCC;CLK1;TNK1;ABL1;SRMS;FRK
prerank,adenyl ribonucleotide binding (GO:0032559),0.3063776875036077,0.9074476843339202,0.7512537612838516,0.9208572593529284,1.0,67/291,18.96%,PRPS2;ME1;ABCD3;N4BP2;GCLC;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ACVR1;ERN2;TLK1;ABCF1;IRAK3;RPS6KA4;AK6;AKT2;HSPA14;PIP4K2B;PEX1;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;EIF4G1;LIG4;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;LATS2;HACL1;CDC42BPB;TLK2;IDE;MPPED2;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2
prerank,SUMO binding (GO:0032183),0.423555163612729,0.9052513078051199,0.610803324099723,0.9229916774586235,1.0,8/13,35.85%,TDG;USPL1;RNF4;SIMC1;RNF111;HERC2;USP25;CBX4
prerank,snRNA binding (GO:0017069),0.35477978236242413,0.9046185628283313,0.6295871559633027,0.921824912246149,1.0,15/42,29.41%,SNRNP70;CCNT2;LSM2;HEXIM1;SNRPA;RBM22;NCBP2;LARP7;SNRPB2;HNRNPU;SNRNP35;DDX39B;TOE1;CDK9;MEPCE
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.36991745771159695,0.9042077854865217,0.6212303980699638,0.9201283355921802,1.0,14/29,33.67%,ACER3;GAA;GALC;HEXD;GANAB;PARG;GUSB;ADPRS;GANC;CTBS;MGAM;HPSE;GBA2;HYAL3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.36681884481425114,0.9033556991565812,0.6203143893591294,0.9193479873281105,1.0,7/33,17.07%,ERI3;REXO2;DIS3L2;XRN1;EXOSC4;CNOT8;DIS3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3988912149679888,0.9023580428273759,0.619235836627141,0.9189193663557684,1.0,4/18,8.51%,SOCS7;SOCS4;SOCS6;SOCS2
prerank,kinesin binding (GO:0019894),0.3719552215939628,0.9018376479028563,0.6078431372549019,0.9176146371318774,1.0,12/27,29.26%,KLC2;PLEKHM2;IFT88;SPAG9;KIF1B;ARHGEF10;MAPK8IP3;FAM83D;MAPK8IP1;NEK6;TTBK2;KIFAP3
prerank,voltage-gated ion channel activity (GO:0005244),-0.3364107652706012,-0.8998020176927252,0.587360594795539,0.9436771370859725,1.0,3/14,8.49%,CACNA1E;KCND2;ANO6
prerank,transmitter-gated ion channel activity (GO:0022824),0.36994205152670145,0.8995904751971064,0.6148148148148148,0.9197815353721146,1.0,2/29,5.17%,GRIK4;GABRA3
prerank,death receptor activity (GO:0005035),-0.3622520935328291,-0.8978191798953796,0.5958188153310104,0.9387831737649651,1.0,5/11,18.11%,TNFRSF19;FAS;TNFRSF1A;TNFRSF11A;TNFRSF25
prerank,endopeptidase activator activity (GO:0061133),-0.3705729900066196,-0.8958378854170612,0.5993377483443708,0.9336623557730422,1.0,7/10,29.94%,PSME3;PSME1;APH1B;NLRC4;PSME2;APH1A;PSENEN
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2786336701447945,-0.8947286817772804,0.6321243523316062,0.9268898405719886,1.0,3/26,3.51%,AEBP1;CPM;AGBL4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.35953602886940483,0.8931269725222951,0.6526946107784432,0.9301767036129628,1.0,6/34,9.18%,CYTH3;ARAP1;GAB2;GBF1;OGT;DAPP1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.4288802017813507,0.8927486460020949,0.6067892503536068,0.9283773753852808,1.0,6/12,27.75%,ENTPD2;ENTPD6;ENTPD7;ENTPD5;NUDT18;CANT1
prerank,phosphatidylglycerol binding (GO:1901611),0.42397413173948667,0.8922070088816892,0.6135734072022161,0.9269331330908797,1.0,5/13,23.39%,PITPNC1;PITPNA;GSDME;UQCC3;STOML2
prerank,protein tyrosine kinase activity (GO:0004713),0.3142240471476458,0.8921335459999687,0.6838235294117647,0.9246245233256386,1.0,16/108,10.59%,EGFR;PKDCC;DDR2;CLK1;NTRK3;NTRK1;EPHB2;SCYL1;TNK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;ABL1
prerank,cytokine receptor binding (GO:0005126),0.317065589288494,0.8900805784927135,0.692063492063492,0.9260777361225973,1.0,5/83,4.20%,PGF;VEGFA;INHBC;SPRED2;TGFB2
prerank,ATPase activator activity (GO:0001671),0.3936451711782467,0.8884936530696459,0.6311787072243346,0.9266870457579839,1.0,2/20,5.10%,ATP1B1;DNAJA2
prerank,sulfotransferase activity (GO:0008146),0.3579374236141709,0.8883630005771748,0.6312576312576312,0.9244775576014901,1.0,3/33,2.94%,SULT1C2;SULT1C4;CHST11
prerank,delayed rectifier potassium channel activity (GO:0005251),0.35583448907867177,0.8881393053402227,0.6344086021505376,0.9224914817404392,1.0,3/32,12.85%,KCNB1;KCNE5;KCNG3
prerank,cAMP response element binding (GO:0035497),-0.3556435012021933,-0.8880250781143231,0.6006493506493507,0.9332577154040987,1.0,1/10,0.38%,CREB5
prerank,deoxyribonuclease activity (GO:0004536),0.4099528313530382,0.8863047048557303,0.6358695652173914,0.9235228112133576,1.0,8/14,36.01%,ERCC5;ERCC4;DFFB;ZRANB3;DNASE1L2;MBD4;MRE11;APLF
prerank,ATPase regulator activity (GO:0060590),0.35319789260880763,0.8857870333947415,0.6517119244391971,0.9221432384611484,1.0,15/38,31.20%,ATP1B1;BAG3;DNAJA2;SIL1;GRPEL1;DNAJA1;DNAJC24;DNAJC1;KATNB1;BAG1;TOR1AIP1;TOR1AIP2;DNAJB1;GRPEL2;HSPH1
prerank,ephrin receptor activity (GO:0005003),0.3957527701948319,0.885634323483196,0.6215846994535519,0.9176311905346092,1.0,3/17,5.82%,EPHB2;EPHB3;EPHB6
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3957527701948319,0.885634323483196,0.6215846994535519,0.9176311905346092,1.0,3/17,5.82%,EPHB2;EPHB3;EPHB6
prerank,protein kinase activator activity (GO:0030295),0.33022528395727635,0.8853946069360694,0.6782902137232846,0.9157343670392337,1.0,19/60,26.38%,GAS6;FGF13;STRADA;CALM2;ABI1;PAK2;MADD;WNK1;IQGAP1;CALM3;DBF4;DUSP19;FAM20A;RPTOR;STK3;DAXX;TAOK1;IGF2;WNT11
prerank,triglyceride lipase activity (GO:0004806),0.381973058077992,0.884978199096872,0.6236842105263158,0.9141754346113622,1.0,4/20,20.83%,CEL;PNPLA3;PLA2G15;DAGLB
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.3713873499444693,0.8827462051909153,0.6347381864623244,0.9160189936691323,1.0,3/21,8.43%,DRD1;CHRNB2;CHRNA5
prerank,estrogen receptor binding (GO:0030331),0.35433095435174633,0.8822980138288438,0.642512077294686,0.9145331182477874,1.0,8/32,18.79%,ESR1;NRIP1;NSD1;DCAF13;MMS19;DNAAF4;LCOR;CCDC62
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.35310506575727424,-0.8808122226318132,0.5852842809364549,0.9407829675059436,1.0,3/10,8.91%,DPP4;DPP10;DPP6
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3120860569765417,-0.8804738021398779,0.6417322834645669,0.9319748913568324,1.0,5/15,11.88%,EPB41;PICALM;ZFYVE9;SESTD1;SCARB1
prerank,channel activity (GO:0015267),-0.24218167042612354,-0.8798918276371768,0.697841726618705,0.9239142123023389,1.0,10/41,17.79%,BCL2;AQP11;TRPV2;CHRNB1;KCNK3;MCUB;TMEM120B;TRPV4;SLC14A1;TRPA1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3535293545480632,-0.8791197963170874,0.5745341614906833,0.9166408421436996,1.0,1/11,4.13%,NUDT4
prerank,tau protein binding (GO:0048156),-0.2574303114114026,-0.8753287927516751,0.7096774193548387,0.9169966829627628,1.0,4/40,2.53%,ROCK2;APOE;MAP2;PICALM
prerank,acyl-CoA hydrolase activity (GO:0047617),0.38792416912418426,0.8751858139966153,0.6322418136020151,0.925212956101977,1.0,4/17,24.67%,ACOT11;ACOT13;ABCD1;ACOT8
prerank,actinin binding (GO:0042805),0.3693223082819244,0.8736806534196531,0.6253164556962025,0.9255666510605524,1.0,4/21,15.52%,CACNA1C;RARA;CSRP3;PKD2L1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3587452313822114,0.8732745294562863,0.6369268897149938,0.9239422660947478,1.0,13/27,29.94%,POLR3H;CRCP;POLR2F;MED21;POLR3K;MED20;POLR1D;POLR1C;POLR2B;PRIMPOL;PRIM1;POLR2I;POLR2L
prerank,phosphatidic acid binding (GO:0070300),0.3828184059249851,0.8732344218990189,0.6274768824306473,0.9216723784445254,1.0,3/19,4.74%,PITPNC1;MARK1;PITPNM1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3110183155623351,0.8719386067896193,0.7052518756698821,0.92175752203379,1.0,13/85,18.91%,MGLL;PLA2G4F;PLA2G4A;CEL;ABHD6;PTRH2;PAFAH1B2;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;PAFAH1B3
prerank,pyridoxal phosphate binding (GO:0030170),0.38099990194648636,0.8716275383095914,0.6513409961685823,0.9200229790146729,1.0,5/20,19.03%,PYGB;SRR;SHMT2;SHMT1;PSAT1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4090398644823262,0.87141401620516,0.6498637602179836,0.9180933341454097,1.0,9/14,33.91%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;MTMR2;MTMR12;MTMR9;MTMR4
prerank,GTPase activator activity (GO:0005096),0.2935358079735936,0.8694779231656881,0.8232931726907631,0.9193274486796682,1.0,74/313,17.28%,SGSM2;PLCE1;SRGAP2;ARHGEF28;CYTH3;ARFGAP1;ARFGAP3;ASAP3;TIAM1;ARAP1;FARP1;NPRL3;DOCK4;RCC1L;ANKRD27;VAV2;TBC1D8B;TBC1D2B;SIPA1L1;SEC23A;FGD6;ARHGAP17;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;CDC42EP2;LAMTOR1;RASGEF1B;RIC1;ARFGAP2;BCR;DOCK5;LLGL1;MON1A;PGAM5;ADAP1;KALRN;RGPD1;RGP1;MADD;RCC1;ARHGAP20;EVI5L;ARHGAP8;IQSEC2;NRP1;STXBP5;TBC1D9B;ARHGAP44;OCRL;GAPVD1;TBC1D25;WDR41;NUCB1;PREB;RANBP2;HPS4;TBCK;FARP2;TBC1D10A;SIPA1L3;AKAP13;SOS1;ARRB1;IQGAP1;TBC1D17;TAGAP;TBCD;EEF1B2;NF1;DIS3;NGEF;FLCN
prerank,lipase activity (GO:0016298),0.3302540376624553,0.8677915722691119,0.6850574712643678,0.9201472670872154,1.0,8/43,22.65%,MGLL;CEL;ABHD6;PNPLA3;PLA2G15;SEC23IP;DAGLB;ABHD12
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4148771073484146,0.866730017378973,0.6382393397524071,0.9173841092027493,1.0,6/11,31.20%,BAG3;SIL1;GRPEL1;BAG1;GRPEL2;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),0.4148771073484146,0.866730017378973,0.6382393397524071,0.9173841092027493,1.0,6/11,31.20%,BAG3;SIL1;GRPEL1;BAG1;GRPEL2;HSPH1
prerank,epidermal growth factor receptor binding (GO:0005154),0.3614297385711171,0.8666423401833893,0.6466992665036675,0.9152640849763636,1.0,9/25,23.27%,SHC1;SNX2;AGR2;ARF4;SNX1;HIP1;CNOT9;ATXN2;SNX4
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3488177454665655,-0.8657809454823027,0.6443661971830986,0.9298000766142914,1.0,2/10,8.49%,ANO1;ANO6
prerank,protein tyrosine phosphatase activity (GO:0004725),0.31617753233354473,0.8653036912903364,0.7003293084522503,0.9152458952993815,1.0,14/71,14.37%,EYA2;UBASH3B;PTPN3;PTPRS;PTPRF;PTP4A2;DUSP11;PTPRU;CDC14A;PTPN18;CDC25B;PTPDC1;PTPN2;DUSP18
prerank,CoA hydrolase activity (GO:0016289),0.3925146026044487,0.8650563454700348,0.6551282051282051,0.9134323500472232,1.0,5/16,27.11%,ACOT11;ACOT13;ABCD1;ACOT8;HIBCH
prerank,titin binding (GO:0031432),0.40647955493433946,0.8646573615473141,0.6364846870838882,0.9118860562434014,1.0,2/13,5.05%,CAMK2D;CALM2
prerank,ribonuclease P RNA binding (GO:0033204),0.4254642520625523,0.863905877327464,0.6206415620641562,0.9110668815752728,1.0,4/10,27.07%,RPP40;RPP14;RPP21;POP5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4194515590366156,0.8632837420378279,0.6453407510431154,0.9099583342715443,1.0,2/11,15.19%,SLC25A25;SLC35B3
prerank,cytokine receptor activity (GO:0004896),0.30932471744560947,0.862857684392041,0.7159699892818864,0.9085214218889788,1.0,8/83,8.47%,CMKLR1;F3;GHR;CNTFR;MPL;IL12RB2;IFNLR1;ACKR4
prerank,motor activity (GO:0003774),-0.22424989607963733,-0.8611815180246154,0.7654320987654321,0.9307653633604758,1.0,20/60,17.88%,STARD9;DYNC1I1;MYO6;KIF3C;MYL6;MYH9;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF1C;KIF11;KIF5B;KIF26B;KIF15;KIF21B;DNAH3;GPR88;KIF27
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3116125478037809,0.8584724932480329,0.7116630669546437,0.9140335076351683,1.0,24/69,27.39%,PLA2G4A;SOAT1;LPCAT4;LPCAT3;KAT6B;ZDHHC16;NAA16;HHAT;GLYAT;ZDHHC13;CREBBP;PLA2G15;LIPT1;ZDHHC20;ELP3;MCAT;KAT8;ZDHHC9;KAT2B;NMT1;CERS3;NAA15;ESCO1;SOAT2
prerank,calcium-activated potassium channel activity (GO:0015269),0.4187780437735358,0.8553889697333924,0.6567375886524822,0.9171068559735743,1.0,3/11,16.57%,KCNN1;PKD2L1;KCNN4
prerank,metalloexopeptidase activity (GO:0008235),0.3199655668229133,0.8551695903257207,0.7004504504504504,0.9152884551470393,1.0,18/51,24.75%,CPZ;CPQ;MMP14;XPNPEP1;AGBL5;AGBL3;MMP16;LNPEP;CPXM2;LAP3;NPEPPS;LVRN;CPB2;RNPEPL1;METAP1D;DPEP1;METAP2;VASH1
prerank,rRNA binding (GO:0019843),0.3319789389411056,0.8544725854723556,0.7071759259259259,0.9142861146200432,1.0,15/42,29.73%,RCC1L;RRS1;EMG1;PPAN;PTCD3;CAVIN1;CIRBP;SBDS;GTF3A;MRPS18A;RPS9;NOP53;MRPL11;RPF2;ERI1
prerank,glycine binding (GO:0016594),0.41011991936593883,0.8530903033478556,0.6596045197740112,0.9143687049125508,1.0,4/11,20.41%,GRIN3A;SRR;GNMT;GLRB
prerank,phosphatase activator activity (GO:0019211),0.39554956078494763,0.8516106351687138,0.68646408839779,0.9146630525256852,1.0,4/14,16.86%,CALM2;GTF2F1;PPP2R5C;CALM3
prerank,ribonuclease P activity (GO:0004526),0.4134699899277582,0.8511967477171879,0.6616438356164384,0.9131344070225416,1.0,5/11,30.84%,RPP40;RPP14;RPP21;POP5;PRORP
prerank,death domain binding (GO:0070513),-0.32910882149931747,-0.8497888253634498,0.6544117647058824,0.9468502082029926,1.0,3/11,8.64%,BCL2;BCL2L1;DAPL1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.33258615640146366,0.8495937821550763,0.6850117096018735,0.9136319536174083,1.0,5/38,13.24%,SERPINH1;ANXA2;SERPINF1;SERPINB9;SERPINE2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3407932935188717,0.8486780217849763,0.6891252955082743,0.9129556324193311,1.0,11/34,26.37%,STRADA;CALM2;CCNT2;IQGAP1;CALM3;DBF4;CKS1B;FAM20A;STK3;TAOK1;IGF2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.31602930167345683,-0.8484627802898574,0.6653225806451613,0.9409708992369433,1.0,3/13,6.40%,RYR2;PRKAR2B;PRKAR1B
prerank,GDP binding (GO:0019003),0.3138032725433688,0.8463549595508408,0.7182320441988951,0.9148087823865277,1.0,22/63,32.21%,MRAS;RAB2A;RAB21;RAB8A;RAB11B;RAB3B;RASL12;RAB5B;RHEB;RAB4A;RAB18;NRAS;KRAS;RAB5A;DIRAS1;RALA;RAB5C;MIEF1;RAB27B;RAP2C;ARL3;RAB12
prerank,peptidase inhibitor activity (GO:0030414),0.33468315077615984,0.8442965525360855,0.6754176610978521,0.9160218576083666,1.0,8/33,24.22%,GPC3;TIMP2;CST3;RENBP;CAST;UCHL5;SIMC1;USP14
prerank,carboxy-lyase activity (GO:0016831),0.3640044550908818,0.84336720584669,0.6785260482846251,0.9153728737254467,1.0,5/23,22.16%,GGCX;CSAD;AZIN1;ACOD1;ECHDC1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.35821409990757813,0.8425989588231036,0.6807151979565773,0.9144409873991621,1.0,4/23,9.26%,PLEKHA4;GBF1;WIPI2;SH3PXD2B
prerank,ephrin receptor binding (GO:0046875),0.3577955504366763,0.841658303198388,0.6679738562091503,0.9138198727047427,1.0,7/21,19.61%,EFNA5;SHC1;CBL;ABL1;EFNA1;CRK;ANKS1B
prerank,muscle alpha-actinin binding (GO:0051371),0.38101530549772433,0.8399721080978628,0.6733333333333333,0.9144405496040479,1.0,3/15,15.52%,PDLIM7;PALLD;PKD2L1
prerank,GABA receptor binding (GO:0050811),-0.3368678487269182,-0.8373706963650919,0.6545454545454545,0.9550558543726456,1.0,4/11,16.54%,TRAK2;TRAK1;GABARAP;GABARAPL1
prerank,water transmembrane transporter activity (GO:0005372),0.4102029194711879,0.8373599615935738,0.6785225718194254,0.9165293151473275,1.0,1/11,5.65%,SLC4A11
prerank,double-stranded RNA binding (GO:0003725),0.30543427889546054,0.8356143518277528,0.7382256297918949,0.9171499843792125,1.0,12/70,14.08%,STRBP;SIDT2;MBNL1;PRKRA;ILF3;AGO1;DGCR8;EIF4A1;AGO2;HSPD1;SUPV3L1;CLTC
prerank,GTPase regulator activity (GO:0030695),0.28718683335161493,0.8349344845332249,0.8272727272727273,0.916162315053541,1.0,46/212,16.39%,SLIT2;SGSM2;SRGAP2;ARFGAP1;ARFGAP3;ASAP3;ARAP1;NPRL3;TBC1D8B;GDI1;TBC1D2B;SIPA1L1;SEC23A;IPO5;ARHGAP17;RAB3GAP1;CDC42EP2;ARFGAP2;BCR;LLGL1;GPS1;PDE6D;PGAM5;ADAP1;RGPD1;ARHGAP20;EVI5L;ARHGAP8;NRP1;STXBP5;TBC1D9B;ARHGAP44;OCRL;TBC1D25;ARL2;PREB;RANBP2;TBCK;TBC1D10A;SIPA1L3;SOS1;ARRB1;IQGAP1;TBC1D17;TAGAP;TBCD
prerank,SH2 domain binding (GO:0042169),0.3389200864015832,0.8346653823546093,0.6734449760765551,0.9144466199312244,1.0,5/31,14.33%,IRS1;SH3PXD2B;ABL1;KHDRBS1;SQSTM1
prerank,snoRNA binding (GO:0030515),0.3383852932596925,0.8337437409586627,0.7039312039312039,0.9137926948080436,1.0,10/30,31.72%,TSR1;PRKDC;WDR3;BYSL;NOP56;TBL3;NOP58;DKC1;NOP10;NOP14
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.40564899597868315,0.830846793350778,0.6955922865013774,0.916413029504549,1.0,2/12,6.77%,TENT4B;TENT5A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.34673784486210746,0.8307973996503886,0.6920152091254753,0.9143828199323613,1.0,2/23,3.19%,PLCE1;EDNRA
prerank,WW domain binding (GO:0050699),0.3429270601953254,0.8285115234271593,0.6886446886446886,0.9157760559632586,1.0,5/26,18.25%,PMEPA1;SCNN1A;NFE2;PRRG4;KIF20B
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3393516614539025,0.8280525645201599,0.6980440097799511,0.9144077895526533,1.0,2/29,3.41%,CIT;SPRED2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4054524569312218,0.8256291042011256,0.6787330316742082,0.9160566382024007,1.0,2/10,9.01%,B4GALT1;B4GALT5
prerank,endodeoxyribonuclease activity (GO:0004520),0.3536582462175424,0.8241785714102337,0.6954887218045113,0.916085674099371,1.0,11/20,36.82%,ERCC5;RBBP8;ERCC4;RAD50;ENDOV;ZRANB3;MBD4;ERCC1;MRE11;APLF;EXOG
prerank,voltage-gated cation channel activity (GO:0022843),0.2884020099820112,0.8204598836729636,0.7814776274713839,0.9198488563078627,1.0,11/97,12.85%,CACNA1C;KCNB1;GRIN3A;HCN4;CACHD1;KCNE5;KCND1;CATSPER3;ITGAV;CACNA2D2;KCNG3
prerank,AMP binding (GO:0016208),-0.33024983022787946,-0.8201512583860859,0.6587837837837838,0.9810840190358525,1.0,3/11,8.79%,PRKAG2;ACSS2;PRKAG3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4079632229635724,0.8152651361402545,0.702513966480447,0.9257315167417242,1.0,5/10,33.34%,NAA60;NAA16;NAA15;NAA25;NAA20
prerank,monocarboxylic acid binding (GO:0033293),0.3594404029626863,0.8145291942786035,0.7038007863695938,0.9247061632665761,1.0,3/18,8.81%,RXRA;RARA;AKR1C1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.36978059184031986,0.8124987843638817,0.7150395778364116,0.9257065769397707,1.0,10/16,33.91%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;SACM1L;MTMR2;MTMR12;MTMR9;MTMR4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.38888111648959084,0.8124285505196018,0.717948717948718,0.9236900750794821,1.0,4/13,17.92%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3680464820139028,0.8112421679222097,0.6972602739726027,0.9233267988252207,1.0,4/14,26.01%,DHRS9;AKR1A1;DHRS3;RDH10
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.29371758578955576,0.8111747211917694,0.7867965367965368,0.9213158870879424,1.0,8/73,13.11%,GALR1;NPR3;FSHR;EDNRA;FPR3;GLP1R;F2R;MC4R
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2943042975184026,0.8109345349201907,0.7826552462526767,0.9195641447532159,1.0,15/74,16.07%,PAPSS2;PIK3C2B;NADK;SHPK;HYKK;FCSK;DGKQ;ETNK1;PANK4;DCAKD;PIK3CB;ADPGK;CLP1;CHKB;PI4KB
prerank,actin binding (GO:0003779),0.27341581877446547,0.8100092730261781,0.8562753036437247,0.9187715516784171,1.0,26/170,13.38%,MICAL2;FXYD5;MAP1B;GSN;P4HB;PRKCE;RDX;PDLIM7;LIMA1;COBL;TNNT3;ADCY8;SPATA32;DMD;EPS8L1;PFN2;SLC6A2;GIPC1;ABL1;TLNRD1;EZR;BCL7B;CAP1;PARVA;ADD1;PFN4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.26311669531753906,-0.8084803617741905,0.7422222222222222,0.9859200999972275,1.0,5/21,10.51%,CDK6;CDK14;CDK19;CDK15;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.26311669531753906,-0.8084803617741905,0.7422222222222222,0.9859200999972275,1.0,5/21,10.51%,CDK6;CDK14;CDK19;CDK15;CDK8
prerank,active ion transmembrane transporter activity (GO:0022853),0.31587116852425334,0.8084774634138951,0.7391826923076923,0.91914723024805,1.0,3/37,5.65%,SLCO3A1;SLCO2A1;SLC4A11
prerank,alpha-tubulin binding (GO:0043014),0.3243282706676777,0.8048209749782792,0.7360774818401937,0.922410906597521,1.0,10/31,27.26%,TBCE;BEX4;SPAST;TRAPPC14;HDAC6;DIP2B;SETD2;TAOK1;DNAL1;EFHC1
prerank,RNA stem-loop binding (GO:0035613),-0.3080968422686655,-0.8044180685008916,0.70703125,0.9853657318704128,1.0,3/12,9.59%,MYH10;DDX3X;ZC3H12A
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.38035377908855394,0.7999199730189485,0.7319316688567674,0.9273349958074364,1.0,2/13,8.18%,GDI1;GDI2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2510535606981564,-0.7994355344175937,0.7757847533632287,0.98632963809336,1.0,5/24,9.79%,OSBPL8;PLEKHA5;CERT1;SESTD1;LANCL2
prerank,phospholipase binding (GO:0043274),-0.3061535246820391,-0.7975946527820117,0.7447552447552448,0.9808157615945786,1.0,1/13,0.73%,ARHGAP6
prerank,U6 snRNA binding (GO:0017070),0.37260055908714873,0.7972006494182667,0.7235213204951857,0.9291858805096503,1.0,5/14,25.11%,METTL16;LSM2;RBM22;LARP7;DDX39B
prerank,kinase activator activity (GO:0019209),0.32500450595780417,0.7943681009557066,0.7556675062972292,0.9311827030207458,1.0,8/30,26.38%,FGF13;STRADA;MADD;WNK1;DUSP19;RPTOR;DAXX;WNT11
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.32754203692271483,0.7916770219034712,0.7481296758104738,0.932950834920009,1.0,4/27,12.60%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,MAP-kinase scaffold activity (GO:0005078),0.38521876385445714,0.7909172832038172,0.7551319648093842,0.9320530998129446,1.0,7/11,25.15%,AKAP13;IQGAP1;SPAG9;DUSP19;SH3RF1;MAPK8IP3;MAPK8IP1
prerank,steroid hydroxylase activity (GO:0008395),-0.27815694919073075,-0.7901828244890745,0.8157894736842105,0.9852061047605588,1.0,2/16,5.31%,CYP7B1;CYP27A1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.28447824553080076,-0.789419282786345,0.7841726618705036,0.9781370458352769,1.0,11/15,42.17%,P2RY14;GPR34;P2RY1;P2RX7;P2RX5;P2RX3;GPR171;P2RX1;GPR87;P2RY13;P2RX6
prerank,neuropeptide hormone activity (GO:0005184),0.33345095086208815,0.7868358745022224,0.7468513853904282,0.935940592815529,1.0,7/22,33.66%,VIP;AGRP;PENK;NMB;SPX;HCRT;NPFF
prerank,protein phosphatase regulator activity (GO:0019888),0.2944704869100575,0.7855213429067396,0.7932960893854749,0.9358196794828312,1.0,23/53,29.05%,PPP1R9B;CALM2;PPP6R1;PPP6R3;RCAN1;CABIN1;SHOC2;DMPK;PPP2R2D;ARPP19;PPP2R5C;CALM3;PPP6R2;SAG;RCAN3;PPP1R7;BOD1L1;LMTK2;MGAT5;PPP2R1A;PPME1;B3GAT3;PPP2R1B
prerank,phosphatase activity (GO:0016791),0.28294182226248493,0.7845721431334436,0.8235930735930735,0.9350696982383451,1.0,8/73,8.39%,ALPL;PLPP3;PPP1CC;PLPP5;DUSP11;PLPP1;PGAM5;NANP
prerank,single-stranded DNA helicase activity (GO:0017116),0.34340807492902026,0.7844052212684807,0.7509481668773704,0.9332144062451088,1.0,2/19,7.92%,HELB;MCM2
prerank,tau-protein kinase activity (GO:0050321),0.33599018062092234,0.7840698250261906,0.735632183908046,0.9316253776083959,1.0,7/20,28.21%,MARK1;MARK4;CDK5;ROCK1;TAOK2;TAOK1;TTBK2
prerank,peptidoglycan binding (GO:0042834),0.3819776810234375,0.7831499391450073,0.7304347826086957,0.9308159449957368,1.0,1/10,4.59%,RNASE7
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3379633093978134,0.7829208998436278,0.7468193384223919,0.9291009118013017,1.0,8/21,24.92%,PRRC1;EZR;AKAP9;GSKIP;AKAP8;PRKACA;ARFGEF2;ACBD3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.30209007432706075,-0.7821002278143195,0.7410071942446043,0.9825112080277586,1.0,3/12,13.07%,CNOT1;NOCT;CNOT6L
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3827172833996164,0.7809074076338368,0.7452415812591509,0.9298347215939455,1.0,3/10,22.11%,FAAP20;IDE;DNAJC2
prerank,carboxypeptidase activity (GO:0004180),-0.22384288440313907,-0.7802795984773265,0.875,0.9772790207682911,1.0,3/35,3.51%,AEBP1;CPM;AGBL4
prerank,PDZ domain binding (GO:0030165),0.2897948895162319,0.7779929308758898,0.8060200668896321,0.9317801262987158,1.0,9/61,9.50%,CIT;CRIM1;DOCK4;SLC26A6;ERC1;KIDINS220;FZD7;DLG4;NSF
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2029440643381579,-0.7760192735479816,0.9142857142857143,0.9763877761515612,1.0,17/57,24.70%,COX8A;NDUFC2;COX4I1;UQCR11;COX10;NDUFA13;NDUFB2;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA4L2;NDUFA8;UQCRQ;NDUFS6;NDUFA4;CYB561D2
prerank,microtubule motor activity (GO:0003777),-0.20806536690468874,-0.7701961890010709,0.8736842105263158,0.9770195377530504,1.0,15/51,16.12%,STARD9;DYNC1I1;KIF3C;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF1C;KIF11;KIF5B;KIF26B;KIF15;KIF21B;DNAH3
prerank,exopeptidase activity (GO:0008238),-0.20571273097296028,-0.7672121274395984,0.9538461538461539,0.9734581479233838,1.0,9/50,12.55%,DPP4;DPP10;CPM;ENPEP;TRHDE;ACE;DPP6;ACE2;GGH
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.30929441682775344,0.766357491551997,0.8112305854241338,0.9454803056530957,1.0,6/34,17.07%,ERI3;REXO2;DIS3L2;EXOSC4;CNOT8;DIS3
prerank,protein heterodimerization activity (GO:0046982),0.260222284155728,0.7656414194860083,0.9076142131979695,0.9444141158850333,1.0,28/178,14.26%,EXT1;KCNB1;ATP1B1;P4HB;SNX2;CD3E;ATF4;ADCY8;BHLHE40;IRAK3;SMC3;SNX1;CHUK;IRAK1;RCC1;BCL2L2;NEUROD2;AOC3;TENM1;MICU2;HEXA;ADD1;PAFAH1B2;NPAS1;MEF2A;YWHAE;NOLC1;MICU1
prerank,beta-tubulin binding (GO:0048487),0.3085892528948735,0.7652062141727528,0.8,0.9428868689330117,1.0,4/31,9.94%,FGF13;BCAS3;SMC3;SPAST
prerank,protein tyrosine kinase binding (GO:1990782),0.2776077635168862,0.7617495517503433,0.8478260869565217,0.9455460902233975,1.0,12/71,14.33%,GAS6;DOCK4;PRR7;SHC1;PITPNM1;ACVR1;NOX4;CBL;ANGPT4;KHDRBS1;PTPN2;SQSTM1
prerank,phospholipase C activity (GO:0004629),0.3134409643081415,0.7615948740033882,0.7762669962917181,0.9436954431042256,1.0,2/25,3.19%,PLCE1;EDNRA
prerank,calcium activated cation channel activity (GO:0005227),0.3385726182440175,0.761395387955218,0.7579365079365079,0.9419185480507364,1.0,4/17,16.57%,KCNN1;TRPM4;PKD2L1;KCNN4
prerank,neuropeptide receptor binding (GO:0071855),0.3473519491238535,0.7606292646956408,0.7628726287262872,0.9408608524553307,1.0,2/14,12.25%,SHANK1;AGRP
prerank,NAD+ binding (GO:0070403),0.3619050822748924,0.7593860043844577,0.7585714285714286,0.940456452151233,1.0,3/12,15.49%,SIRT5;SIRT2;CRYL1
prerank,exonuclease activity (GO:0004527),0.28785063985630416,0.757960461452609,0.8218390804597702,0.9402224782410679,1.0,9/46,16.07%,REV3L;REXO2;RAD1;WRN;REXO1;RAD50;DCLRE1B;EXOSC4;AEN
prerank,tubulin binding (GO:0015631),0.25307570148710096,0.7548338849508037,0.9639278557114228,0.9423862213370758,1.0,67/296,22.75%,MAP7D3;FGF13;MAP1B;CFAP157;STMND1;KIF13A;TBCE;TTLL2;MID1;RAE1;TUBGCP3;BCAS3;DNM2;BLOC1S2;GPAA1;SYBU;ALMS1;NDRG1;BEX4;SMC3;AGBL5;TPGS1;SPAST;MTUS1;MACO1;EML3;CKAP5;CCDC66;GIT1;RAB11FIP5;RCC2;MID2;EZR;CHP1;TRAPPC14;MAPRE3;REEP3;MARK4;NDEL1;RMDN1;HDAC6;TBCD;VBP1;POLB;DIP2B;KIF20B;KATNA1;BIRC5;MAST2;KIF6;KIF1B;CDK5;DLGAP5;APPL1;DCTN1;CCDC61;STMN2;CLIP2;KIF21A;RITA1;CRIPT;SBDS;LRRK2;CDK5RAP2;SETD2;PEX14;CAPN6
prerank,nucleotide diphosphatase activity (GO:0004551),-0.276686126231054,-0.7546767735285234,0.7873134328358209,0.9840477107224954,1.0,5/14,19.18%,ENPP1;NUDT4;CILP;NUDT12;CILP2
prerank,palmitoyltransferase activity (GO:0016409),-0.23275830892410054,-0.7524193347191822,0.8817204301075269,0.979135484617168,1.0,13/28,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.29153017999991343,-0.752082076992895,0.7963636363636364,0.9716889609986548,1.0,4/12,13.22%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,CXCR chemokine receptor binding (GO:0045236),0.3693686117276931,0.751129775477119,0.7994186046511628,0.9450656955246458,1.0,2/11,10.99%,ITCH;YARS1
prerank,ribosomal small subunit binding (GO:0043024),-0.2574373018191371,-0.7509960698140983,0.8054474708171206,0.9653211873995546,1.0,2/17,5.11%,CPEB2;DDX3X
prerank,P-type ion transporter activity (GO:0015662),-0.29056316090335077,-0.750419223025605,0.7712177121771218,0.958536740774754,1.0,2/12,8.71%,ATP2B1;ATP2A3
prerank,cardiolipin binding (GO:1901612),0.36885992832824,0.7484248026836222,0.7659574468085106,0.9463027047621921,1.0,4/10,31.00%,GSDME;UQCC3;STOML2;PLEKHN1
prerank,microtubule binding (GO:0008017),0.2525975077659443,0.7472283202118866,0.9397590361445783,0.9457237904696646,1.0,51/222,22.75%,MAP7D3;FGF13;MAP1B;CFAP157;KIF13A;MID1;RAE1;CLIP4;TUBGCP3;DNM2;SYBU;ALMS1;NDRG1;STIM1;TPGS1;SPAST;MTUS1;MACO1;EML3;CKAP5;CCDC66;RCC2;MID2;EZR;CHP1;MAPRE3;REEP3;MARK4;NDEL1;RMDN1;HDAC6;POLB;KIF20B;KATNA1;BIRC5;MAST2;KIF6;KIF1B;CDK5;DLGAP5;DCTN1;CCDC61;CLIP2;KIF21A;CRIPT;SBDS;LRRK2;CDK5RAP2;CAMSAP3;PEX14;CAPN6
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3435071261477706,0.7449946230914274,0.7956698240866035,0.9464742975408086,1.0,4/15,17.92%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,calcium:sodium antiporter activity (GO:0005432),0.36788515151238244,0.7404102039099024,0.793205317577548,0.9500698612381628,1.0,1/10,1.39%,SLC24A3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3540274330546777,0.7389503817440306,0.778236914600551,0.9498232519113201,1.0,2/12,15.19%,SLC25A25;SLC35B3
prerank,GABA-A receptor activity (GO:0004890),-0.25302683987371855,-0.7379390469828919,0.8407079646017699,0.9678492491745752,1.0,4/18,13.22%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.36718344289586313,0.7373635138505541,0.8070175438596491,0.9496378040680149,1.0,1/10,5.17%,GABRA3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.23340674293591082,-0.7356322068835276,0.863849765258216,0.963419863502382,1.0,5/24,10.34%,RPS14;MYH10;DDX3X;RPL26;RPS7
prerank,glucose transmembrane transporter activity (GO:0005355),0.33212442015168697,0.7348883103241551,0.7949061662198391,0.9507710485863766,1.0,3/17,17.11%,SLC5A2;SLC2A2;SLC2A10
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.3462646500964679,0.7320035857368734,0.8228730822873083,0.9523413784016022,1.0,4/13,15.88%,PIK3C2B;PIP4K2B;PIK3CB;PIP5K1A
prerank,histone acetyltransferase binding (GO:0035035),0.3108367945152504,0.7289145244695802,0.8122605363984674,0.9538144982521215,1.0,7/21,24.30%,BCAS3;MEF2A;SIRT2;CITED2;KANSL1;GLI3;TP53
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.33291263526169745,0.7287334258755758,0.8136054421768707,0.9520268176026374,1.0,2/14,11.54%,NOX4;AIFM1
prerank,alanine transmembrane transporter activity (GO:0022858),0.34810662582562235,0.7285374562049859,0.7949438202247191,0.9502588805450046,1.0,4/12,23.42%,SLC38A3;SLC1A4;SLC3A2;SLC36A1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.28896348469711414,-0.7274469207209553,0.7973421926910299,0.9670199751916979,1.0,3/12,10.51%,CDK6;CDK19;CDK8
prerank,mRNA 3'-UTR binding (GO:0003730),0.26303854509271957,0.7268625563438671,0.8924387646432375,0.9502202083253641,1.0,28/79,29.95%,DDX5;YBX3;PABPC1;PUM1;CRYZ;HNRNPA2B1;ILF3;PCBP4;DAZAP1;AUH;RBM4;HNRNPC;EXOSC4;SECISBP2;CIRBP;FXR2;RNF20;HNRNPU;TP53;RBM24;PABPC4;RPL41;CCT5;FXR1;LARP1;PUM2;ZFP36L1;KHSRP
prerank,protein phosphatase 2A binding (GO:0051721),0.3036127427236275,0.7226789224350598,0.8148614609571788,0.9531035278904305,1.0,3/23,7.41%,GRIN3A;ADCY8;STRN4
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3289564325197238,0.7201025611618009,0.8,0.9540133982221234,1.0,2/15,9.26%,PLA2G4A;SH3PXD2B
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.28572342390802824,0.7182144351277951,0.8335315101070154,0.954189018576183,1.0,4/33,12.60%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,syntaxin-1 binding (GO:0017075),0.3077083372339981,0.714200766858859,0.8329238329238329,0.9566767996038363,1.0,4/22,12.59%,UNC13B;PRRT2;NSF;STXBP5
prerank,pentosyltransferase activity (GO:0016763),0.2778192823959082,0.7140790917156266,0.8573127229488704,0.954860302193919,1.0,7/36,16.22%,PARP3;SIRT5;QPRT;UPP2;TNKS2;SIRT2;PARP1
prerank,retinoic acid receptor binding (GO:0042974),0.32129954307024294,0.7119953663380904,0.825503355704698,0.9551706241339528,1.0,5/17,17.76%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.2524786255040652,-0.709057871426521,0.871244635193133,0.98141044582089,1.0,9/16,28.45%,CD38;MACROD2;SARM1;NEIL1;NEIL3;RPS3;OARD1;NEIL2;MACROD1
prerank,fatty acid synthase activity (GO:0004312),0.3445996369054505,0.7024683633696293,0.832409972299169,0.9634393334308645,1.0,4/10,27.16%,ELOVL5;CBR4;MCAT;ELOVL1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2924020605807037,0.7022933654906978,0.8421052631578947,0.9616564092404308,1.0,6/25,20.17%,PLEKHA4;GAB2;DAPP1;HIP1;AKT1;MAPKAP1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.33989507618290804,0.6981552670698813,0.8371428571428572,0.9642001254111574,1.0,4/10,23.23%,OTUD5;YOD1;DESI2;CYLD
prerank,neuropeptide receptor activity (GO:0008188),0.2820379402032168,0.6958938730171761,0.8448275862068966,0.9646112986463821,1.0,1/29,1.82%,GALR1
prerank,protein phosphatase activator activity (GO:0072542),0.330479857319287,0.6932719126469629,0.8465829846582985,0.9653010549832218,1.0,3/13,16.86%,CALM2;PPP2R5C;CALM3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.32964325131007166,0.6927045284660023,0.8398876404494382,0.9638923877471325,1.0,5/11,27.37%,PPEF2;DUSP19;TCF3;STK38;MAP3K11
prerank,amyloid-beta binding (GO:0001540),0.24698241851010194,0.6906108565290799,0.9278131634819533,0.964066433425031,1.0,10/79,10.65%,LRP1;EPHB2;APBB3;LRPAP1;TGFB2;FZD5;IAPP;CST3;BACE1;COL25A1
prerank,ATP hydrolysis activity (GO:0140603),0.26833643891511505,0.6865988693560926,0.9040284360189573,0.9661458967659923,1.0,10/41,23.29%,CHD1L;VCP;CHD3;MYO1E;ABCB6;VWA8;KIF20B;CLU;ABCD1;ABCB10
prerank,hexosaminidase activity (GO:0015929),-0.2636792582298804,-0.6857718708288836,0.8853046594982079,0.9981032797905196,1.0,3/12,16.10%,CEMIP;CEMIP2;HYAL2
prerank,hormone activity (GO:0005179),0.2579369527813735,0.6849886367133281,0.8992161254199328,0.9657964446008993,1.0,5/54,13.03%,INSL6;EDN3;VIP;AGRP;INHBA
prerank,G protein-coupled receptor activity (GO:0004930),0.22923557796968233,0.6826826733329909,0.9798994974874372,0.9660329960531095,1.0,9/239,2.75%,CMKLR1;PDGFRL;GPR27;GALR1;NPR3;GNRHR;DRD1;FSHR;ADGRL2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2809939324002767,0.6777419739830964,0.8716302952503209,0.9686675789092104,1.0,6/26,22.07%,CHPF2;B3GNT7;B3GNT9;B3GNT6;B4GALNT3;B3GNT2
prerank,FMN binding (GO:0010181),-0.26439851103225737,-0.6770929239943856,0.8626760563380281,0.9987920893316657,1.0,7/11,33.41%,NOS3;NOS1;PNPO;NDOR1;NOS2;POR;HAO1
prerank,proton transmembrane transporter activity (GO:0015078),0.2671378225097852,0.6765755319871926,0.8972188633615478,0.9679026624149151,1.0,5/39,13.39%,SLC4A11;SLC9A1;CLCN4;NNT;ATP6V1B2
prerank,acetylcholine receptor activity (GO:0015464),0.2841102495983192,0.6754778781031533,0.8626943005181347,0.9670285192187537,1.0,2/22,8.43%,CHRNB2;CHRNA5
prerank,translation elongation factor activity (GO:0003746),0.31556166511234773,0.6746508907909751,0.8587412587412587,0.9658629728888402,1.0,5/14,23.98%,EEF1B2;TUFM;EEFSEC;GTPBP2;EIF5A2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.24182075036852368,-0.6696601671451144,0.9133858267716536,0.998394607850442,1.0,1/16,1.69%,PIR
prerank,adenylyltransferase activity (GO:0070566),0.28596967293373604,0.6649694346499553,0.8793532338308457,0.9729208655873459,1.0,9/21,33.10%,TENT4B;ABL1;NMNAT3;NMNAT2;TENT2;SELENOO;NMNAT1;PAPOLG;COASY
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3236872700509349,0.6635263494525717,0.8772189349112426,0.9722279887485693,1.0,8/11,34.35%,PIGF;PTDSS1;PTDSS2;SGMS2;PIGN;GNPTAB;PIGO;SAMD8
prerank,MAP kinase activity (GO:0004707),0.3047212897544608,0.663168818332661,0.8825136612021858,0.9706135068284889,1.0,3/14,11.43%,MAPK15;MAPK8;MAPK12
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.2880809855449244,0.6619639717906416,0.8970588235294118,0.969715338909028,1.0,6/18,25.24%,ANXA2;PAK4;ANXA1;CNN3;BAIAP2L1;S100A11
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2881112427214791,0.6614675848232028,0.8891786179921773,0.9682425983464865,1.0,5/20,17.92%,LPCAT1;GPAT4;PNPLA3;PLA2G15;AGPAT5
prerank,ion channel inhibitor activity (GO:0008200),0.2633122303664927,0.6610830887557072,0.8980582524271845,0.9666882351132057,1.0,3/35,5.05%,NEDD4;CAMK2D;CALM2
prerank,methyl-CpG binding (GO:0008327),-0.21424948350350542,-0.6570107318159578,0.9018691588785047,1.0,1.0,5/22,14.60%,MBD2;CXXC4;TET1;ERH;CXXC5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.27047632421293805,0.6561734385836382,0.9013398294762485,0.9690758837702661,1.0,7/28,27.07%,AGO2;RPP40;ELAC2;RPP14;ENDOV;RPP21;POP5
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2555366524936401,0.6543692415889029,0.9218203033838973,0.9686309056971332,1.0,6/42,14.30%,CCNL2;CCNL1;CCNT2;CCNG2;CCNE2;HEXIM1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.32105555637932465,0.6526835909239072,0.882183908045977,0.9681702876955741,1.0,1/10,5.99%,NOX4
prerank,bHLH transcription factor binding (GO:0043425),0.2853052238221382,0.651870256501864,0.8904458598726115,0.9669693781768169,1.0,5/19,19.79%,TWIST1;BHLHE40;MAP3K10;CREBBP;TCF3
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2771320664409894,0.6482434558405983,0.8894806924101198,0.9681066608461366,1.0,2/21,8.43%,CHRNB2;CHRNA5
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23786510873445457,0.6470204127194793,0.9480088495575221,0.9672580694630347,1.0,7/60,8.99%,PPP1CC;PPP1R3C;PHLPP2;CDC14A;PPM1H;PGAM5;PPM1M
prerank,MAP kinase kinase activity (GO:0004708),-0.23088837514738247,-0.6455794699491457,0.8984375,1.0,1.0,2/15,6.04%,MAP2K6;PAK3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3120051662275091,0.643908742153307,0.8823529411764706,0.9679860397743508,1.0,3/11,21.87%,HNRNPA2B1;RAD50;HNRNPA1
prerank,thioesterase binding (GO:0031996),-0.24976060425965294,-0.640327843304425,0.9172413793103448,1.0,1.0,4/11,22.57%,ADRA2A;CDC42;TRAF2;TRAF1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.30593085693458966,0.6374906222245169,0.8908355795148248,0.9714174703201589,1.0,4/12,24.96%,CASP1;BAD;RPS27L;BCL2L13
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.2949239572527734,0.6359554587108747,0.8955431754874652,0.9707258351645588,1.0,6/14,24.48%,ALDH1L2;MTHFD1;NOXRED1;MTHFR;PYCR1;CRYM
prerank,glycerophospholipid flippase activity (GO:0140333),0.3037593810003071,0.632470098792425,0.9021897810218978,0.9715591110194571,1.0,2/11,9.19%,ATP8B2;ATP8A1
prerank,MHC class I protein binding (GO:0042288),-0.2293445504771472,-0.6284580167927378,0.9316546762589928,1.0,1.0,13/13,77.09%,ATP5F1B;TAP1;CD8B;ATP5F1A;ABCB9;TUBB;PILRA;CD8A;TAPBP;TAP2;LILRB1;TUBB4B;DERL1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.27789132914748627,0.6248209187476159,0.9082687338501292,0.9753802531645711,1.0,8/17,35.47%,AKR1C1;BDH2;SRD5A3;MECR;DECR2;TM7SF2;TECR;BLVRA
prerank,protein phosphatase inhibitor activity (GO:0004864),0.25869505084573235,0.6239582960714443,0.9326805385556916,0.9741346096388169,1.0,10/26,29.28%,PPP1R9B;PPP1R8;CABIN1;ARPP19;SAG;BOD1L1;LMTK2;MGAT5;PPME1;PABIR1
prerank,GABA receptor activity (GO:0016917),-0.2051245689199429,-0.622133589351935,0.9624413145539906,0.9995968345453886,1.0,4/21,13.22%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.29347260324988755,0.6197564436265466,0.8932584269662921,0.9752975027478498,1.0,8/12,36.41%,HDAC1;TBP;FOS;TAF1;H3-3A;RELA;RUVBL2;POU2F1
prerank,chloride channel regulator activity (GO:0017081),0.28260455015026853,0.6147293645391942,0.9162087912087912,0.9768227134560807,1.0,5/14,26.59%,WNK1;STX1A;SGK3;VTI1B;SGK1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2556388745988736,0.613252670436386,0.9371859296482412,0.9759626246501366,1.0,5/25,16.22%,PARP3;SIRT5;TNKS2;SIRT2;PARP1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.19111326330720824,-0.6115315580003098,0.9842105263157894,0.9989760578803906,1.0,9/28,25.93%,STAT1;BABAM2;EDA;TRAP1;MYD88;TRAF2;TRAF1;FADD;FEM1B
prerank,chloride channel inhibitor activity (GO:0019869),-0.23718213020792425,-0.6045685508467922,0.934375,0.9958614185745069,1.0,3/10,14.72%,WNK2;WNK4;CFTR
prerank,microtubule plus-end binding (GO:0051010),0.25823657258100086,0.5987999911618288,0.9308578745198464,0.9832231311271549,1.0,5/20,20.75%,CLIP4;STIM1;MAPRE3;DCTN1;CLIP2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.24443756334875172,0.5944408590938761,0.9489671931956257,0.9840948036764009,1.0,4/29,10.59%,NBR1;CDK5RAP3;NFATC1;ABL1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.28819824977317793,0.593628441334652,0.9231884057971015,0.9826835714968672,1.0,3/10,25.58%,FAAP20;IDE;DAXX
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.27818399626349044,0.5806133726524423,0.9463276836158192,0.9880154750373018,1.0,2/11,22.13%,SLC25A47;SLC22A3
prerank,ribosomal large subunit binding (GO:0043023),0.2810176880113766,0.5798590046109812,0.9442119944211994,0.9865255298515656,1.0,4/11,24.95%,LTN1;EIF6;CPSF6;RBM3
prerank,peptidase activator activity (GO:0016504),0.24903593929154194,0.5770763468408501,0.9509043927648578,0.9860318332577539,1.0,4/22,16.38%,VCP;PCOLCE;TANK;PSMD14
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.1655160794915883,-0.5671815560865692,0.9939393939393939,0.9993002256351081,1.0,33/34,72.68%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.1655160794915883,-0.5671815560865692,0.9939393939393939,0.9993002256351081,1.0,33/34,72.68%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.21207935710698145,-0.5637827756643254,0.9659090909090909,0.9938867319035526,1.0,13/13,78.82%,DNA2;DNASE1L1;EXO1;FEN1;GEN1;DNASE1;DNASE1L3;DICER1;ZGRF1;FAN1;DNASE1L2;SLX4;ENDOV
prerank,microtubule minus-end binding (GO:0051011),0.2567781569618549,0.5502476400602712,0.9514563106796117,0.9964255207724217,1.0,1/13,5.06%,TUBGCP3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.2622767294908272,0.5475419671652141,0.9347826086956522,0.9957552052410072,1.0,1/11,8.41%,DDAH1
prerank,voltage-gated anion channel activity (GO:0008308),0.25098202172287803,0.544359003263312,0.953083109919571,0.9951189454723939,1.0,2/15,11.05%,CLCN4;VDAC2
prerank,C-C chemokine binding (GO:0019957),-0.18053197349256878,-0.5392217618992055,0.9868995633187773,0.9952561952830408,1.0,3/22,12.04%,CCR9;CX3CR1;ZFP36
prerank,phosphate ion binding (GO:0042301),-0.22270038220216776,-0.5360464381968173,0.9684542586750788,0.9895824329956141,1.0,2/10,14.85%,PDE2A;ADSS1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.24802356346216337,0.5283917477773497,0.9623430962343096,0.998704790882174,1.0,3/13,24.15%,GABRA3;GLRB;GABRE
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.19785404872070936,-0.5204782335792474,0.9857142857142858,0.9867610282724475,1.0,6/11,27.11%,NEIL1;NEIL3;RPS3;HMGA2;NEIL2;APEX1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.25041798789447106,0.5072873615764545,0.9739010989010989,1.0,1.0,7/10,41.89%,CASP1;CASP2;CASP6;CASP7;CASP8;CASP12;CFLAR
prerank,RNA methyltransferase activity (GO:0008173),0.21912646524462903,0.5060504642784849,0.9784656796769852,1.0,1.0,6/19,35.08%,TYW3;FBL;METTL8;MEPCE;TGS1;MRM2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.19583617614989968,0.4784264979981644,0.9878640776699029,1.0,1.0,11/28,30.96%,SBK2;AKT1;MAP2K3;PRKACA;MAP2K7;LRRK2;RPS6KA2;RPS6KB1;SGK1;MAP2K4;MAP2K5
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.22316408065571391,0.4766282303834383,0.9853917662682603,1.0,1.0,4/14,24.96%,CASP1;BAD;RPS27L;BCL2L13
prerank,neuropeptide binding (GO:0042923),0.18542489257922318,0.42537942904695775,0.9961636828644501,1.0,1.0,4/18,31.91%,MC4R;NMUR1;GPR37;SSTR2
prerank,5'-3' exonuclease activity (GO:0008409),0.19415023358335054,0.41841805335263244,0.9917355371900827,1.0,1.0,7/14,36.82%,DCLRE1B;XRN1;DXO;CPSF3;FAN1;MRE11;EXOG
prerank,C-C chemokine receptor activity (GO:0016493),0.17648978501271517,0.4114956021961753,1.0,1.0,1.0,4/21,26.08%,ACKR4;CXCR4;ACKR3;CCRL2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.20153241348912665,0.40200860505200264,0.9955686853766618,1.0,1.0,2/10,23.44%,HEXIM1;KAT2B
prerank,death receptor binding (GO:0005123),0.17976536065680318,0.3881385280077906,0.995945945945946,1.0,1.0,3/15,26.25%,MADD;BID;RIPK1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.1768635176713366,0.36185294602719914,0.9972565157750343,1.0,1.0,7/11,41.89%,CASP1;CASP2;CASP6;CASP7;CASP8;CASP12;CFLAR
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.17200554975242513,0.3498243205997049,0.9985207100591716,1.0,1.0,4/10,36.23%,DCLRE1B;POLD1;MGME1;TATDN1
prerank,MHC protein binding (GO:0042287),0.1422187799102609,0.325992026642844,1.0,0.9999004061617802,1.0,5/20,34.30%,LAG3;DERL1;TUBB4B;LILRB1;TAP2
